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QUILL ON SCALPEL This section
provides a medium through which Canadian 
surgeons can declare themselves, briefly and in­
formally, on the day-to-day affairs of surgery.
ARE T-TUBES REALLY NECESSARY?
In “Quill on Scalpel” in the July 1971 
issue, J. C. Osborne described three pa­
tients who had developed bile peritonitis 
after removal of T-tubes from the common 
bile duct. His experience has prompted 
the question in my title and these com­
ments.
The question implies two other questions: 
(1) should a common bile duct be drained 
after it is explored, and (2) if drained, 
should it be by a T-tube? I do not intend 
to discuss the first question. Most surgeons 
agree that, after exploration, the duct 
should be drained, both as a precaution 
against temporary obstruction at the am­
pulla of Vater and to provide an oppor­
tunity for a postoperative cholangiogram.
But, why a T-tube? Certain advantages 
seem obvious. A free passage for bile is 
provided, and the cross-bar of the T  gives 
some stability in the duct. If circumstances 
make it necessary, the tube can be left in 
place for a long time. There was a time 
when surgeons believed that splinting a 
healing wound in a duct assisted healing; 
most now accept that a foreign body in 
contact delays healing.
Against these possible advantages, there 
are some disadvantages. In the days when 
it was part of my job to remove T-tubes, 
I was always horrified by what I thought 
I was doing to that fragile but vital duct. 
Pulling the tube out often required a sur­
prising amount of force. One could picture 
the duct, perhaps somewhat unsupported 
after the operative dissection, containing a 
little sutured incision and, at 10 or 12 days, 
in one of the weakest stages of healing; 
then the pull comes on, the tube stretches, 
the cross-bar buckles and, suddenly, the 
tube tears its way out of the duct.
More and more over the years, surgeons 
have come to realize that adequate drain­
age can be provided by a small calibre 
tube and various maneuvers have been 
used to make extraction less violent: the 
arms have been cut short, a notch has been 
cut opposite the stem, or the cross-bar has 
been sliced open. Even so, the fact remains 
that to emerge, the cross-bar must buckle, 
and requires a hole at least twice as large 
as the one occupied by the stem. Some 
violence must be done, but in the great 
majority of patients we get away with it.
There is an alternative. One of my old 
chiefs, the late Norman Shenstone, did not 
like T-tubes. He also appreciated that a 
very small tube could provide sufficient 
drainage. After the exploration he intro­
duced a straight tube, which was distinctly 
smaller than the duct, with an open end 
directed towards the liver, and extending 
about one inch beyond the edge of the in­
cision. The defect in the wall was repaired 
and, as the last stitch was placed, a stabi­
lizing loop was passed around the tube and 
tied. Suitable slack was allowed and a 
further stitch fastened the tube to the skin. 
A postoperative cholangiogram could be 
done in the usual way. When the time 
came to remove the tube, it could easily 
be slipped out all the way, or just enough 
to free it from the duct, and then left for 
a further day or two as a precaution 
against leakage.
Having used this technique many times 
myself, I can attest that it is both simple 
and satisfactory.
F. G. Kerc.in
KNEE-LIGAMENT INJURIES
With the current emphasis on fitness and 
athletic activity, an increasing number of 
“week-end athletes” are engaging in sports 
such as skiing, snowmobiling, rugger, 
soccer and touch football, each of which
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carries a significant risk of knee injury. 
Add these usually ill-conditioned amateurs 
to the large numbers of well-conditioned 
athletes in organized sport who are ex­
posed to violent trauma, and it is no sur­
prise that the incidence of major disrup­
tions of knee ligaments is increasing at an 
alarming rate.
Despite the fact that knee-ligament in­
juries are now commonplace, physicians 
and surgeons know surprisingly little about 
their diagnosis and treatment, and in many 
undergraduate and postgraduate institu­
tions teaching concerning the recognition 
and management of these acute injuries is 
inadequate. Most of the current literature 
is devoted to a variety of methods of re­
pair for chronically unstable knees and the 
large number of patients described in some 
of these series suggests that the recognition 
or initial treatment of the acute injury was 
unsatisfactory.
While reviewing major knee-ligament 
injuries in the Wellesley Hospital, Toronto, 
the most striking finding was that the 
seriousness of the problem was unrecog­
nized by the initial examiner in virtually 
every case. Invariably radiographs were 
made but these do not reveal the extent 
of the soft-tissue trauma.
Is it important to recognize a serious 
knee-ligament disruption? The amount of
Fig. 1.—Laxity of the medial collateral liga­
ment eight weeks after a severe rugger injury.
Fig. 2.—Laxity of the lateral collateral ligament 
eight months after the patient was struck by a 
car.
instability shown in two knees, eight weeks 
(Fig. I )  and eight months (Fig. 2) after 
injury, illustrates that these ligaments do 
not heal themselves effectively without 
adequate initial treatment. I would empha­
size that such errors in diagnosis are not 
confined to small emergency departments 
or country hospitals. The patient whose 
knee is shown in Fig. 3 was sent home 
from our emergency department with un­
recognized tears of the following struc­
tures: lateral collateral ligaments, postero­
lateral joint capsule, popliteus tendon, ilio­
tibial band, biceps femoris tendon, lateral 
meniscus and both the anterior and 
posterior cruciate ligaments! Fortunately, 
he was reassessed 10 days later by a knowl­
edgeable medical student. The seriousness 
of his injury was recognized, the structures 
were repaired and a good stable knee re­
sulted. There should be no doubt, how­
ever, that inadequate initial treatment leads 
to a poor result which, at best, may limit 
an athlete’s performance and, at worst, may 
finish his career and produce permanent 
disability.
How is a serious knee injury recognized? 
As in any medical or surgical condition, 
by taking an adequate history. If the pa-
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Fig. 3.—Marked instability of the lateral side of the knee 10 days after a rugger injury.
tient has significant trauma and is unable 
to continue his activity, be highly sus­
picious of a major ligament disruption. 
Physical examination may be misleading, 
because muscle spasm may mask gross in­
stability. If the history is one of immedi­
ate disability and the physical examination 
equivocal, examine the patient under gen­
eral anesthesia and obtain a stress radio­
graph of the knee; only in this way can 
you assess the injury accurately. An 
arthrogram, which may be combined with 
this examination, gives further information 
about the type of ligament tear and the 
state of the menisci.
Is a serious knee injury best treated 
by operative repair or plaster immobiliza­tion? There are many vociferous propon­ents of both approaches. My experience 
suggests that pure collateral-ligament tears treated for eight weeks in a long-leg 
plaster with the knee flexed at 90° heal with minimal residual laxity. On the other 
hand, treatment in a simple plaster cylinder 
with the knee extended seldom restores 
stability to a severely injured knee. If bony 
fragments are avulsed or cruciate liga­
ments torn, careful operative repair ap­
pears to give the best results.
Can an athlete continue to perform on 
an unstable knee after acute injury and 
have a repair at the end of the season? 
This approach fnay be advocated by 
coaches, managers and avid sports fans, 
but it is not in the athlete’s best interests. 
The time to deal with a major knee-liga­
ment injury is when it occurs; delayed 
repair will never give as satisfactory a re­
sult as proper initial treatment.
What is desperately needed is a set of 
guidelines to determine what is, indeed, the best treatment of an acutely injured 
knee. A controlled objective measurement of laxity at the time of injury followed by 
an identical assessment at regular inter­
vals up to three years after treatment is 
essential to establish such guidelines. Hope­
fully, this will place the diagnosis and 
treatment of knee-ligament injuries on the 
firm scientific basis expected of twentieth century medicine.
D. E. H astin g s
The Wellesley Hospital,Toronto, Ont.
This editorial is based on an address given at the Grey Cup Symposium, Canadian Academy of Sports Medicine, Toronto, Ont., November 27, 1970.
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R E V I E W  A R T I C L E S
THE GASTROINTESTINAL HORMONES
JOHN DUPRE, M.A., M.R.C.P., Montreal, Que.
R ec en t  advances in protein chemistry and 
in assays for peptide hormones have 
yielded much new information on the en­
docrinology of the gastrointestinal tract. 
Some of the findings do not fit easily into 
classical descriptions of the physiology of 
gastrointestinal hormones. Because much 
of this new knowledge will shed light on 
common disease processes, it is useful to 
review the subject and to consider its 
possible applications to clinical medicine.
The gastrointestinal hormones were 
identified during the search for the physio­
logic stimuli that regulate the exocrine 
secretions of the gut. The well-character­
ized members of the group were recog­
nized as activities in extracts of gastro­
intestinal mucosa: secretin as a stimulus 
to increased output of bicarbonate-rich 
pancreatic exocrine secretion, 1 gastrin as a 
stimulus to gastric-acid secretion,2 ’ 3 and 
pancreozymin as a stimulus to pancreatic 
enzyme secretion.4 Although the nervous 
system may modify both the release and 
the effects of these agents, they can prob­
ably act independently of the nervous 
system, because in each case their endo­
genous release leads to the expected re­
sponse even in denervated target glands.5 
Analogous mechanisms stimulate gall­
bladder contraction when fat enters the 
small intestine, 6 and inhibit gastric-acid 
secretion when acid enters the small in­
testine; 7 the names cholecystokinin and 
enterogastrone have been given to these 
putative hormones. In the expectation that 
a specific humoral agent would be found 
to regulate each of the exocrine secretions, 
the control of production of duodenal and 
small intestinal succus entericus was at­
tributed to hormones dubbed “duocrinin” 
and “enterocrinin”. In addition, when 
secretin was discovered it was already
“Associate Professor, Department of Medicine, 
McGill University; Director, Fraser Laboratory 
for Research in Diabetes, Royal Victoria Hospital, 
Montreal, Que.
known that the pancreas affects carbo­
hydrate metabolism by producing a hypo­
glycemic agent, and some speculated that 
this function might also be controlled by 
an intestinal hormone. Evidence was ob­
tained of the existence of such an agent8 
and it was named “incretin”. However, 
interest in this question waned when other 
workers could not confirm the findings 
upon which the conclusion was based, 9 and 
found evidence that blood glucose levels 
could regulate pancreatic endocrine func­
tion.10’ 11
Until recently, progress in the study of 
gastrointestinal hormones was hampered 
by the impurity of preparations derived 
from extracts of intestinal mucosa. More­
over, the classical techniques of extirpation 
and replacement treatment, used to study 
the physiology of the discrete endocrine 
glands, could not be applied readily to 
these problems. Nevertheless all accepted 
the physiologic importance of an array of 
intestinal hormones which might co-oper­
ate with the nervous system in regulating 
digestive function. Recent studies using 
protein chemistry and radioimmunoassays 
for peptide hormones have answered some 
of these questions and have posed new 
ones. With the preparation of highly puri­
fied or synthetic hormones, further exam­
ination of the pharmacology of these agents 
has revealed the remarkably wide and 
overlapping ranges of their actions. Several 
workers have used assays capable of 
estimating peptide hormones in biologic 
fluids to examine their functions more 
directly. Others have searched for the ana­
tomical sources of these hormones using 
optical and electron microscopy. As a re­
sult we can now investigate a number of 
disease states which involve abnormalities 
of humoral secretions of the intestine. This 
review will describe briefly the chemistry, 
pharmacology, and physiology of the 
identified gastrointestinal hormones. It will 
also examine evidence concerning the ana­
tomical sources of these hormones, consider
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studies of their pathophysiology in human 
disease, and interpret observations based 
on classical and modern techniques, show­
ing that both are necessary in this field.
T he C hem istry  and  Pharmacology 
of Secretin, G astrin, and 
Pancreozym in
Secretin
Secretin is assayed in terms of its 
capacity to stimulate secretion of bicarbon­
ate-rich pancreatic secretion. This activity 
was isolated from extracts of porcine duo­
denojejunal mucosa:12 its structure has 
been determined and its synthesis 
achieved.13’ 14 Secretin contains 27 amino
Structurally, secretin and glucagon are 
similar: 14 of the amino-acid residues oc­
cur at corresponding loci in each (Table 
I ). These similarities may underlie the 
effects that the two hormones have in 
common, such as their insulinotrophic21’ 28 
and choleretic actions,16’ 27 and may also 
explain their ability to inhibit each other; 
e.g. glucagon depresses secretin-stimulated 
exocrine secretion.28
Gastrin
The gastrins were the first gastroin­
testinal hormones to be identified structur­
ally and the first to be synthesized. Two 
gastrins, assayed in terms of their ability 
to stimulate gastric-acid secretion, were
TABLE I.—St r u c t u r a l  Sim il a r it ie s  of Se c r e t in  and G l u c a g o n *
Secretin His. Ser. Asp. Gly. Thr. Phe. Thr. Ser. Glu. Leu. Ser. Arg. Leu. Arg. Asp.
Ser. Ala. Arg. Leu. Gin. Arg. Leu. Leu. Gin. Gly. Leu. Val.-■n h 2
Glucagon His. Ser. Gin. Gly. Thr. Phe. Thr. Ser. Asp. Tyr. Ser. Lys. Tyr. Leu. Asp.
Ser. Arg. Arg. Ala. Gin. Asp. Phe. Val. Gin. Try. Leu. Met, Asn. Thr.
‘ Fourteen loci with corresponding residues are underlined.
acids in an open chain. When the biologic 
activity of synthetic partial secretin pep­
tides was examined, no potent subunit was 
identified, and even the hexacosapeptide 
(2-27) showed very little activity.15 In 
addition to its actions on pancreatic exo­
crine function, secretin stimulates produc­
tion of bile and increases bicarbonate out­
put by the liver.18 In the dog, it also stimu­
lates the secretion of pepsin17 and of duo­
denal succus entericus.18 Gastrin-stimulated 
gastric-acid secretion is inhibited in the 
dog19 and in man.20 In addition to these 
effects on external secretions, exogenous 
secretin stimulates the release of insulin 
from the pancreas in man and in the 
dog.21’ 22 This hormone also has a lipolytic 
effect on adipose tissue in vitro.23 Secretin 
can inhibit gastric motility,24 and can in­
crease pancreatic blood flow.25 All these 
experiments were done with porcine secre­
tin and, while there is considerable varia­
tion in the sensitivity of different species 
to the several effects of the hormone, we 
have no information as yet concerning 
possible species variation of the hormone 
itself.
isolated from extracts of porcine pyloric 
mucosa29 and two analogous peptides were 
later derived from human antral mucosa.30 
The agents prepared in this way, hepta- 
decapeptide amides, occur in each species 
in two forms, which differ only in that they 
are non-sulfated or sulfated at the tyrosyl 
residue adjacent to the C-terminal penta- 
peptide; these variants are designated 
gastrin I and gastrin II respectively. The 
biologic activities of gastrins I and II are 
closely similar. A variety of abbreviated 
synthetic analogues retain the biologic 
activity of the total peptide, which resides 
in the C-terminal tetrapeptide and is 
virtually abolished when the terminal 
amide group is removed.31 A synthetic 
pentapeptide with gastrin activity has been 
used widely in pharmacologic and clinical 
studies.32
In addition to stimulating gastric-acid 
secretion, gastrin evokes secretion of pep­
sin33 and intrinsic factor34 by the stomach. 
It has a weak secretin-like effect and a 
powerful pancreozymin-like effect on the 
exocrine pancreas.35 The outflow of bile is 
stimulated.30 Administration of the hor-
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mone can increase the rhythmic motor 
activity of the stomach33 but may also 
delay gastric emptying.37 In some species, 
but not in man, high doses of gastrin in­
hibit gastric-acid secretion.38 With regard 
to possible effects of gastrin on pancreatic 
endocrine function, the evidence is con­
flicting; intravenous injection of bolus doses 
of gastrin may stimulate secretion of in­
sulin in vivo,22 but an insulinotrophic effect 
is not demonstrable in vitro 39 Gastrin may 
act as a direct humoral stimulus to release 
secretin,40 a finding that must be taken 
into account when interpreting the effect 
of exogenous gastrin on pancreatic func­
tion in vivo.
mones, the two activities kept company, 
and we now know that both reside in the 
same peptide.45 In several recent accounts, 
this hormone has been called pancreo- 
zymin-cholecystokinin but, in this review, 
it will be referred to as “pancreozymin” .
As isolated from porcine duodenojejunal 
mucosa, pancreozymin is a single-chain 
peptide with 33 amino-acid residues 
(Table II). The C-terminal pentapeptide 
is identical with that of the gastrins, and 
the adjacent residue is tyrosyl, sulfated as 
in gastrin II.48 Studies with various partial 
peptides showed that, on a molar basis, the 
C-terminal octapeptide with a sulfated 
tyrosyl residue has cholecystokinin activity
T A B L E  I I .— G a s t r in , P a n c r e o zy m in -C h o l e c y st o k in in , an d  C a e r u l e in *
Glu. Gly. Pro. Try. Leu. Glu(5). Ala. Tyr. (So,H)
Gly. Try. Met. Asp. Phe-NH2
Glu. Gin. Asp. Tyr.(Sn3H) Thr. Gly. Try. Met. Asp. Phe-NH2
Lys. (Ala1, Gly2, Pro1, Ser2) Arg. Val. (Isoleu1, M et1, Ser1) Lys. Asp.
(Asx1, Glx1, His1, Leu2, Pro1, Ser2) Arg. Isoleu. Ser. Asp. Arg. 
Asp. Tyr.(So3H) Met. Gly. Try. Met. Asp. Phe-NIL
*Octapeptide (single-underlined) has cholecystokinin activity; pentapeptide (double-underlined) has 
gastrin activity.
Human gastrin II
Caerulein
Porcine
panereozymin-
cholecystokinin
Before the heptadecapeptide gastrins 
were identified, evidence suggested that 
biologic gastrin-like activity may be asso­
ciated with a molecule that is larger than 
these purified peptides.41 Recently, the 
immunoassay for gastrin-like materials has 
demonstrated a large-molecular-weight im- 
munoreactive gastrin present, in addition 
to “small” gastrin, both in the blood42 and 
in extracts of gastrointestinal tissues.43 
Preliminary evidence suggests that these 
two immunoreactive gastrins have similar 
biologic activities.43 Thus, the heptadeca­
peptide amides may not be the only 
physiologically important gastrins.
Pancreozymin
Pancreozymin, recognized and assayed 
as a stimulus to the external secretion of 
pancreatic enzymes, was isolated from ex­
tracts of porcine duodenojejunal mucosa.44 
Cholecystokinin, assayed in terms of 
stimulation of contraction of gallbladder 
muscle, was present in similar extracts. In 
the progressive purification of these hor-
greater than that of the total peptide, and 
the corresponding non-sulfated octapeptide 
has greatly diminished cholecystokinetic 
activity.47 However, since the sulfated and 
non-sulfated gastrins do not differ in their 
cholecystokinin potency, it is apparent that 
this biologic activity is not simply related 
to the presence or absence of sulfate at the 
tyrosyl residue.
In addition to its effects on pancreatic 
enzyme secretion and its cholecystokinetic 
action, pancreozymin can stimulate gastric- 
acid secretion in some species,48 and can 
stimulate secretion of duodenal succus 
entericus.49 Pancreozymin can also act as 
a competitive inhibitor of gastrin-stimu­
lated gastric-acid secretion.50 The hormone 
inhibits gastric motility but increases duo­
denal motility and relaxes the sphincter of 
Oddi.45 Exogenous pancreozymin is a 
potent stimulus to insulin secretion in 
man51 and in the dog,22 and can stimulate 
glucagon secretion in the dog22 and prob­
ably in man.51 As we know with secretin, 
there are species variations in responses
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to pancreozymin, but there is no informa­
tion about possible species variations of 
the hormone itself.
Caerulein, another naturally occurring 
polypeptide with pharmacologic and struc­
tural similarities to pancreozymin and 
gastrin, was recently identified in extracts 
of the skin of the Australian frog, Hyla 
caerulea52 (Table II). This agent, a de- 
capeptide, has powerful pancreozymin and 
cholecystokinetic activities; the C-terminal 
pentapeptide is identical with that of pan­
creozymin and the gastrins, and it has an 
adjacent tyrosyl residue. Caerulein stimu­
lates gastric-acid secretion in the fasting 
state, but can act as a competitive inhibitor 
of gastrin-stimulated acid secretion, 53 a 
property also exhibited by pancreozymin. 54 
These findings have stimulated the search 
for synthetic competitive inhibitors of acid 
secretion with negligible gastrin-like ac­
tivity-agents that might be useful in the 
management of clinical conditions associ­
ated with gastric hypersecretion.
Concerning the species variations that 
have been encountered in the responses to 
the pure peptides, Grossman54 suggested 
that structural similarities between secre­
tin and glucagon, on the one hand, and be­
tween the gastrins and pancreozymin, on 
the other, may explain synergistic or in­
hibitory interactions within each of these 
pairs, and that the secretin-like pair and 
gastrin-like pair may act at separate re­
ceptor sites on target cells. However, there 
are interactions between the pairs, which 
may be direct or indirect, and it remains 
to be seen whether the two-receptor hypo­
thesis will stand up to detailed examina­
tion. In this context, the pancreatic hor­
mone glucagon can be regarded as a 
gastrointestinal hormone because onto- 
genetically the endocrine cells of the pan­
creas are related to those of the intestine. 
The demonstration of so-called entero- 
glucagons in intestinal tissues, and of 
gastrin-like and secretin-like agents in pan­
creatic tumours, which will be considered 
later, may further illustrate this relation­
ship. Track55 has discussed the evolutionary 
significance of these relationships.
Thus, their pharmacologic effects sug­
gest that the intestinal hormones so far
identified might provide the humoral com­
ponent of physiologic regulation of gastric, 
pancreatic, and duodenojejunal secretions. 
Whether this proves to be so must depend 
on later descriptions of their actions in 
physiologic conditions, and on the dis­
covery of the factors that control their 
secretion.
Sig n if ic a n c e  of R espo n ses  o f  T a r g et
E x o c r in e  G lands in  Stu d ies  o f
E f fe c t s  o f  H o r m o n es
Evidence of Endogenous Secretion
of Hormones
The classical descriptions of the control 
of secretion of these hormones are largely 
based on indirect evidence obtained in 
studies of the responses of target glands 
in vivo:' Thus, secretion of gastrin can be 
inferred from effects on the denervated 
fundus, and such evidence suggests that 
vagal activity, antral distension, and eleva­
tion of gastric mucosal pH evoke release 
of the hormone. From the responses of the 
target glands, it seems that gastrin secre­
tion is inhibited by a feedback mechanism 
called into play by acidification of the duo­
denal mucosa or by the arrival of certain 
nutrients there, and also by a direct in­
hibitory action of acid at the antral 
mucosa. In the dog, the late intestinal 
phase of gastric-acid secretion resists in­
hibition by acidification of the antral 
mucosa; 88 in this phase, humoral gastrin­
like activity may be secreted by the small 
intestine. Wang and Grossman57 used the 
same approach to study secretin and pan­
creozymin secretion. The most powerful 
stimulus to secretin release appears to be 
acidification of the duodenal mucosa, and 
protein hydrolysates appear to be the most 
potent stimulus to pancreozymin-like 
effects on pancreatic exocrine secretions. 
No one has yet identified inhibitory feed­
back mechanisms originating in the gut 
and affecting the secretion of hormones 
that regulate pancreatic exocrine function, 
but the interaction of these hormones with 
the control mechanisms regulating pancre­
atic endocrine function, which will be 
described later, may provide such a feed­
back. In the case of pancreozymin, this 
interaction may be important in interrupt-
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ing the stimulus to continued release of the 
hormone, which would be provided by the 
delivery of protein in the form of pan­
creatic enzymes secreted in response to this 
hormone.
Studies of this kind have demonstrated 
that a variety of stimuli can produce effects 
supposedly due to the identified hormones, 
under more or less artificial conditions. 
These studies have been designed as far as 
possible to isolate the mechanism under 
investigation from other possible stimuli. 
Evaluation of the multiple potential 
stimuli which must be considered in 
physiologic conditions, presents a problem 
of great complexity. Interactions among 
identified stimuli have been studied largely 
by examining the effects of exogenous 
hormones, administered in various com­
binations, sometimes in conjunction with 
pharmacologic or surgical interference with 
the autonomic nervous system. However, 
it is obvious that such experiments cannot 
be interpreted unless we know the physio­
logically appropriate dosage of the hor­
mones.
Effects of Exogenous Hormones
Until recently, in studies with gastro­
intestinal hormones it has been necessary 
to assume that doses that evoke responses 
in the physiologic range are themselves 
physiologic. However, this presupposes 
that the test agent is equivalent to the 
endogenous hormone. Thus, in attempts to 
relate effects of an exogenous agent to 
those of the endogenous hormone, we can 
place greater reliance on the pattern of 
effects produced by the test substance than 
upon its ability to evoke a selected re­
sponse. A lack of correspondence between 
these patterns suggests either that the endo­
genous hormone in physiologic conditions 
exerts effects that depend upon interactions 
with other mechanisms or that the native 
agent differs from the endogenous one. This 
is illustrated by studies of the mechanism 
whereby stimulation of the small intestine 
inhibits gastric-acid secretion. Delivery of 
acid or fat into the small intestine inhibits 
acid secretion in man, and this effect is 
attributed to the release of enterogastrone. 
The same stimuli appear to cause the re­
lease of secretin and pancreozymin, as 
judged by their effects on the exocrine 
pancreas, and both these hormones can 
inhibit gastrin-stimulated gastric-acid secre­
tion. The stimuli that evoke the release of 
native enterogastrone inhibit both gastrin- 
stimulated and histamine-stimulated acid 
secretion, but secretin and pancreozymin 
have relatively little effect on the response 
to histamine. These and other findings 
suggest that physiologic enterogastrone 
activity may depend on an agent or agents 
not yet identified. The physiologic entero­
gastrone may be represented by a peptide 
recently isolated from extracts of porcine 
duodenojejunal mucosa. This agent is 
chemically distinct from secretin and pan­
creozymin, and has been shown to inhibit 
both histamine and gastrin-stimulated acid 
secretion by the canine stomach.58
In teractions B et w e en  C ontrol 
Mech a n ism s in  t h e  R egulatio n  
of E xocrine S ecretio n s
Combinations of the known gastro­
intestinal hormones show powerful synerg­
istic actions under certain conditions; e.g. 
the stimulatory effect of secretin on bi­
carbonate output by the pancreas can be 
greatly potentiated by concurrent admin­
istration of pancreozymin.59 Such effects 
show that the response of target organs 
cannot safely be interpreted in terms of a 
single hormonal stimulus. In studies of 
humoral regulatory systems, we need a 
more direct approach and, at present, this 
is offered by assays for the individual hor­
mones in the blood. In interpreting the re­
sults of such studies, it is important to 
take account not only of interactions be­
tween hormones but also of the role of 
the nervous system. Thus, the autonomic 
nervous system may affect the activity of 
target glands directly, and also indirectly, 
by modifying their sensitivity to humoral 
stimuli.
Interactions Between Gastrointestinal 
Hormones and the Autonomic Nervous 
System in Regulation of Exocrine 
Secretions: Gastric Secretions
The response to sham feeding and its 
abolition by vagotomy5 suggested a vagally
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mediated cephalic phase of gastric-acid 
secretion. This phase is associated with 
the release of gastrin, which potentiates 
the effect of vagal stimulation on acid 
production. Thus, in dogs, subthreshold 
doses of gastrin increase acid secretion in 
response to feeding after surgical removal 
of the gastrin-secreting area of the stom­
ach.80 Such observations suggest that a 
pathologic increase in acid secretion could 
be produced by nervous or humoral mech­
anisms or both, or by intrinsic overactivity 
of parietal cells. More direct studies of 
gastrin secretion by assays for this hor­
mone may clarify the picture, but the re­
sults of such studies in man are conflict­
ing. These observations will be discussed 
later in relation to the immunoassay tech­
nique and the pathophysiology of peptic 
ulceration.
Interactions With the Nervous System:
Pancreatic Secretions
Although vagal stimulation affects pan­
creatic secretion, the physiologic import­
ance of direct vagal activity and its pos­
sible influence on responses to humoral 
stimuli have been difficult to assess. Recent 
studies in the dog assumed that selective 
gastric vagotomy abolished the release of 
secretin by preventing gastric-acid secre­
tion and it was observed that this pro­
cedure did not reduce the volume of pan­
creatic secretion during the first 30 minutes 
after feeding.61 The authors concluded that 
there is an important direct vagal contribu­
tion to the early phase of pancreatic secre­
tion during a meal. However, although the 
volume of pancreatic secretion after feed­
ing increased in spite of selective vag­
otomy, the pancreatic exocrine response in 
terms of bicarbonate output was strikingly 
diminished. This suggests that the stimula­
tion of bicarbonate production was 
abolished when secretin release was pre­
vented, while the preservation of an in­
creased volume of pancreatic secretion 
suggests that this response may be under 
nervous control. Electrical stimulation of 
the vagus nerve shows that it can exert 
direct effects on the pancreas. Stimulation 
of the nerve in the dog at an intensity that 
by itself has no effect on exocrine secretion
can make the pancreas respond to sub­
threshold doses of secretin or pancreo­
zymin.62 Experiments of this kind strongly 
suggest that there is an interaction between 
the nervous system and the humoral 
mechanisms regulating pancreatic exocrine 
secretion, and that an intact autonomic 
nervous system is necessary for physiologic 
responses. However, as in analogous 
studies of gastric secretion, these experi­
ments cannot distinguish direct effects of 
the humoral stimulus on secretion from 
effects on the sensitivity of the target 
organs to other stimuli.
Assays fo r  G a str o in testin a l
H o r m o n es  in  th e  B lood
It is apparent from the overlapping 
pharmacologic effects of purified peptides 
derived from the gastrointestinal tract, and 
from structural similarities among them, 
that we cannot assume specific biologic or 
immunologic properties for agents detected 
in the blood. However, assays capable of 
measuring such activities in blood would 
be extremely valuable in studying the 
functions of gastrointestinal hormones.
Bioassays
Bioassays for hormones affecting gastro­
intestinal exocrine secretions do not con­
sistently detect activity in unprocessed 
serum or plasma. Circulating gastrin- and 
secretin-like activities have been detected 
in the blood from patients with tumours 
associated with abnormal exocrine secre­
tions.66 In spite of defects in sensitivity and 
specificity, with further refinement bio­
assays may prove increasingly valuable in 
the elucidation of clinical syndromes asso­
ciated with very high levels of humoral 
activity in the blood.
Radioimmunoassays for
Gastrointestinal Hormones
Since Berson and Yallow applied the 
principle of competitive binding to the 
radioimmunoassay for insulin, analogous 
systems have been developed for many 
peptide hormones. Antibodies have been 
raised to gastrin, secretin, and pancreo­
zymin; radioiodinated preparations of
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these hormones have been used as “tracers” 
in immunoassay systems. We can now de­
tect agents in the blood that compete with 
standard preparations of the hormones for 
binding to antibody, and these endogenous 
agents have been quantitated in terms of 
the purified standards. We must recognize 
that antibodies may cross-react with ma­
terial other than that used as the antigen. 
An assay may detect more than one variant 
of the antigenic hormone, as in the case of 
insulin and proinsulin; 64 it may detect 
degradation products of the hormone, as 
in the case of ACTH.65 Cross-reactions 
must depend on structural similarities 
among the materials detected and may ex­
tend to agents of unknown biologic signifi­
cance.
Radioimmunoassays for Gastrin
In these assays, antibodies raised to pre­
parations of porcine gastrin of various 
degrees of purity, to synthetic human 
gastrin, or to pentagastrin, have been used 
with iodinated porcine or human gastrins 
as tracers. These antisera may cross-react 
with pancreozymin, presumably because of 
the pentapeptide common to the two hor­
mones, but, with selected antisera, the 
cross-reaction with pancreozymin may be 
sufficiently weak to permit specific estima­
tion of gastrin in the presence of physio­
logic concentrations of the other hormones. 
These assays have been used mainly in 
human studies, and here we can discuss 
the findings in pathophysiologic states and 
those obtained in normal subjects.
Normal subjects and patients with peptic 
ulceration have detectable levels of im- 
munoreactive gastrin in the blood after 
fasting overnight. Assays using crude por­
cine gastrin antiserum, 86 or antipenta- 
gastrin serum, 67 have demonstrated fasting 
hypergastrinemia in patients with duodenal 
ulcers. With these assays, similar patients 
showed exaggerated serum gastrin re­
sponses after ingestion of protein. How­
ever, assays using antibodies to synthetic 
human gastrin yielded normal values in 
patients with duodenal ulcers.68 It is pos­
sible that these differences arise because 
antibodies to mixed gastrins from crude 
mucosal extracts or to the common gastrin
pentapeptide detect a variety of gastrin­
like agents,69’ 70 only one of which is 
recognized by the synthetic human gastrin 
antibody. In studies of the role of the 
nervous system in the regulation of gastrin 
secretion, there have been discrepancies 
among the results obtained with the differ­
ent systems. The assay using antiserum to 
pentagastrin showed that, in normal sub­
jects, atropine inhibits gastrin secretion 
after feeding; that fasting gastrin levels are 
reduced after vagotomy in patients with 
duodenal ulcers; and that gastrin is 
elevated during hypoglycemia induced by 
insulin. Indeed preliminary studies with 
antipentagastrin serum suggest that reduc­
tion of fasting gastrin levels after vago­
tomy correlates with reduction of gastric- 
acid secretion in response to hypoglycemia, 
and that failure of vagotomy to depress the 
gastrin response to hypoglycemia may help 
the surgeon to recognize those patients 
who are liable to recurrent ulceration. 
However, these effects of medical or surgi­
cal vagotomy and of hypoglycemia on 
blood gastrin levels detected with anti­
pentagastrin serum were not duplicated 
with assays using antisera to synthetic 
human gastrin or to crude porcine 
gastrin.71 ’ 72 Instead, assays using the 
latter two types of antibodies have shown 
exaggerated increments of serum gastrin 
after ingestion of food, both after admin­
istration of atropine and after vagotomy.
In view of the well-known variability of 
individual antisera raised to the same anti­
gen, the reproducibility of findings with 
these three types of antiserum in the 
different gastrin immunoassays must be 
confirmed. If the reactions are consistent, 
the different antisera may be useful in 
differentiating the several hypothetical 
gastrins. At present, the results with the 
antipentagastrin serum suggest that hyper­
acidity depends on hypersecretion of 
gastrin; this hypersecretion, in turn, may 
depend on vagal activity and might indeed 
be due to primary vagal overactivity. Even 
the maintenance of normal levels of gastrin 
in the blood of patients with hyperacidity 
suggests inappropriate release of the hor­
mone, because its secretion should be in­
hibited by the local feedback mechanism.73
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In attempts to reconcile the conflicting re­
sults, the possible importance of humoral 
gastrin-like agents derived from the in­
testine must be considered, especially since 
the intestinal phase of gastric-acid secre­
tion may resist inhibition by acidification 
of the antral mucosa,56 and since there is 
evidence that vagal effects on exocrine 
functions distal to the stomach may resist 
atropine. In addition, although attention 
has been focused on the role of gastrins, 
the conflicting results obtained with assays 
for this hormone suggest that circulating 
inhibitors of the effects of gastrin (entero- 
gastrones) may be equally important in the 
physiologic or pathophysiologic control of 
acid secretion.
In two well-defined conditions, the re­
sults of the various immunoassays for 
gastrin have agreed. The great majority of 
subjects with pernicious anemia have very 
high levels of gastrin in the blood in the 
fasting state.7 4 , 75 In some of these indi­
viduals the fasting levels of serum gastrin 
have been lower, but such subjects may 
have gastritis involving the gastrin-produc­
ing cells of the antrum. Mean fasting levels 
of immunoreactive gastrin rise with in­
creasing age, but this trend disappears 
when subjects with impaired acid secre­
tion are eliminated. 76 In subjects with per­
nicious anemia, acidification of the gastric 
mucosa rapidly reduces serum gastrin 
levels.75 These findings suggest that, in this 
disease, hypersecretion of gastrin depends 
on loss of feedback inhibition as a conse­
quence of failure of the target parietal cells 
to produce acid.
In the Zollinger-Ellison syndrome, im­
munoassays for gastrin-like agents in the 
blood also yield abnormally high levels of 
activity in the fasting state. In these pa­
tients, tumour extracts contain activity that 
is biologically77 and immunologically78 in­
distinguishable from synthetic human 
gastrin. Elevated immunoreactive gastrin 
in the blood of these patients presumably 
represents autonomous secretion by the 
tumours. Such a finding is valuable diag­
nostically: in the great majority of these 
cases gastrin blood levels fall in a range 
that is otherwise attained only in achlor­
hydric subjects, with whom they should
not be confused. However, although very 
high levels of gastrin in the blood have 
characterized the patients with hyper­
acidity associated with gastrin-producing 
tumours so far reported, the differentiation 
of these patients from those with the com­
mon variety of peptic ulcer disease may 
prove to be less clear cut, as patients with 
less classical forms of the Zollinger-Ellison 
syndrome are investigated. It is important 
also to consider the possibility that high 
rates of gastrin secretion might occur in 
the absence of gastrin-producing tumours 
following interruption of the inhibitory 
feedback effect of acid on the antral 
mucosa as a consequence of previous surgi­
cal intervention. In this situation, the sur­
geon could be led to a false diagnosis of 
the Zollinger-Ellison syndrome. Should this 
problem arise it would be useful to de­
termine the gastrin content of antral biopsy 
material, which might be very low in the 
presence of a gastrin-secreting tumour.
Radioimmunoassay for Secretin
Young, Lazarus and Chisholm76 have de­
scribed a radioimmunoassay capable of 
estimating secretin-like materials in peri­
pheral blood from human subjects, and in 
tests with other gastrointestinal hormones 
they demonstrated no cross-reactions. In 
normal subjects, ingestion of food or 
acidification of the duodenum produced 
the expected elevation of serum secretin­
like immunoreactivity, and this immuno- 
reactivity rose very rapidly after the admin­
istration of gastrin. This response probably 
does not depend on the effect of gastrin- 
stimulated acid secretion on the release of 
secretin but may reflect a direct secretin­
releasing action of gastrin itself: 40 it was 
not abolished by aspirating stomach con­
tents or by neutralizing gastric acid with 
bicarbonate, and was preserved in one of 
two achlorhydric subjects.
The chief application of this assay for 
secretin has been in studies of the role of 
the hormone in response to glucose ad­
ministration in man. These studies suggest 
that secretin is a physiologic regulator of 
insulin secretion. Serum secretin-like im­
munoreactivity is substantially, though 
briefly, elevated after glucose ingestion,40
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or after infusion of glucose into the small 
intestine.80 The latter finding conflicts with 
the classical evidence suggesting that 
carbohydrate does not stimulate the re­
lease of secretin. 5 7 ' 81 However, in the 
classical studies, conditions may not have 
favoured a demonstrable exocrine response; 
in any case, we cannot assume that release 
of secretin in quantities that do not evoke 
a pancreatic exocrine response has no 
physiologic significance. So far, the most 
striking feature of radioimmunoassay 
studies of secretin has been the continuous 
inverse relationship between serum insulin 
and serum secretin in man. In normal man, 
insulin seems to exert an inhibitory feed­
back effect on the release of secretin: the 
elevated fasting serum-secretin levels in 
untreated diabetes mellitus, and low 
serum-secretin levels after insulin in normal 
or diabetic subjects apparently represent 
modifications of this feedback. When im­
munoassays for secretin are applied to 
exocrine aspects of disorders such as de­
structive disease of the pancreas, their 
interpretation will be complicated by these 
endocrine interrelationships. Thus, in dis­
orders of metabolism, the concentration of 
this hormone in the blood will probably 
not be a reliable guide to the functional 
capacity of the exocrine pancreas.
Radioimmunoassay for Pancreozymin
Antibodies raised to pancreozymin may 
be expected to cross-react with gastrin be­
cause the two molecules have a common 
pentapeptide, but the reaction between 
selected antisera and gastrin may be weak 
enough to permit their use in assays for 
pancreozymin in the blood. Such an assay 
has been used to demonstrate increments 
in pancreozymin in blood after the inges­
tion of protein or fatty meals, 82 and after 
the ingestion of very large doses of glucose. 
Since pancreozymin may have a physio-1 
logic role in the regulation of pancreatic 
endocrine secretion,22' 83 we shall prob­
ably encounter interactions similar to those 
described for secretin. These would com­
plicate the interpretation of assays for 
pancreozymin in studies of diseases of the 
exocrine pancreas.
Radioreceptor Assays
Recently, a number of workers have 
studied the binding of radioactive hor­
mones to the membranes of target cells. 
This approach may lead to the develop­
ment of assays that use the biologic 
properties of target tissues to provide 
specific binding agents which may have ad­
vantages over the antibodies used in ana­
logous radioimmunoassay systems.
A n a to m ic a l  S ources of
G a str o in testin a l  H ormones
Numerous cells in the gastrointestinal 
mucosa have morphologic features that 
suggest endocrine secretory activity. Re­
cently, these cells have been examined in 
detail by light microscopy and by electron 
microscopy, and classified with special em­
phasis on staining characteristics and on 
the properties of the secretory granules. 
There is now more than one classification 
of these cells,84' 85 and a recent conference 
attempted to accommodate the classifica­
tions to a single convention,86 which will 
be followed here. An electron-microscopic 
study of human specimens distinguished 
four types of endocrine cells in the stomach 
and three in the intestine. Only in the 
gastrin-producing cells has a cell been 
identified with its endocrine function.87’ 88
Gastrin or “G” cells constitute a group 
that are morphologically recognizable, are 
concentrated in the mid-third of the glands 
of the antrum where extractable gastrin is 
also concentrated, and can be shown to 
contain immunoreactive gastrin-like ma­
terial by immunofluorescence techniques. 
Although the first observations with the 
immunofluorescence technique used anti­
bodies that would cross-react with pan­
creozymin, the findings have since been 
confirmed with a highly specific antiserum 
to synthetic gastrin.89 We have some in­
formation regarding these cells in various 
pathologic states: 90 ' 91 in patients with 
duodenal ulceration they are very numer­
ous and poorly granulated; in patients with 
carcinoma of the stomach the G cells are 
large and fully granulated. The immuno­
fluorescence technique has also demon­
strated apparent hyperplasia of G cells in 
subjects with hypersecretion of acid in the
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range associated with duodenal ulceration. 
Although the immunofluorescence was not 
quantitated, it seemed to be more intense 
and more widely distributed in these pa­
tients. In subjects with pernicious anemia, 
G-cell hyperplasia has been inferred from 
the distribution of immunofluorescence, 
which, however, was of low intensity. 
These studies were done using antiserum 
to synthetic human gastrin. Their inter­
pretation, in terms of the production and 
release of hormone by the cells, is compli­
cated both by the problems encountered 
with immunoassays for gastrin already dis­
cussed and by the fact that such studies 
give a static picture of the cells, which 
does not necessarily indicate their func­
tional state.
In addition to the G cells, electron- 
microscopic examination has defined three 
further types of cells in the stomach: the 
enterochromaffin cell, or “EC” cell; the “B” 
cell, with distinctive granules; and the 
“E C L” cell, which resembles superficially 
the pancreatic beta cell.
In the human duodenal mucosa, the 
most easily recognized cell is the EC cell, 
which, in this location, has larger granules 
than the antral EC cells. In the duo­
denum, the most numerous endocrine cell 
is a large granulated cell, labelled the “L” 
cell, and a third duodenal endocrine cell 
with small granules recognized on electron 
microscopy has been labelled the “S” cell. 
The L cell, which resembles the pancreatic 
glucagon-secreting cell, may be the source 
of enteric glucagon-like material, and the 
other cell types may be the sources of 
secretin and of pancreozymin. In man, at 
present, there is no information regarding 
the appearance of the endocrine cells of 
the small intestine in pathologic states. We 
have not yet been able to correlate the 
classifications of endocrine cells character­
ized by light microscopy and various stain­
ing techniques with the classifications 
based on electron-microscopic findings, 
even in identifying the cells that contain 
immunoreactive gastrin-like material.92 
Further, although substantial quantities of 
immunoreactive gastrin can be extracted 
from the mucosa of the upper small in­
testine in man, a G-like cell has not been 
recognized in this tissue.
At the present time, when we attribute 
functions on the basis of cellular morpho­
logy and distribution alone we are merely 
speculating. In view of the potential cross­
reactivity of antibodies raised to identified 
hormones, even studies with the immuno­
fluorescence technique are equivocal. How­
ever, we can expect soon to obtain more 
detailed information on the morphology of 
the intestinal endocrine cells, and correla­
tion of this with functional states will be 
the next step.
F u rther  Studies o f  G a s t r o in t e st in a l  
E ndo crin e  F u n c tio n  in  P a th o lo g ic  
States in  M an
Endocrine Responses in Patients 
With Steatorrhea
In patients with the non-tropical sprue 
syndrome, the pancreatic exocrine response 
to exogenous pancreozymin is apparently 
normal. Infusion of essential amino acids 
into the duodenum provides a potent 
stimulus to pancreozymin-like effects on 
pancreatic secretion and on the gall­
bladder.93 Di Magno, Go and Summer- 
skill94 used these responses as a guide to 
pancreozymin secretion in patients with 
sprue: gallbladder responses to duodenal 
amino-acid infusions were diminished, and 
they attributed this to defective secretion 
of pancreozymin. Thus, disorders of biliary 
and pancreatic function may arise as a re­
sult of diseases affecting the production of 
intestinal hormones.
Forell95 has suggested that bile salts 
have a direct or indirect pancreozymin-like 
effect on the exocrine pancreas. It remains 
to be seen whether this is an important 
factor regulating pancreozymin secretion or 
modifying the effects of this hormone.
Gastrointestinal Hormones in Syndromes 
Associated With Abnormal Exocrine 
Secretions and Tumours of 
Intestinal Origin
Hormones secreted by tumours of the 
gastrointestinal tract have pathophysiologic 
importance in at least two clinical condi­
tions—the Zollinger-Ellison syndrome and 
the syndrome of watery diarrhea without 
hyperacidity. The former, which was dis-
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cussed in relation to application of assays 
for gastrin to extracts of tissues and to 
peripheral blood of Zollinger-Ellison pa­
tients, resolves when the adenoma is re­
moved. However, in many patients, the 
tumour is malignant and cannot be re­
moved completely. Some of these patients 
improve rapidly after gastrectomy, and 
their survival may be unexpectedly pro­
longed.96 While this may occur because 
the tumours are relatively benign, in 
several instances the neoplastic tissue ob­
jectively regressed. Indeed, it was this ob­
servation that led to the hypothesis that 
the growth of the tumour depends on a 
humoral factor of gastric origin.97 Alterna­
tively, continued secretion of excessive 
quantities of acid may release trophic 
agents from the small intestine; this too 
would be prevented by gastrectomy. There 
is evidence that small intestinal hormones 
can have trophic effects on pancreatic 
tissues; for example, crude extracts of in­
testinal mucosa can induce hyperplastic 
changes in the islets of the cat.98 Thus, 
gastric support of tumour growth in the 
Zollinger-Ellison syndrome might be medi­
ated by humoral secretions derived from 
the small intestine or from the stomach.
A second clinical syndrome, probably de­
pendent on autonomous secretion of 
humoral agents from neoplastic gastro­
intestinal tissues, consists of copious diar­
rhea with disturbance of extracellular fluid 
composition and gastric-acid hyposecre- 
tion." In this syndrome, tumours usually 
arise in the pancreas and commonly meta­
stasize. The combination of excessive in­
testinal exocrine secretion with diminished 
gastric-acid secretion suggested that the 
syndrome might be caused by overproduc­
tion of a secretin-like agent. In support of 
this suggestion, it has been shown that 
extracts of tumour tissues contain secretin­
like biologic activity. 100 In some of these 
patients, secretin-like activity has been de­
tected in the peripheral blood by bio­
assays.83 Both diarrhea and depression of 
gastric-acid secretion may be relieved by 
removing tumour tissue. However, as noted 
earlier, bioassays for secretin-like activity 
are not specific and, in man or in the dog, 
secretin in large doses does not produce 
diarrhea. Thus, at present, the circulating
agent in this syndrome remains to be 
identified.
These tumours may release humoral 
agents that differ from those present in 
normal gastrointestinal endocrine cells, and 
such activity may represent atavistic or 
distorted peptide synthesis by neoplastic 
tissue. It is not easy to explain why the 
tumours show such a marked predeliction 
for the pancreas, not only when they 
secrete hormones resembling insulin or 
glucagon but also when their products re­
semble hormones normally released by 
endocrine cells in the intestine. However, 
gastrin-like material has been identified by 
immunofluorescence in the islet cells from 
normal pancreas, and these cells may be 
the source of gastrin activity in tumours.92 
Likewise, the pancreatic islets may contain 
cells that can produce secretin and pan­
creozymin, and humoral agents with 
trophic actions may favour the develop­
ment of the tumours within the pancreas. 
We may soon recognize more precisely de­
fined clinical syndromes attributable to 
effects of hormones resembling physiologic 
endocrine secretions of the gut and pan­
creas.
Gastrointestinal H ormones and
Pancreatic E ndocrine Function
Secretin or pancreozymin can release 
insulin from the pancreas, and pancreo­
zymin can also release pancreatic gluca­
gon.22 We have increasing evidence that 
regulation of the endocrine pancreas by 
gastrointestinal hormones is physiologically 
and pathophysiologically important. For 
example, glucose absorbed from the gastro­
intestinal tract is disposed of more effi­
ciently than glucose delivered parenter- 
ally102' 103 and this is not due simply to 
hepatic uptake of glucose from the portal 
blood. 1 0 4 ,103 After glucose ingestion blood 
levels of immunoreactive insulin106- 107 or 
insulin-like activity108 are higher than 
levels attained after intravenous glucose 
infusion in man. These observations re­
vived the idea that the intestine might 
mediate the stimulation of insulin secretion 
during absorption of nutrients. Now that 
we know that secretin,20 pancreozymin, 21 
or glucagon26 can stimulate insulin release,
November 1971 GASTROINTESTINAL HORMONES 369
and that biologic109 and immunoreactive110 
glucagon-like materials can be derived 
from the intestine, these agents become 
candidates for roles in mediating intestinal 
effects of pancreatic endocrine function. 
As noted earlier, studies with the immuno­
assay for secretin suggest that this hor­
mone contributes to stimulation of insulin 
secretion when man ingests glucose. The 
role of intestinal glucagon is not clear; this 
material is composed of at least two differ­
ent agents and both are immunochemically 
distinguishable from pancreatic gluca­
gon. 111 While it seems that a component 
of intestinal glucagon can stimulate insulin 
secretion, the amounts released in response 
to glucose ingestion probably cannot pro­
duce this effect. 112 With respect to pan­
creozymin, available evidence does not 
suggest that the intake of physiologic 
amounts of glucose leads to secretion of 
this hormone, 113 but pancreozymin is cer­
tainly released in response to mixed meals. 
The most potent stimulus to pancreozymin 
secretion appears to be protein intake. 
When protein alone is ingested, this hor­
mone may be an important stimulus to 
insulin secretion, and its stimulation of 
pancreatic glucagon release may help to 
maintain blood glucose concentration in the 
face of increased insulin secretion.20
The effects of extracts of intestinal tissues 
on insulin release from slices of pancreas 
or from isolated pancreatic islets39 suggest 
that the identified hormones can cause 
insulin release by direct action on the 
pancreas; 114 however, these studies also 
suggest that intestinal tissues may contain 
other unidentified agents with similar 
activity.115 While an unidentified hormone 
may contribute to the intestine’s action on 
the endocrine pancreas, probably secretin 
has the major effect in man. As pointed 
out earlier, secretin probably takes part 
in continuous interactions with other hor­
mones affecting intermediary metabolism, 
and the acute responses to ingestion of 
food are superimposed upon these. Ab­
normalities of the endocrine function of 
the gut may be present in disorders of 
metabolism, such as diabetes mellitus, 116 
in which there are no obvious defects in 
digestive function. It seems likely that we 
will recognize further interactions between
the intestinal endocrine system and other 
endocrine mechanisms affecting metabolism 
and homeostasis. Finally, interactions of in­
testinal endocrine secretions with the nerv­
ous system in regulation of other functions 
will probably prove to be physiologically 
important, for example, the inhibition by 
atropine of the insulin response to glucose 
absorbed from the gut—an effect not seen 
with parenteral administration of glu­
cose. 101
C on clusion
The availability of pure preparations of 
humoral agents derived from the gastro­
intestinal tract has led us to recognize the 
broad and overlapping ranges of their 
actions. The effects of agents so far 
identified appear to cover the range of 
actions attributed to endogenous hormones. 
However, within this range, there may be 
many unrecognized hormones with im­
portant physiologic activities. Our experi­
ence with immunoassay systems developed 
with the identified agents suggests that the 
endogenous hormones may be present as 
variants of the purified peptides derived 
from extracts. Interactions with the nervous 
system and among the hormones may 
affect both the secretion and the effects 
of these agents. The regulatory functions 
of the intestinal hormones are apparently 
integrated into physiologic systems, which 
affect the disposal and the metabolism of 
nutrients as well as their digestion and ab­
sorption.
In spite of these complexities, recent 
technical developments promise to further 
our understanding of important patho­
physiologic mechanisms in gastrointestinal 
diseases affecting exocrine secretions, in 
clinical syndromes associated with en­
docrine tumours of gastrointestinal origin, 
and in disorders of metabolism with 
primary or secondary abnormalities of the 
gastrointestinal endocrine system.
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R e s u m e
Depuis quelques annees, des preparations pures, 
composees de substances humorales, et extraites 
du tube digestif, sont maintenant disponibles. On 
a determine l’ordre naturel de l’acide amine lequel 
est present dans les gastrines de diverses especes, 
dans la secretine porcine et dans la pancreozymine-
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eholecystokinine; puis on a etudie la pharmacologie 
de ces hormones. Grace a ces etudes, on a de- 
couvert l’etendue et le double emploi des effets 
propres aux hormones reconnues du systeme 
gastrointestinal. Par suite d’etudes physiologiques 
et erudites, on constate que leurs effets semblent 
etre analogues a ceux des hormones endogenes. 
Cependant, compte tenu de leurs actions a double 
emploi, il est fort possible qu’il existe des hor­
mones actuellement non identifiees dont les 
actions physiologiques sont d’une grande im­
portance. Notre experience avec les systemes 
d’essais immunologiques et congus pour les hor­
mones reconnues nous montre aussi que les hor­
mones endogenes peuvent etre presentes sous 
forme de variantes des peptides depures et de­
rives des extraits tissulaires. Les possibilites de 
telle hormone ainsi que des interactions des hor­
mones reconnues du systeme gastro-intestinal, 
dont on soupgonne la presence depuis longtemps, 
avec le systeme nerveux restent a etre reconnues. 
De plus, il est a remarquer que les hormones 
gastro-intestinales lesquelles reglent les secretions
d’exocrine dans le tube digestif sont integrees a 
des systemes physiologiques lesquels reglent les 
secretions internes du pancreas, et possiblement de 
d’autres glandes endocrines. Ces hormones affec- 
tent done l’elimination et le metabolisme des sub­
stances nutritives ainsi que leur digestion et leur 
absorption. Par consequent, il apparait que des ano­
malies metaboliques peuvent etre repetees dans des 
aberrations de la secretion emise par les hormones 
gastro-intestinales. Cependant, de telles deviations 
ne peuvent etre interpretees uniquement en rap­
port avec des anomalies des fonctions digestives 
de l’intestin.
Malgre ces complexicites, de nouvelles de- 
eouvertes scientifiques nous aideront a appro- 
fondir nos connaissances ayant trait aux me- 
canismes pathophysiologiques de grande imoor- 
tance dont on retrouve dans les syndromes clini- 
ques et associes aux tumeurs des glandes endo­
crines, d’origine gastro-intestinale, et dans des 
troubles metaboliques demontrant des anomalies, 
d’importance primaire ou secondaire, dans le 
systeme endocrinien du tube digestif.
MANAGEMENT OF ACUTE UPPER ALIMENTARY BLEED IN G 0
W. C. WATSON, M.D., Ph.D., F .R .C .P .(G las.),t London, Ont.
When a patient presents with acute upper 
alimentary bleeding, the questions to be 
answered are:
(1 ) Is he still bleeding?
(2 ) Why is he bleeding?
(3 ) Where is he bleeding?
(4 ) How much has he bled?
(5 ) Is he likely to bleed again?
(6 ) What needs to be done now?
(7 ) What may need to be done in the 
near future?
Questions 1 to 5 concern the diagnosis and 
current assessment of the patient. Ques­
tions 6 and 7 relate to treatment.
Diagnosis
Diagnosis is the best prelude to treat­
ment and this applies as much to acute
“From the Gastrointestinal Unit, Department of 
Medicine, Victoria Hospital, University of Western 
Ontario, London, Ont.
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alimentary bleeding as to any other condi­
tion. Occasionally, management may have 
to proceed in the absence of a firm diag­
nosis, but early diagnosis and specific 
treatment of a precise source of hemor­
rhage are life-saving1 and many unneces­
sary operations are avoided by an early 
precise diagnosis.2
The key steps in the diagnosis are the 
history, clinical examination, observations 
of gastric aspiration, endoscopy, radiology 
and, in a proportion of cases, exploratory 
laparotomy with or without gastrotomy.
The history may be obtained from the 
patient or relatives. It is diagnostically and 
prognostically important to establish 
whether bleeding has been solely as hema- 
temesis, as melena, or the two combined. 
In a recent large series of over 2000 pa­
tients,3 mortality was related to the type of 
bleeding as follows: hematemesis only— 
12%, hematemesis and melena—9.4% , 
melena only—5.4%. These figures reflect 
the fact that hematemesis alone is more 
often associated with rebleeding4 and that
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hematemesis as such is more directly asso­
ciated with bleeding from esophageal 
varices and gastric ulcer, the two condi­
tions that bear the highest mortality.
The nature of a hematemesis is helpful. 
Bright red blood welling effortlessly out 
of the mouth usually indicates bleeding 
from esophageal varices, whereas the 
vomiting of small amounts of “coffee 
grounds” or altered blood suggests duo­
denal bleeding, or less severe gastric bleed­
ing. If patients are alert enough to estimate 
the volume of blood lost by hematemesis, 
about one-half will be accurate to within 
0.2 l.5 On the other hand, if the patients 
have been drinking alcohol they are likely 
to overestimate the volume lost, often by 
large amounts.
A history of dyspepsia associated with 
a known organic lesion may give a direct 
clue to the diagnosis, but, according to 
Palmer,0 this may be misleading in as many 
as 40% of patients, in whom the bleeding 
will be due to another lesion. A similar 
degree of error was also reported by Mailer 
et al.7 A common example of this kind of 
confusion is the patient with a known duo­
denal or gastric ulcer who takes an aspirin- 
containing analgesic for the relief of pain 
and bleeds from salicylate-induced ero­
sions. McCray et al.8 described a series 
of 27 patients with known varices who 
presented with acute bleeding. Only five 
(18.5% ) were found to be bleeding from 
the varices. The causes in the remainder 
were gastric erosions (16), duodenal ulcer 
(two), gastric ulcer (tw o), unknown 
( two).
A history of recent or current drug in­
gestion is essential. The main drugs to be 
asked about are aspirin, alcohol, anti­
coagulants, phenylbutazone and steroids. 
Since the report by Muir and Cossar,9 
many papers have testified to the role of 
aspirin in the causation of alimentary 
bleeding. However, the incidence of the 
association varies in the different series and 
with the diligence and pertinacity with 
which the history is taken. Specific trade 
brands should be asked about by name. 
Common examples are Alka-Seltzer, 
Bromo-Seltzer, Anacin, Instantine, Frosst 
tablets, and Darvon ( compound tablets). It
is not generally known that the “seltzers”, 
drugs widely advertised for upset stomach 
(which must include a great deal of ulcer 
dyspepsia or alcoholic gastritis), contain 
aspirin. Also, many patients who have 
peptic ulcer are not specifically advised by 
their doctors to avoid aspirin-containing 
drugs. This is a failure of preventive medi­
cine. Many elderly people take aspirin on 
retiring as a kind of hypnotic or sedative, 
and this timing of aspirin ingestion seems 
particularly prone to induce bleeding. The 
damaging effect of aspirin on gastric 
mucosa is well established, even in normal 
individuals.10’ 11
A history of a bleeding tendency, easy 
bruising, nose bleeds or a family history 
of bleeding, may reveal a predisposing 
cause for alimentary bleeding. Curiously, 
hemophilia is rarely encountered in the 
patient with acute intestinal bleeding.
The clinical examination contributes to 
the diagnosis and hemodynamic assess­
ment of the patient. Spider nevi, palmar 
erythema, hepatosplenomegaly and ascites 
indicate cirrhosis, portal hypertension and 
bleeding varices. A caput medusae and 
hemorrhoids reinforce this suspicion. Jaun­
dice may be due to cirrhosis but, if due 
to other causes, it may indicate hypo- 
prothrombinemia secondary to poor ab­
sorption of vitamin K. Angiomas and tel­
angiectatic lesions of the nose, lips and 
mouth suggest Rendu-Osler-Weber disease, 
and larger blue rubber-bleb nevi suggest 
Bean’s syndrome. Pigmentation of the lips 
and mucocutaneous junction may reveal 
the Peutz-Jeghers syndrome, and paper- 
thin scars or inelastic skin, the Ehlers- 
Danlos syndrome. These disorders are 
interesting, but rare, and constitute a small 
proportion of the large series of gastro­
intestinal bleeds.
Pulse rate and blood pressure contribute 
to the assessment of the hemodynamic 
status of the patient. Pulse rate may bear 
a poor relationship to the amount of blood 
lost5 because it is affected by excitement, 
alcohol, anxiety and other medications. On 
the other hand, blood pressure on admis­
sion is a valuable sign which correlates 
well with blood loss and prognosis. Schiller, 
Truelove and Williams3 found that when
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the admission blood pressure was equal 
to or above 100 mm. Hg, the mortality rate 
was 8%, when it was between 80 and 99 
mm. Hg, it was 17%, and when it was 
below 80 mm. Hg, the rate was 33%.
Laboratory Investigations
The essential data are the hemoglobin 
level, hematocrit, leukocyte count, platelet 
count, prothrombin index and partial 
thromboplastin time. The blood urea nitro­
gen is a clue to underlying renal disease, 
and the serum proteins, bilirubin, alkaline 
phosphatase and transaminase levels con­
tribute to the assessment of liver disease.
tained. Then, if the Ewald tube has been 
used, it should be replaced by a Levin 
tube. Thereafter, intermittent or continu­
ous suction is used to monitor for bleeding. 
Occasionally, even with a wide-bore tube, 
blood clot will block the tube and prevent 
adequate aspiration. There is a general 
belief, unproven, that cold-water lavage 
contributes to hemostasis. There is no 
opinion that it does harm.
Special Investigations
Since 1952 Palmer6,12 has been the chief 
advocate of the “vigorous diagnostic ap­
proach” to alimentary bleeding. He and
TABLE I.— I ncid en ce  of C a u se s  of U p p e k  G a st r o in t est in a l  B l e ed in g  C o m pa rin g  C o n s e r v a t iv e  
I n v estig a tio n 3, 16,17 W it h  t h e  V igorous D iagn ostic  Approach .6, 13,16 
F ig u r e s  a r e  P er c en t a g e s
Reference no. 3 16 17 6 13 16
Diagnosis:
Duodenal ulcer............... ........  29.0 36
Gastric ulcer................... ........  15.1 14
Gastritis/erosions.......... ....... ... 4
Hiatus hernia........................... ... 4
Varices........................................  2 .4 2
Gastric carcinoma.......... ........  2 .2 3
Miscellaneous................... ........  25.2 3
No diagnosis..................... ........  26.2 34
Electrocardiogram
Electrocardiography should be per-
formed in all patients admitted following 
acute upper alimentary bleeding, especially 
in those over 50 years of age. Myocardial 
infarction is a well-established complica­
tion especially when blood loss is severe.
Gastric aspiration is a simple, valuable, 
but often-neglected step in the manage­
ment of the bleeding patient. A practical 
problem is whether to use a wide-bore 
Ewald tube or a Levin tube at the first 
intubation. A helpful rule is to use the 
Levin tube when melena is the main symp­
tom or when hematemesis has been mild 
or as “coffee grounds”. On the other hand, 
when hematemesis has been severe and has 
occurred within a few hours, the larger 
tube should be used. Whichever tube is 
used, the first objective is to wash out the 
stomach with cold, even ice-cold, tap 
water. Amounts of one to two gallons are 
appropriate. Aspiration should be by hand 
suction or by siphon, and should continue 
until a clear or blood-tinged return is ob-
35.0 27.7 19.3 18
16.5 12.6 10.0 18
— 20.2 20.0 32
2 .4 — 2 .0 4
2.7 18.7 18.7 2
2 .7 — 2 .0 4
15.1 13.7 6 .2 8
25.6 7 .0 18.7 14
others1,7*13-15 have shown that the early 
use of endoscopy and radiology increases 
the accuracy of diagnosis and confidence 
in the management of the patient. It has 
also increased our awareness of the wide 
range of lesions that can cause bleeding. 
Lesions such as gastritis and the Mallory- 
Weiss syndrome, which are radiologically 
negative, figure more prominently in series 
including early endoscopy in the diagnostic 
work-up. Table I compares the incidence 
of diagnoses in three series from the era of 
conservative investigation, with three series 
from the era of the vigorous diagnostic ap­
proach. The former have a very small to 
no incidence of erosions or gastritis and a 
high incidence of “no diagnosis”, whereas 
the latter have a high incidence of gastritis 
and erosions and a smaller incidence of 
“no diagnosis”.
It is a matter of opinion whether endos­
copy or radiology should be performed 
first. Often the order is dictated by factors 
other than preference. One reason for per­
forming endoscopy first is that barium can
376 THE CANADIAN JOURNAL O F SURGERY Vol. 14
spoil the view for up to 12 hours. Another 
is that, although the radiologist may 
demonstrate a lesion, there is no certainty 
that this is the bleeding lesion. Although 
the endoscopist’s view is confined to the 
esophagus and stomach (the duodenoscope 
has extended this) it may be obvious that 
bleeding is duodenal or jejunal if fresh 
blood is seen regurgitating through the 
pylorus or a stoma. If a duodenal ulcer 
is then shown radiologically, it is almost 
certain that it is the site of bleeding. Simi­
lar observations apply to esophageal 
varices.
Endoscopy
Flexible fiberoptic endoscopes are suffi­
ciently well established to require no ex­
planation or justification. In terms of safety 
and viewing capacity they are now the only 
acceptable instruments for upper alimen­
tary endoscopy. The well-known American 
and Japanese models have individual modi­
fications, but most are satisfactory except 
perhaps in relation to the ease and ac­
curacy with which biopsies may be taken.
The examination may be carried out in 
the patient’s own bed or in a special room. 
Palmer uses no sedation or premedication. 
We adhere to the same routine as for elec­
tive endoscopy, namely, 1.2 mg. atropine 
is injected intramuscularly 30 to 60 minutes 
beforehand and diazepam 10 mg. (Valium) 
intravenously before the instrumentation; 
the throat is sprayed with Lignocaine 
(lidocaine). The atropine may be omitted 
in the interests of urgency. The examina­
tion may be carried out with a Levin tube 
in position.
The following information is sought. 
Whether there is fresh or altered blood 
in the stomach; fresh blood is evidence of 
active bleeding. Whether there is a definite 
lesion—erosion, ulcer, neoplasm, angioma. 
Whether such a lesion is the source of the 
bleeding or not. Whether bleeding is oc­
curring outside the stomach—duodenum, 
jejunum, or esophagus. Tlius, the endo­
scopic diagnosis may be direct or infer­
ential. It may be complete or incomplete 
and require radiologic simplification.
Those who have written about endos­
copy stress that in their hands it has not
caused rebleeding.6- 7- 13 This is our own 
view. There is even the possibility that the 
total management procedure associated 
with endoscopy diminishes the incidence 
of bleeding. The total incidence of rebleed­
ing in Mailer’s series7 was 15%, whereas 
in a non-endoscopic study18 it was 32%.
Radiology
This should be carried out in the radi­
ology department. It is seldom that a pa­
tient cannot be brought to a sufficiently 
stable hemodynamic state to permit radi­
ology. Barium sulfate is the preferred radio­
paque medium. The value and safety of 
early radiology are well established.19-21
Recently, selective angiography of the 
celiac axis or superior mesenteric artery 
has been employed when the site of bleed­
ing remains obscure. It may either demon­
strate a site of active bleeding, or it may 
reveal a lesion, such as a hemangioma or 
tumour, which it is reasonable to regard 
as a likely source of previous bleeding. 
Baum et al.,22 who pioneered the tech­
nique, demonstrated experimentally that 
active bleeding could be visualized only if 
the rate of bleeding was greater than 0.5 
ml./min. With subsequent experience of 
the method,23 Baum demonstrated the 
bleeding lesion in 18 of 21 patients. Reuter 
and Bookstein24 had success in 11 of 16 
acute “bleeders” and in nine of 13 with 
chronic recurrent bleeding. In an enlarged 
series25 they demonstrated a lesion in 25 
of 45 acute “bleeders”. These authors 
recommend that when a patient with a 
history of recurrent undiagnosed upper 
gastrointestinal bleeding is admitted with 
an acute “bleed”, angiography should be 
the first investigation. In 31 patients so in­
vestigated there was a high incidence of 
unusual and arcane lesions such as arterio­
venous malformations, hemangiomas and 
aneurysms.
Measurement of Blood Loss
When a patient is seen soon after an 
acute “bleed”, the amount of blood loss 
correlates poorly with pulse rate and hemo­
globin level5- 7 but correlates well with 
central venous pressure (CVP) and blood 
pressure.26'28 Direct measurement of blood
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volume using 12BI-labelled albumin and an 
automatic blood-volume computer facili­
tates the recognition of those who, while 
they give a history of serious bleeding, 
have normal hemoglobin levels and have 
not bled significantly. This can avoid un­
necessary admission. Many of such pa­
tients have been drinking heavily and have 
confused the colour of spirit or cheap wine 
with blood.5 More positively, accurate 
assessment of blood loss increases, the ac­
curacy of transfusion orders.
Measurement of central venous pressure 
(right atrial pressure) is more generally 
practicable, and if the manometer is ac­
curately set up and maintained, it pro­
vides a valuable monitor of the bleeding 
state of the patient and of his transfusion 
requirements.
Andersen27 used the CVP as a primary 
indication for operation, even in the ab­
sence of a diagnosis. A patient qualified 
for operation on the grounds of major 
arterial hemorrhage if (1) there was a drop 
in CVP of at least 2 mm. PPO/min., (2) 
there was a bleeding rate of 600 ml./hr. 
based on the transfusion rate needed to 
maintain a normal CVP, (3) there was 
intermittent hemorrhage. His contention is 
that patients with the above criteria have 
bleeding arteries which need surgical 
management and are so gross as to be 
found easily. Radiologic and endoscopic ex­
aminations were not performed as a rule.
Northfield and Smith28 support Andersen 
in general terms. They found the CVP use­
ful in assessing transfusion requirements 
and detecting the high-risk patient. Their 
normal value was a reading of 5 cm. HaO 
with zero 4 cm. below the manubriosternal 
junction in the supine position. They 
recommend that patients be transfused to 
a normal blood volume, which is indicated 
by a normal CVP. In their opinion re­
bleeding is likely if the initial transfusion 
requirement is six units or more. They 
state that rebleeding can be positively 
diagnosed if the CVP falls from 4 cm. 
IPO or above to zero in five hours.
The measurement of CVP must be per­
formed accurately. In a brief critique of 
the method, Eliahou et al.29 confirm its 
value in the management of uncomplicated
hemorrhage, but advise caution in the 
management of shock in such non-hemor- 
rhagic conditions as chest injury, blast 
lung, cardiac decompensation, or when 
the patient is on a respirator.
Fecal blood loss is easily measured using 
51Cr-labelled red cells,30 but is of no value 
in the monitoring of alimentary bleeding 
because of the valuation in the passage of 
feces.31
T r e a t m e n t
The management of acute gastroin­
testinal bleeding is best undertaken by a 
team consisting of “a keen physician and a 
somewhat reluctant surgeon”.32 The ma­
jority of patients are managed without 
surgery—75% to 80% in most series.
Blood transfusion is the mainstay of 
treatment and is required in about 75% of 
patients.3 Schiller, Truelove and Williams 
found that more than one-half of those 
transfused required more than five bottles 
of blood. Some authors advocate trans­
fusion to maintain a normal CVP and hence 
a normovolemic state.27,28 This concept 
has been challenged.16 It has been shown, 
during experimental arterial bleeding in 
dogs,33 that animals that are transfused 
have the largest blood loss and the longest 
bleeding times. Blood loss and bleeding 
times diminish when the dogs are un­
treated, rendered hypovolemic before 
bleeding is induced, given a vasodilator 
drug, or given a vasodilator drug and 
transfused, in that order of progression. 
Mean blood loss in the untreated dogs was 
323.7 ml. compared with 1522.4 ml. in the 
transfused dogs and fell to 25.8 ml. in 
animals given a vasodilator.
For various reasons, not least medico­
legal, it is difficult to refrain from trans­
fusing the bleeding patient, but the policy 
of transfusing to maintain a normal CVP 
or blood pressure can be legitimately ques­
tioned. It is our practice to transfuse to 
maintain the hemoglobin level between 
10 and 11 g./lOO ml.—a program that is 
especially important in the elderly patient 
to avoid confusion arising from cerebral 
ischemia. In Schiller’s series, the lowest 
mortality occurred in those not transfused 
or given less than five units of blood. While
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this relationship is probably due to the less 
severe bleeding in these patients, it is pos­
sible that, in some of them, the favourable 
factor was the small amount of the trans­
fusion.
When transfusion requirements are large, 
say over 15 units, the bleeding may be 
aggravated by citrate toxicity. This can 
be treated by intravenous calcium.
Drugs should be used sparingly and 
rationally. Unless the patient is in pain he 
does not need an analgesic. Pressor agents 
are contraindicated. If the patient has been 
on anticoagulants they should be stopped 
at once. The antidote for Coumadin drugs 
is vitamin Kj and for heparin, protamine 
sulfate. If liver function is good, low pro­
thrombin levels will be corrected in a few 
hours by the parenteral administration of 
vitamin K.
Patients with gastrointestinal bleeding 
are often significantly deficient in vitamin 
C,34 yet this fact is seldom regarded in 
management. It is our practice to give 
every patient admitted with an acute ali­
mentary “bleed”, 500 mg. of ascorbic acid 
intravenously at once, and to repeat this 
dose orally or parenterally daily thereafter 
until the bleeding state is controlled. The 
substance is cheap and safe and the reasons 
for giving it rational, though its thera­
peutic value has not yet been proved by 
a clinical trial.
Sedation should be administered to the 
anxious or agitated patient, but with care 
in the elderly and not as a substitute for 
the treatment of hypovolemic shock. Seda­
tive drugs must be used sparingly in pa­
tients with liver disease and the orders for 
these should be reviewed daily.
Gastric cooling, first introduced by Wan­
gensteen et al. in 1958,35 is no better than 
conservative management.36
Selective arterial drug infusions have 
been advocated for the control of massive 
bleeding. In a preliminary report, Rosch 
et a l 37 claim to have controlled bleeding 
successfully in 10 of 11 patients using 
selective infusion of the superior mesen­
teric artery with propanolol and epineph­
rine. A major difficulty seems to be the 
evanescence of the drug action, and a 
larger study seems to be warranted before 
this technique can be recommended.
The dietary management of peptic ulcer 
and its complications remains an area of 
black magic in modern medicine. As soon 
as vomiting ceases, if there is no immedi­
ate prospect of surgery and if the patient 
feels like it he should be allowed to eat 
food of his own choice. There is no evi­
dence that food causes bleeding. In so far 
as many patients with peptic ulcer have 
been eating a diet of inferior nutritional 
value (often on medical advice) the 
quicker they return to a proper diet the 
better.
Surgical Intervention
The indications for surgical intervention 
are as follows:
(1) Unmanageable bleeding or massive 
hemorrhage defined as “acute blood loss 
sufficient to reduce the circulating red cell 
mass to below 18 ml./kg. body weight or 
60% of estimated normal”,38 or major 
arterial hemorrhage as already defined on 
the basis of the CVP measurement.27 Katz 
et al.13 defined “severe bleeding” as a 
hemoglobin level of 8.5 g./lOO ml. or less 
at the time of admission, or the trans­
fusion of four units of whole blood during 
the first 24 hours. Using these criteria, the 
leading causes of severe bleeding requir­
ing operation were varices, duodenal ulcer 
and acute gastric ulcer, in that order.
(2) Rebleeding is an indication for 
operation, especially in the elderly. It may 
be detected by fresh melena or hema- 
temesis, by rising pulse rate, falling hemo­
globin and blood pressure, or by a fall­
ing CVP. Patients admitted with hema- 
temesis have a higher incidence of re­
bleeding than those with melena,4 and pa­
tients who have not bled for 48 hours are 
unlikely to bleed again in the near future.
(3) If transfusion requirements reach 10 
units.
(4) When the patient has a rare blood 
group and there is uncertainty about the 
prognosis.
(5) In relation to the diagnosis; other 
conditions being equal, operation for bleed­
ing duodenal or gastric ulcer is indicated 
before procedures for gastric erosions or a 
Mallory-Weiss tear.
(6) Age is a consideration. Patients over
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the age of 50 are at greater risk from re­
bleeding,3 although the incidence of re­
bleeding is no higher in the older age 
group, nor is it higher in men compared 
to women.4
(7) The special problems that relate to 
esophageal varices.
The surgeon assumes his task either 
knowing the precise diagnosis or not. His 
objectives are to identify the bleeding site, 
stop the bleeding and try to prevent its 
recurrence. When the source of bleeding 
has been identified, it should be stopped at 
once either by oversewing or by applying 
a clamp. This is only feasible in certain 
circumstances, such as bleeding from a 
single ulcer, and is not feasible if the 
bleeding is caused by multiple erosions.
Freeark, Norcross and Baker39 described 
their experience in emergency operations 
for acute gastrointestinal bleeding in 77 of 
212 patients in whom preoperative investi­
gation had not established the diagnosis. 
At operation a meticulous exploration of 
the upper abdomen was carried out in an 
attempt to establish the cause of bleeding. 
But either because nothing was found, or 
because the findings were inconclusive, 
gastrotomy through a 15-cm. anterior in­
cision was carried out. A bleeding site was 
accurately identified in 74 of the patients. 
Unsuspected gastric and duodenal ulcers, 
varices, Mallory-Weiss tears, gastritis, pan­
creatic cysts and gastric neoplasms were 
among the lesions encountered. A signifi­
cant number of the bleeding sources could 
not have been controlled by empiric resec­
tion of the distal two-thirds of the stomach. 
However, they caution that complications 
directly related to the long gastrotomy are 
frequent unless adequate precautions are 
taken to prevent their occurrence.
Until 1958, partial gastrectomy was the 
operation most frequently employed, par­
ticularly for bleeding peptic ulcer, and 
depending on many factors, mortality 
figures varied from 5%40 to 15%.18 Then 
Smith and Farris41 suggested the use of 
more conservative surgery, namely direct 
suture of the bleeding site with vagotomy 
and a drainage procedure. Carruthers et 
al.i2 reported their experience in 117 pa­
tients, 55 of whom had either a Polya or
Billroth I gastrectomy and 57 of whom had 
a vagotomy and pyloroplasty with suture 
of the bleeding vessel. Their conclusions 
were in general agreement with those of 
Foster, Hunt and Dunphy.43 Mortality in 
the conservative group was 7% compared 
with 18% in the radical group. They 
stressed that their good results were mainly 
in patients with bleeding duodenal ulcer. 
They thought that comparable results 
might be obtained with gastric ulcer, but 
were less hopeful regarding erosions. Their 
experience differed from that of Kelley, 
Grant and Elliott44 who found no differ­
ence in mortality rate when comparing the 
radical and conservative methods, and of 
Akin and Sullivan45 who had poor results 
in a small series of 20 patients. Opinions 
were mixed regarding the incidence of re­
bleeding after either type of operation.
The recent operative data of Schiller, 
Truelove and Williams3 are persuasive. In 
their series of 2149 patients studied over 
a 15-year period, the highest mortality rate 
was associated with the Polya procedure 
(21.1%), the Billroth I operation occupied 
a middle position (13.2%), and the best 
result was with vagotomy and drainage 
(8.0% ). The trend applied to both sexes. 
The poor mortality rate for the Polya 
operation applied throughout the 15 years 
of the review. Analysis of their data showed 
that the improved results applied almost 
entirely to the over-60 age group. Vag­
otomy and drainage was the most success­
ful operation for duodenal and gastric 
ulcer and, for the other conditions, it was 
as good as a Billroth operation and better 
than the Polya. Regarding rebleeding, the 
differences between the three operations 
were marginal.
In spite of the better surgical results 
associated with the shift to the vagotomy 
and drainage operation, Schiller, Truelove 
and Williams found no overall improve­
ment in the mortality of patients admitted 
with acute upper alimentary bleeding. 
They concluded that this was because 
fewer patients were being submitted for 
emergency operation. They advocate that 
emergency procedures be performed more 
frequently and that vagotomy and drain­
age be the operation of choice for all 
causes of bleeding, except varices.
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E lective Surgery
Once bleeding is controlled, operation 
may be required to prevent further bleed­
ing, for the definitive treatment of the 
primary lesion (or both). If operation is 
indicated for either of these reasons, it 
should be performed as soon as possible, 
taking into consideration all relevant facts. 
Elective surgery will be more specifically 
related to the diagnosis. In our opinion, a 
patient who has bled from esophageal 
varices should have an appropriate pro­
cedure as soon as he is fit enough. If there 
is delay beyond this point there is a high 
risk of rebleeding with a sharp rise in mor­
tality rate. In bleeding duodenal ulcer there 
are differences of opinion as to the value 
of operation in preventing relapse. Some 
authors consider the relapse rate after 
operation to be high, although their re­
sults are better than from medical treat­
ment alone.46"48 A recent paper,49 however, 
reports substantially better results after 
surgery. The differences could be due to 
variations in the natural history of the dis­
ease and in operative practice in different 
countries.
Summing U p
There are no short cuts and there are no 
absolute rules. There are valuable guide­
lines.
Whether the patient is first seen by the 
physician or the surgeon they should col­
laborate as soon as possible. This does not 
always require the physical presence of 
the partner. With time, trust in the other’s 
judgment develops.
No matter how ill the patient, a history 
should be obtained and a quick but 
thorough clinical examination carried out. 
With the exception of bleeding esophageal 
varices, exsanguination is seldom an im­
mediate threat. If pulse, blood pressure and 
hemoglobin are satisfactory (e.g. less than 
100/min., more than 100 mm. Hg systolic, 
and more than 10 g./lOO ml.), the patient 
is in no immediate danger and detailed in­
vestigation can proceed at once. Endoscopy 
followed by radiology is the better order, 
but is not obligatory. Either is better than 
none.
If the patient’s condition is poor, trans­
fusion should be initiated and regulated 
according to blood pressure, CVP and 
hemoglobin. It may not be desirable to try 
to restore these to normal. Once trans­
fusion is under way, other investigations 
can continue.
Coagulation disorders should be sought 
and appropriate therapy given or stopped. 
There is a case for the administration of 
vitamin C to all patients with acute ali­
mentary bleeding.
If emergency operation is required it 
should usually be undertaken during the 
first 48 hours after admission. With the ex­
ception of bleeding varices and the possible 
need for diagnostic gastrotomy, suture and 
vagotomy with a drainage procedure would 
seem to be the operation of choice at the 
present time.
R e f e r e n c e s
1. C am m ock  EE, H a l let t  WY, N yhus LM,
et al: Diagnosis and therapy in gastro­
intestinal hemorrhage. Study of 410 pa­
tients. Arch Surg (Chicago) 86 : 608, 1963
2. C a p pe r  WM, B u c k ler  KG: D eterm ination of
cause of bleeding in surgery for massive 
haematemesis. Brit J  Surg 51: 752, 1964
3. Sc h il l e r  KF, T ru elo v e  SC , W il l ia m s  D C :
Haematemesis and melaena, with special 
reference to factors influencing outcome. 
Brit Med J  2: 7, 1970
4. No r th fiel d  TC: Factors predisposing to re­
current haemorrhage after acute gastro­
intestinal bleeding. Brit Med J. 1: 26, 1971
5. W atson  W C, Sa l la m  M : Blood-volume de­
termination in acute upper alimentary 
bleeding. Canad J Surg 14: 260, 1971
6. Pa l m e r  ED: Vigorous diagnostic approach
to upper-gastrointestinal tract hemorrhage. 
23 year prospective study of 14,000 pa­
tients. JAMA 207: 1477, 1969
7. M a il e r  C, Go ld berg  A, H arden  RM, et al:
Diagnosis of upper gastrointestinal bleed­
ing. Brit Med J  2: 784, 1965
8. M cC ra y  RS, M artin  F, Am ir -A hm adi H,
et al: Erroneous diagnosis of hemorrhage 
from esophageal varices. Amer ] Dig Dis 
14: 755, 1969
9. M u ir  A, C ossar IA: Aspirin and ulcer. Brit
M ed J  2: 7, 1955
10. D o u th w a ite  AH, L in to t t  GA: Gastroscopic
observation of effect of aspirin and certain 
other substances on stomach. Lancet 2: 
1222, 1938
11. D a v en po rt  HW: Gastric mucosal hemorrhage
in dogs: effects of acid, aspirin and alco­
hol. Gastroenterology 56: 439, 1969
12. Pa l m e r  ED: Observations on vigorous diag­
nostic approach to severe upper gastro­
intestinal hemorrhage. Ann Intern Med, 36: 
1484, 1952
November 1971 UPPER ALIMENTARY BLEEDING 381
13. K atz D, D ouvres P, W e isb e r g  H, et al:
Early endoscopic diagnosis of acute upper 
gastrointestinal hemorrhage. Demonstra­
tion of relatively high incidence of erosions 
as source of bleeding. JAMA 188: 405, 
1964
14. G ordon  HE, Cl a r k e  JS, G o l d s t e in  H, et a l:
Diagnosis and management of gastroin­
testinal bleeding. Ann Intern M ed  71: 993,
1969
15. W atson  WC, M a x w e l l  JD, F erg uso n  A:
Fiberoscopy in management of acute upper 
alimentary bleeding, in Endoscopy o f Di­
gestive System, edited by M a ra tka  Z, 
Setka  J ,  New York, Karger, 1969 , p 77
16. E nquist IF , K arlson  K E , D en n is C, et al:
Statistically valid ten-year comparative 
evaluation of three methods of manage­
ment of massive gastroduodenal hemor­
rhage. Ann Surg 162 : 550, 1965
17. J ones FA: Problems of alimentary bleeding.
Rendiconti Romani di Gastroenterologia 2: 
118, 1970
18. W ard-M cQuaid JN, Pe a se  JC, Sm it h  AMcE,
et al: Surgery in bleeding peptic ulcers. 
Gut 1: 258, 1960
19. K now les HC, F el so n  B, S h apiro  N, et al:
Emergency diagnosis of upper digestive 
tract bleeding by roentgen examination 
without palpation ( “Hampton technic” ). 
Radiology 58: 536, 1952
20. C handler GN, C a m ero n  AD, Nunn  AH, et
al: Early investigation of haematemesis. 
Gut 1: 6, 1960
21. O n ea i. WJ, H ir sh  MA: Em ergency barium
study of severe hematemesis. Surgery 52: 
592, 1962
22. B aum  S, Nu sba u m  M, B la k em o r e  W S, et al:
Preoperative radiographic demonstration of 
intra-abdominal bleeding from unde­
termined sites by percutaneous selective 
celiac and superior mesenteric arterio­
graphy. Surgery 58: 797, 1965
23. B aum  S, Nu sba u m  M, C l e a r fie l d  HR, et al:
Angiography in diagnosis of gastrointestinal 
bleeding. Arch Intern M ed (Chicago) 119: 
16, 1967
24. R eu te r  SR, B o o k stein  JJ : Angiographic
localization of gastrointestinal bleeding. 
Gastroenterology 54: 876, 1968
25. F r ey  CF, R e u t e r  SR, B ookstein  J J :  Local­
ization of gastrointestinal hemorrhage by 
selective angiography. Surgery 67 : 548,
1970
26. L andis EM, H o r t e n st in e  JC: Functional
significance of venous blood pressure. 
Physiol Rev 30: 1, 1950
27. Andersen  D: Use of measurement of central
venous pressure in selection of patients 
with massive gastroduodenal haemorrhage 
for emergency operation. Scand J  Gastro- 
ent 5: 25, 1970
28. N o r th field  TC, Sm it h  T : Central venous
pressure in clinical management of acute 
gastrointestinal bleeding. Lancet 2 : 584, 
1970
29 . E liahou  HE, W ein b er g  U, R eisin  E, et al:
Central venous pressure and blood volume. 
Lancet 2: 1252, 1970
30. Anderson  ET, P assovoy M, T robaugh  FE :
Quantitation of gastrointestinal bleeding by 
use of large volume scintillation detector. 
J  Nucl Med 7: 612, 1966
31. H u g h es JP, B u r k in sh a w  L: Management of
acute gastrointestinal bleeding: measuring 
faecal blood loss with 51Cr. Brit M ed J  2: 
890, 1962
32. J ones FA: Hematemesis and melena: with
special reference to causation and to factors 
influencing mortality from bleeding peptic 
ulcers. Gastroenterology 30: 166, 1956
33. C h iu  CJ, Sh a fta n  GW, D en n is  C: Hypo­
tension: determinant in spontaneous con­
trol of arterial hemorrhage. Surg Forum  
15: 3, 1964
34. R u s s e l  RI, W il l ia m s o n  JM, G o l d b e r g  A, et
al: Ascorhic-acid levels in leucocytes of 
patients with gastrointestinal haemorrhage. 
Lancet 2: 603, 1968
35. W a n g en steen  OH, R oot HD, J e n so n  CB,
et al: Depression of gastric secretion and 
digestion by gastric hypothermia: its clini­
cal use in massive hematemesis. Surgery 
44: 265, 1958
36. M cF arla n d  JB, Gow JG : Trial of gastric
cooling for haematemesis. Brit M ed J  3: 
831, 1967
37. R osch J, Gray RK, G r o llm a n  JH , et al:
Selective arterial drug infusions in treat­
ment of acute gastrointestinal bleeding. 
Preliminary report. Gastroenterology, 59: 
341, 1970
38. St e w a r t  JD, Sc h a e r  SM, P oher  W H, e t al:
Management of massively bleeding peptic 
ulcer. Ann Surg 128: 791, 1948
39. F r e e a r k  RJ, No rcro ss W J, B a k e r  R J: Ex­
ploratory gastrotomy in management of 
massive upper gastrointestinal hemorrhage. 
Arch Surg (Chicago) 94 : 684, 1967
40. Og il v ie  AG, Cardoe N, B e n t l e y  FIT: Treat­
ment of massive bleeding from peptic 
ulcer. Brit Med J  2 : 304, 1952
41. Sm it h  GK, F a rr is  JM : Rationale of vag­
otomy and pyloroplasty in management of 
bleeding duodenal ulcer. JAMA 166: 878, 
1958
42. C a r r u th er s  RK, G il e s  GR, C la rk  CG, et al:
Conservative surgery for bleeding peptic 
ulcer. Brit Med J  1: 80, 1967
43. F o ste r  JH , Hunt TK, D u n ph y  JE : Emer­
gency operation for massive upper gastro­
intestinal haemorrhage. Brit J  Surg 51: 757, 
1964
44. K e l l e y  HG, Gra n t  GN, E l l io t t  D W : Mas­
sive gastroduodenal hemorrhage. Changing 
concepts of management. Arch Surg (C hi­
cago) 87: 6, 1963
45. Akin  JM , Sullivan  MB: Pyloroplasty and
vagotomy; compromise procedure for con­
trol of acute peptic ulcer hemorrhage. 
Surgery 54: 587, 1963
46. B o les  RS, Cassidy W J ,  J ordan  SM: Medical
versus surgical management for complica­
tion of hemorrhage in duodenal ulcer. 
Gastroenterology 32: 52, 1957
47. L e a p e  L L, W elch  C E: Late prognosis o f
patients with upper gastrointestinal hemor­
rhage. Amer J Surg 107: 297, 1964
48. Se r e b r o  HA, Me n d e l o f f  Al: Late results
of medical and surgical treatment of bleed­
ing peptic ulcer. Lancet, 2: 505, 1966
49. H a r v ey  RF, L angm an  MJ: Late results of
medical and surgical treatment for bleed­
ing duodenal ulcer. Quart J  Med 39 : 539, 
1970
382 THE CANADIAN JOURNAL OF SURGERY Vol. 14
R e su m e
La clef du succes dans l’hemorragie aigue de 
l’appareil digestif superieur est le diagnostic pre- 
coce quant au siege et a la nature de la lesion. 
Les principales etapes du diagnostic sont l’histoire 
clinique, l’examen clinique, Inspiration du contenu 
gastrique, l’endoscopie et la radiologie. II est 
important de questionner le malade au sujet de 
certains medicaments pris recemment, notamment 
aspirine, anticoagulants et alcool. Le pouls pris a 
l’arrivee renseigne mal, mais la tension arterielle 
donne une bonne idee de la perte de sang et 
permet de preciser un bon pronostic. L’endoscopie
effectuee avec des instruments en fibre optique 
est une methode sans danger qui, conjointement 
avec diverses techniques radiologiques, permet 
d’obtenir un diagnostic precoce, precis dans au 
moins 90% des cas. On peut evaluer la perte de 
sang par mesure directe du volume sanguin on la 
surveiller par enregistrement continu de la pres- 
sion veineuse centrale. La transfusion sanguine 
est Ja  clef de voute du traitement, mais comporte 
un danger, celui de Texces de transfusion. Le 
traitement chirurgical s’impose chez environ 20% 
des malades. La vagotomie et le drainage sont 
greves de la mortality la plus basse.
COMPARATIVE EFFEC TS OF WHOLE BLOOD, HEMODILUTED, AND 
CLEAR PRIMING SOLUTIONS ON MYOCARDIAL AND BODY 
METABOLISM IN MAN*
EMERSON A. MOFFETT, M.D.,t ROGER D. WHITE, M.D.,t 
GEORGE D. MOLNAR, M .D4 and DWIGHT C. McGOON, M.D.,§
Rochester, Minn., U.S.A.
S in c e  1959,1 when various types of clear 
or non-blood solutions began to be used 
for priming the bubble oxygenator, intro­
duced in 1955,2 this system has been used 
more for whole-body perfusion than any 
other. Thousands of perfusions have been 
successfully accomplished with it through­
out the world.
Using a clear prime in the popular 
Travenol disposable bubble oxygenator we 
studied myocardial and body metabolism 
during and after perfusion in six patients. 
The results were compared with those ob­
tained in two groups of five patients each. 
In one group, the patient was perfused 
with diluted acid-citrate-dextrose (ACD) 
blood,3 and in the other, perfusion was 
with fresh heparinized whole blood,4 using 
the vertical-sheet oxygenator at 30° C. in
"Supported in part by Research Grant GM-14919 
from the National Institutes of Health, Public 
Health Service.
■{"Department of Anesthesiology, Mayo Clinic and 
Mayo Foundation, Rochester, Minn.
$Department of Internal Medicine, Mayo Clinic 
and Mayo Foundation.
§Department of Surgery, Mayo Clinic and Mayo 
Foundation.
both groups. In addition to cardiac output 
we determined arterial and coronary sinus 
blood concentrations of oxygen, acid-base 
parameters, electrolytes, and energy pro­
ducing substrates throughout operation 
and for the next three days.
P a t ie n t s  Stu died
Six patients underwent open-heart sur­
gery; perfusion with the bubble oxygenator 
was carried out at 30° C. Information on 
the six patients is shown in Table I. The 
group included one child (aged 6 years) 
and five adults whose ages ranged from 17 
to 48 years. Body weights varied from 46.5 
to 175 lbs. The shortest perfusion time was 
47 minutes, and the longest was 137 (mean 
83 minutes). The three youngest patients 
underwent repair of congenital defects, the 
other three had valvular replacements. 
Patient 3 continued to have heavy drain­
age from the chest tubes, and was re­
explored five hours after operation. No 
other major complications occurred, and 
all patients left the hospital in an average 
of 13.6 days. Mean perfusion time was 82 
minutes in the hemodiluted group and 87 
minutes in the whole-blood group.
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T A B L E  I .— C l in ic a l  D a ta  on  S i x  P a t ie n t s  U n d e r g o in g  Op e n -H e a r t  S u r g e r y
Patient
no. Sex
Age
{years)
Weight 
{lbs.)
Surface 
area 
{sq. m.)
NYHA
class
Perfusion
time
{min.) Operation
i F 6 46.5 0.83 I 65 Closure, ostium primum, 
atrial septal defect
2 M 17 144 1.88 III 47 Closure, atrial septal defect in 
corrected transposition
3 F 18 98 1.47 III 137 Correction, complete 
atrioventricular canal
4 M 44 175 2.00 II 90 Aortic valve replacement
5 F 48 129.5 1.68 III 82 Mitral valve replacement
0 M 48 167 1.87 II 79 Aortic valve replacement
Methods of Study
Techniques of anesthesia for all groups 
were as previously outlined:3 nitrous 
oxide-oxygen with small amounts of halo- 
thane and succinylcholine. Only patient 5 
had an endotracheal tube left in at the end 
of anesthesia, for assisted ventilation over­
night, The fractional concentration of oxy­
gen in inspired air ( F i 0 2 ) ,  before and 
after perfusion, was 0.4; at the end of 
operation, 1.0; and after the operation 
(given by loose facepiece), 0.3 to 0.5.
An arterial blood sample was taken be­
fore anesthesia with the patient breathing 
air. Subsequent samples were obtained 
through a transfemoral catheter in the 
aorta or from the pump oxygenator. After 
thoracotomy, the surgeon inserted a small 
catheter deep into the coronary sinus. 
Simultaneous samples were drawn subse­
quently from these sites. The coronary 
sinus catheter and the catheter placed in 
the left atrium were brought out through 
the chest wall for postoperative sampling 
and dye injection. The schedule of blood 
sampling is shown in the figures.
For the adults in the clear-prime group, 
the priming solution consisted of 1500 ml. 
of 5% dextrose in 0.2% NaCl, 100 ml. of 
0.3M tromethamine (TH AM ), and 2000 
units of heparin. For the child, the amount 
of dextrose was reduced to 1000 ml. and 
the amount of THAM was reduced to 65 
ml. In the hemodiluted group, the prime 
was 60% ACD blood diluted with 5%  
dextrose in 0.45% NaCl, plus 65 ml. of 
THAM3 per 500 ml. of blood. In the third 
group, the pump oxygenator was primed 
with fresh heparinized whole blood.4 Oxy­
gen and carbon dioxide (10 I./min. and 
0.2 l./min. respectively) flowed through 
the oxygenator. Mean arterial flow for the
clear-prime group averaged 2.26 l./m in./ 
sq. m. Maintenance of a steady flow of that 
magnitude required the addition of further 
volume to the circuit. Patients 3 and 5 each 
had 2500 ml. of ACD blood added, whereas 
patients 2 and 6 needed 1000 ml. each. 
Volumes of blood added to patients 1 and 
4 were 250 ml. and 1500 ml., respectively. 
Also given with each 500 ml. of blood 
added to the oxygenator were 150 ml. of 
5%  dextrose in 0.2% NaCl, 65 ml. of 0.3M 
THAM, 0.5 g. of CaCl2 and 2 mEq. of KC1. 
Arterial flows in the other two groups were 
similar to those of the clear-prime group.
Cardiac output was measured by dye 
dilution, after the injection of indocyanine 
green into the left atrium, with sampling 
through the aortic catheter.
All biochemical determinations on blood 
were done as previously reported3 except 
that lactate and pyruvate levels were de­
termined by enzymatic,6 rather than non- 
enzymatic, methods. Samples were iced, 
and p 0 2, pCOo and pH were measured by 
electrodes at 37° C. within 10 minutes. 
Corrections were made when the patient’s 
temperature was below 36°C. Plasma con­
centrations o f sodium, potassium and cal­
cium were measured, and plasma osmo­
lality was determined. Energy producing 
substrates measured across the myocardium 
were glucose, non-esterified fatty acids 
(NEFA), total ketone bodies, lactate, and 
pyruvate. Arterial concentrations of plas­
ma immunoreactive insulin7 and human 
growth hormone8 were measured by 
double-antibody radioimmunoassay.
Analyses of paired data in the clear- 
prime group by the Student t test were 
done, comparing arterial and coronary 
sinus levels of parameters at each sample 
time. Analyses of unpaired data were
Fig. 1.—Oxygen tension and content. In both the clear-prime and 
hemodilution groups, oxygen content was lower during perfusion than in 
the whole-blood group. The oxygen content decreased on days 3 and 4 
in all three groups.
made, comparing arterial concentrations of each parameter in 
the clear-prime group with arterial levels in the other two 
groups.
R esu lts
Mean concentrations of all variables in arterial and coronary 
sinus blood of the clear-prime group are presented, with mean
L  - v
d <
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Fig. 2.—Acid-base balance. Respiratory alkalosis was 
present during operation in all three groups. Buffer base in­
creased after operation, with significantly higher concentrations 
by day 3 in the clear-prime group compared with the hemo­
dilution group.
arterial levels of the hemodiluted and whole-blood groups ( Figs. 
1-8). Because insulin and growth-hormone concentrations were 
not determined in the hemodilution group, mean values of these 
hormones from a seriously ill group (Group 2 from another 
study)9 were used in Figs. 5 and 6. Perfusions and manage­
ment of these patients were identical in all respects with those 
in the hemodilution group.
i
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Fig. 5.—Insulin and glucose. Insulin level was significantly higher 
in the clear-prime and seriously ill9 groups at the end of perfusion and 
after perfusion than in the whole-blood group. Glucose level was higher 
in the clear-prime group during perfusion than in the hemodilution and 
whole-blood groups.
Fig. 6.—Growth hormone and non-esterified fatty acids. Growth-
hormone level was significantly higher in the clear-prime group than in 
the seriously ill group9 at mid-perfusion; in both groups, it peaked after 
perfusion. NEFA level followed a similarly elevated pattern in all three 
groups.
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TABLE II.— S i g n i f i c a n t D i f f e r e n c e s  i n  A r t e r i a l  C o n c e n t r a t i o n s  B e t w e e n  T w o  G r o u p s  U n d e  
g o i n g  O p e n - H e a r t  S u r g e r y
Variable
Clear-prime group greater Clear-prime group less
than hemodiluted group than hemodiluted group
Buffer base Day 3 (p.m.) and dav 4 NonepH Preinduction None
Hemoglobin None Day 3 and day 4 (a.m.)
Hematocrit None Day 3 and day 4 (a.m.)
pCOa None End of operation
Potassium Preinduction None
Sodium None End of operation
Calcium Day 4 (a.m.) Early perfusion through 
day 2 (a.m.)
Osmolality None Day 2 (a.m.)
Glucose Early perfusion through 
remainder of day 1 and 
day 3 (a.m.)
None
Non-este rifled 30 min. after perfusion Before perfusion and
fatty acids and end of operation mid-perfusion
Total ketone Day 2 and day 3 (a.m.) None
bodies
Cardiac index in patients 3 to 6 (Table 
I) averaged 2.2 and 2.8 l./min./sq. m. be­
fore and after perfusion. Two hours after 
operation, the index was lowest at 2.1. At 
3:00 p.m. on days 2 to 4, the mean index 
was 2.2, 2.6, and 2.6 l./min./sq. m., re­
spectively.
Significant differences (P <  0.05) in 
arterial concentrations between the clear- 
prime group and the hemodiluted group 
are given in Table II. A similar compari­
son between the clear-prime group and 
the whole-blood group is given in Table
C o m m e n t
One purported advantage of the bubble 
oxygenator is that, because it is primed 
with a clear solution, the amount of whole 
blood needed is greatly reduced. For the 
initial priming this is true: no blood is 
needed, compared with 2500 ml. for the 
hemodiluted prime in the vertical-sheet 
oxygenator. But to maintain steady pump 
flows acceptable to us ( that is, to replace 
blood and fluid lost from the intravascu­
lar compartment), a mean of 1700 ml. of 
whole blood needed to be added for the
III. five adults. During the perfusions with
.E III.—S i g n i f i c a n t  D i f f e r e n c e s  i n  A r t e r i a l  C o n c e n t r a t i o n s  B e t w e e n  T w o  G r o u p s  U n d e r ­
g o i n g  O p e n - H e a r t  S u r g e r y
Clear-prime group greater Clear-prime group less
Variable than whole-blood group than whole-blood group
Hemoglobin None Early perfusion through 
end of operation
0 2 content None Early perfusion through 
end of operation
pC02 Day 3 None
Sodium None Early perfusion through 
day 1 and day 2 (p.m.)
Potassium During perfusion None
Calcium End of operation None
Osmolality None Day 2 (a.m.)
Glucose Early perfusion to end of 
operation
None
Non-esterified None During perfusion
fatty acids
Total ketone Day 2 and day 3 (a.m.) N one
bodies
Lactate 30 min. after perfusion None
Pyruvate Early perfusion None
Growth Before perfusion and 30 None
hormone min. after perfusion
Insulin End of perfusion and 30 
min. after perfusion
None
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hemodilution, a mean of 300 ml. was added. So the volume of blood saved, for 
equal length of perfusion, was approxi­mately two units (1100 ml.). Priming the vertical-sheet oxygenator with whole 
blood took an average of 3700 ml., with 
another 600 ml. added during perfusion. 
Patients perfused with the whole-blood 
prime had an average chest drainage, un­
til midnight, of 1950 ml., compared with 330 ml. and 850 ml. in the clear-prime 
and hemodiluted groups, respectively. 
Hence, for reasons not investigated, blood 
clotting appeared to be better in the 
patients after perfusion with the bubble 
oxygenator.
Oxygen tension was not different in the 
three groups of patients. Arterial oxygen content was reduced for the remainder of 
the operation when hemodilution was em­
ployed, as compared with no dilution. This 
points out the advisability (with hemodilu­
tion) of maintaining an elevated Pa0 by 
keeping the inspired concentration of oxy­
gen at 40% to 50%. Hemoglobin and oxy­
gen-carrying capacity again decreased on 
the third and fourth days, probably due 
to red-cell destruction and recurring hemo­
dilution.
Patients perfused with the bubble oxy­
genator did not become acidotic during 
perfusion, possibly because THAM was 
given with the non-fresh ACD blood added 
to the oxygenator. After the operation, the 
patients perfused initially with a clear 
priming solution, and those perfused with 
whole blood, experienced a greater degree 
of metabolic alkalosis than did those per­
fused with diluted blood.
Electrolyte behaviour in the three groups 
was related to the differences between 
primes. Hyponatremia was caused by both 
primes involving hemodilution, and sub­
normal plasma sodium concentrations were 
seen after operation in all groups. Only the diluted-blood prime, with THAM and 
glucose, produced hyperosmolality during 
operation. All three groups, including the 
one that did not receive a fluid load during 
operation, showed hypo-osmotic plasma by 
the third and fourth days. This is probably 
due to generalized retention of water by 
the body,10 owing to increased activity of
antidiuretic hormone11 and perhaps other 
factors.Regardless of plasma potassium level 
during perfusion, frankly subnormal con­
centrations are seen by the end of opera­
tion and later in the day. During this 
interval, a large loss of potassium occurs 
by diuresis, and the hyperglycemia and 
hyperinsulinemia may cause intracellular 
movement of potassium.12 This period of 
hypokalemia is known to be associated 
with the development of ventricular ar­
rhythmias. Supplemental potassium given 
after operation has reduced the incidence 
of this ventricular hyperirritability.13
The prime that required the addition of 
calcium was the only one that was fol­
lowed by elevated plasma levels, though 
smaller amounts of calcium were added 
during the perfusions with the bubble oxy­
genator. Cardiac output was not measured 
in the patients with hypercalcemia, and we 
have no data relative to possible positive 
inotropism from these levels of total cal­
cium.
The characteristics of energy metabolism 
depended largely on the amount of glucose 
administered via the priming solution. The 
group perfused with the clear prime in the 
bubble oxygenator received the largest 
glucose load. Even the patients perfused 
with whole blood, who received no exo­
genous glucose, had raised blood levels, 
presumably from glycogenolysis and glu- 
coneogenesis, but only to 165 m g./100 ml. 
by the end of perfusion. This increase in 
glucose concentration elicited only a slight 
increase in the plasma insulin level, where­
as high levels of the plasma insulin were 
seen in the other two groups after termina­
tion of hypothermia. Higher NEFA levels 
were maintained during perfusion when a 
glucose prime was not used, and without 
the insulin response to inhibit NEFA mobi­
lization serum levels of NEFA remained 
higher than in the other groups through 
the hours surrounding the end of opera­tion.
On the days after operation, arterial 
NEFA concentrations were alike in all groups, but, as evidenced by the ketone- 
body response, the rates of lipid utilization were vastly different. The ketone bodies 
accumulate in the blood when the liver is
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unable to metabolize NEFA as rapidly 
as these acids are presented to it. Ketosis 
was severe after the perfusions with the 
clear prime in the bubble oxygenator and 
moderate after the hemodiluted perfusion. 
The pattern after perfusions with whole 
blood was different—a gradual build-up 
after operation. The patients subjected to 
the greatest glucose loads (clear-prime 
group) had no higher insulin responses 
than did the other group that received 
glucose in the prime (hemodiluted group). 
However, the clear-prime group had a 
significantly greater degree of ketosis after 
operation than did the hemodiluted group. 
We also observed this relationship of the 
degree of glucose load during perfusion to 
the severity of the postoperative ketosis in 
children.14 The explanation for this obser­
vation is not apparent.
Lactate levels were highest after perfu­
sion in the two groups that received the 
largest glucose loads. The group of pa­
tients perfused without glucose increased 
their plasma lactate levels to 2y2 times that 
of control before perfusion, with only a 
small further increase during perfusion. 
This group also showed the smallest in­
crease in growth hormone, which can be 
considered to be an indicator of the stress 
response16 of the total organism. Although 
there is evidence16 that insulin and growth- 
hormone levels have an inverse relation­
ship under certain conditions and a 
sequential one in others, the levels of both 
these hormones peaked between the end 
of perfusion and the end of operation. The 
insulin response was appropriate for the 
degree of hyperglycemia. It is possible that 
the magnitude of the stress response over­
came the expected inhibitory effect of 
hyperglycemia on growth hormone.
Sum m a ry
Six patients perfused with a clear prime 
in a bubble oxygenator were studied dur­
ing and after open-heart surgery. Arterial 
and coronary sinus blood levels of oxygen, 
acid-base parameters, electrolytes, energy 
producing substrates, insulin, growth hor­
mone, and cardiac output were determined 
throughout anesthesia and for three subse­
quent days. These six patients had higher
blood glucose levels during operation and 
greater metabolic alkalosis and ketosis 
after operation than did patients studied 
previously during the use of hemodilution 
in the vertical-sheet oxygenator. Differ­
ences between the clear-prime group and 
a group perfused with fresh whole blood 
were related to the presence, or absence, 
of blood dilution. Patients perfused with 
the clear prime in the bubble oxygenator 
were subjected to more dilution of their 
blood and to a greater glucose load. 
Neither of the diluted primes seemed 
superior from the aspects studied, but both 
had advantages over whole blood.
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Resume
Les auteurs ont etudie six malades pendant et 
apres une operation a coeur ouvert, ces malades 
etant soumis a la perfusion d’une solution d'amor- 
gage dans un oxygenateur a barbotage. Pendant
toute la duree de l’anesthesie et pendant les trois 
jours consecutifs a l’operation, ils ont mesure la 
teneur en oxygene du sang arteriel et du sinus 
coronarien, les perametres de l’equilibre acide- 
base, les electrolytes, les substrats energetiques, 
l’insuline, l’hormone somatotrope et le debit car- 
diaque. Ces six malades presentaient une glyce- 
mie plus elevee pendant l’operation et une acido- 
cetose plus forte apres l’operation que des malades 
anterieurement soumis a une hemodilution dans 
un oxygenateur a membrane verticale. Les dif­
ferences constatees entre les malades recevant la 
solution d’amorgage et ceux recevant le sang en- 
tier portaient sur la presence ou l’absence d’hemo- 
dilution. Les malades perfuses avec la solution 
d’amorgage dans l’oxygenateur a barbotage avaient 
une plus forte hemodilution et une charge plus 
forte de glucose. Aucune des solutions hemo- 
diluees ne semblaient presenter d’avantages au 
point de vue des criteres etudies, mais toutes deux 
presentaient des avantages sur le sang entier.
ERYTHROCYTE DYSFUNCTION IN SHOCK AND SEVERE ILLN ESS:
A STUDY OF THE HEMOGLOBIN OXYGEN-CARRYING CAPACITY AS A 
CONTRIBUTING FACTOR IN REFRACTORY HYPOXIA"
E. F. G. BUSSE, M.D., F .R .C .S.[C ],f A. ZEKULIN, B.Sc. and 
F. N. GURD, M.D., F.R.C.S.fC], F.A.C.S., Montreal, Que.
This paper presents a study of the oxygen 
transport mechanism at the level of the 
erythrocyte and its contained hemoglobin. 
Systemic arterial hypoxia, which fails to 
respond to oxygen administration, has be­
come increasingly common in patients suf­
fering from shock, sepsis, and other 
extreme stresses. The current literature is 
filled with studies directed towards the 
analysis and correction of pulmonary in­
sufficiency as the presumed basis for such 
refractory hypoxia. We are fully aware of 
the significance of ventilation-perfusion de­
fects, of intrapulmonary shunting and 
diffusion difficulties, but dissatisfaction
"From the McGill University Surgical Clinic, 
Montreal General Hospital, Montreal 109, Que., 
and The Royal Edward Chest Hospital, Montreal, 
Que.
fPresent address: Medical Arts Clinic, Regina, 
Sask.
Reprint address: Dr. F . N. Gurd, Department of 
Surgery, Montreal General Hospital, Montreal 109, 
Que.
with the standard explanations of cardio­
pulmonary physiology led us to consider 
that the actual capacity of the blood itself 
to accept and transport oxygen might be 
unfavourably affected in these patients. 
The study reported in this paper was 
designed to assess the ability of the blood 
to react with, and to transport, oxygen. The 
oxygen-carrying capacity of the blood of 
12 seriously ill patients from the Intensive 
Care Unit of the Montreal General Hos­
pital was measured with particular refer­
ence to the physical-chemical mechanisms 
involved in oxygen transport. W e were con­
cerned primarily with the hemoglobin 
oxygen-carrying capacity (H O C C ), which 
is defined as the maximal volume of oxygen 
in cubic centimetres carried per gram of 
hemoglobin in the patient’s blood at normal 
pH, p C 0 2, and p 0 2 values. The value of 
the HOCC is generally assumed to be a 
constant of 1.34 c.c./g . and is treated as 
such in many physiologic calculations. We 
observed wide variations of the hemoglobin
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oxygen-carrying capacity in severely ill pa­
tients. The reporting of hemoglobin satura­
tion as a percentage of normal should be 
discouraged, because values greater than 
100% reduce credibility. None the less, as 
with the older conventions of reporting 
hemoglobin content of the blood as a per­
centage of normal, abnormally elevated 
values are physiologically possible.
Maximal oxygen content.—An IL tono­
meter* was used in which a 5-c.c. aliquot 
of blood was suspended and allowed to 
equilibrate for five minutes with a 4.5% 
carbon dioxide-in-air gas mixture, which 
was perfused through the apparatus at 100 
c.c./min. at 37° C. The sample was im­
mediately assessed for pH, p C 0 2, and p 0 2 
using the IL Micro pH and Blood Gas
TABLE I.— R esults  in  10 C o n t r o l  P a t ie n t s  an d  12 ICU P a tie n ts
Controls
Oxygen
Initials
Age
(years) Sex
pO,
(mm. Hg)
pCO,
(mm. Hg) pH
Ilh.
(g./lOO ml.)
content
(c.c.%)
HOCC
(c.c./g.)
E.B. 30 M — — — 14.4 19.9 1.38
A.Z. 20 M — — — 14.2 19.1 1.34
M.W. 23 F 110.0 35.6 7.38 12.5 16.5 1.32
B.W. 22 M — 16.5 21.7 1.32
P.Q. 21 M 110.0 30.0 7.38 16.0 21 .2 1.33
J.G. 40 F 109.0 35.2 7.38 14.2 18.5 1.30
C.H. 20 M 112.0 25.0 7.36 16.5 22.4 1.36
G.B. 39 F 107.0 36.0 7.32 15.0 20.5 1.36
H.G. 83 M — 9.1 12.4 1.34
G.P. 32 M 98.0 34.5 7.45 10.6 14.5 1.36
Mean Value of HOCG 1.34
Range — 1.30-1.38
Patients From the Intensive Care Unit
J.G. 59 M — — — 13.1 14.8 1.13
A.M. 39 F — — — 12.7 18.4 1.45
S.L. 03 F — — 11.6 16.5 1.42
B.F. — F — 13.8 17.2 1.25
R.B. 50 F — 6.8 8. 1 1.19
A.L. 53 M 112.0 35.0 7.43 11.5 14.6 1.22
S.G. 16 F 110.0 35.5 7.41 12.6 14.9 111
M.M. 32 F 110.0 33.0 7.42 12.8 16. 1 1.26
M.C. 70 F 97.0 32.0 7.42 12.9 19.5 1.51
M.G. 73 F 112.0 33.0 7.37 14.6 18.3 1.24
J.T. 31 M 104.0 33.5 7.48 12.0 17.7 1.47
W.M. 45 M 106.0 29.5 7.40 10.2 19.7 1.90
M aterial  and  M ethods
Two groups of individuals were studied: 
the first group, 10 controls, comprised 
normal volunteers and patients on the 
wards of the hospital awaiting elective 
surgery, while a second group consisted of 
12 patients in the Intensive Care Unit 
(ICU) of the Montreal General Hospital 
who were judged to be suffering from 
severe traumatic, septic, or metabolic dis­
orders. In each instance, venous blood 
samples, drawn into heparinized syringes, 
were analyzed according to the following 
techniques.
Hemoglobin concentration. — The stan­
dard clinical laboratory spectrophotometric 
technique was used and results were ex­
pressed in g.Hb./lOO ml. of blood.
Analyzing System Model IL-113-S2* ac­
cording to the techniques outlined by the 
manufacturer. The same sample was then 
assessed for its total oxygen content using 
a Thomas Van Slyke manometric apparatus 
( Magnamatic modelt) according to the 
conventional techniques.
Assessment of the reaction rates between 
the hemoglobin and oxygen.—In addition 
to the parameters measured above and 
using the same apparatus, in several 
instances tonometry was performed for 
different time intervals on different aliquots 
of blood from the same patient and the 
pH, pCOo, p 0 2, and oxygen content were
“ Instrumentation Laboratories, Boston, Mass. 
i'Thomas Company, Philadelphia, Penn.
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determined. From these measurements, the rate of reaction between the hemoglobin and oxygen was assessed.
Results
The results of the measurements outlined above are recorded in Table I, which in­
cludes the value for the HOCC. This value
was calculated by dividing the maximal oxygen content by the hemoglobin con­
centration and expressing it in cubic centi­
metres of oxygen per gram of hemoglobin. 
The data from the control group and from 
the ICU patients are shown separately. 
Not all measurements were made on every 
case. Table II shows the data derived from
T A B L E  II.—R e su l t s  o p  T onometry  E x p e r im e n t s  in  F iv e  C ontrol  and  S ix  ICU P a t ie n t s
Controls
Initials Age(years) Sex
Tonometry equilibra­tion time (min.) pO,(mm. Hg) pCO-z (mm. Hg) pH
Oxygencontent(c.c.%) Hb.(g./lOO ml.)
Hb.-O,content(c.c./g.)
P.Q. 21 M 0 — — — — ___ ___1 70.0 32.0 7.39 19.2 16.0 1.203 108.0 31.0 7.38 20.7 16.0 1.295 110.0 30.0 7.38 21.2 16.0 1.33
J.G. 46 F 0 28.5 58.5 7.28 6.8 14.2 0.481 51.0 41.0 7.38 14.5 14.2 1.023 109.0 35.2 7.38 17.7 14.2 1 .255 110.0 35.2 7.38 18.5 14.2 1 .30
G.P. 32 M 0 14.0 55.0 7.35 — 10.6 0.101 43.0 — — 10.2 10.6 0.983 98.0 29.5 7.46 14.5 10.6 1 365 98.0 34 5 7.45 14.5 10.6 1 .36
C.H. 26 M 0 33.0 35 0 7.24 10.8 16.5 0.651 57.0 25.0 7.40 18.4 16.5 1 .123 112.0 25 0 7.38 21.9 16.5 1 335 112.0 25.0 7.36 22.4 16.5 1.36
G.B. 39 F 0 24.0 52.0 7.28 6,1 15.0 0.461 47.0 38.0 7.34 14.2 15.0 0.943 106.0 36.0 7.34 19.7 15.0 1 .315 107.0 36.0 7.32 20.5 15.0 1.36
Patients F rom the Intensive Care Unit
W.M. 45 M 0 42.0 50.0 7.29 9.9 10.5 0.941 63.0 36.0 7.39 11.8 10.5 1.123 105.0 30.0 7 41 15.5 10.5 1.485 106.0 29.5 7.40 19.6 10.5 1.85
M.G. 73 F 0 — ___ ___ _1 65.0 30 0 7.44 17.9 14.6 1.233 109.0 31.0 7.42 17.9 14.6 1 235 110.0 31.0 7.41 18.3 14.6 1.25
M.M. 32 F 0 39.0 56.0 7.29 9.6 12.8 0.751 71.0 32.0 7.41 13.8 12.8 1.083 110.0 33.0 7.41 14.2 12.8 1.115 110.0 33.0 7.42 16.1 12.8 1 26
M.C. 70 F 0 37.0 35.1 7.42 9.8 12.9 0.761 61.0 33.0 7.45 18.8 12.9 1.453 97.0 32.0 7.43 19.5 12.9 1.515 97.0 32.0 7.42 19.5 12.9 1.51
J.T. 31 M 0 58.0 47.0 7.35 1 1 .8 11.4 1.041 76.0 33.0 7.45 13.5 11.4 1 . 183 93.0 36.0 7.41 15.3 11.4 1.345 93.0 33.0 7.45 16.5 11.4 1.44
W.M. 45 M 0 38.0 40.0 7.34 6.2 10.2 0.611 68.0 32.5 7.37 11.5 10.2 1.123 104.0 30.0 7 42 — 10.2 —5 104.0 19.8 10.2 1.94
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Fig. i .—Hemoglobin-oxygen content at various intervals of tonometry for the control and ICU
groups.
Fig. 2.—Plasma pO* at various intervals of tonometry for the control and ICU groups.
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Fig. 3.—The mean values for p 0 2 and H b.-02 content for the tonometry studies on the five con­trol patients are presented on the left and similar data for the patient M.M. on the right.
the tonometry experiments in which several 
aliquots were equilibrated for different 
time intervals in order to assess the rate 
of the hemoglobin-oxygen (Hb.-Oa) re­
actions; ICU patient W.M. was assessed on 
two separate occasions.
In Figs. 1 to 3, the data from Tables I 
and II are expressed graphically. Fig. 1 
shows data from the tonometry studies for 
the control group and the ICU patients. 
The Hb.-Oa content is plotted against time in each case; mean and range 
values are indicated. For the control group, 
the range of variability was narrow; the five-minute maximal carrying capacity 
mean value was 1.34 c.c./g. with a range of 1.30 to 1.38. For the ill patients, the 
mean value of the HOCC was similar, but 
the range of values varied considerably. 
Similarly we observed a wider range of 
variability at the different time intervals. In Fig. 2, when plasma p 0 2 is plotted 
against time, the range of values for the
control group is again narrow, whereas 
the range for ill patients is wider. Fig. 3 
shows the relationship between the changes 
of pOa and oxygen content after tonometry 
equilibration for different time intervals. 
The mean values for the control group are 
shown and the values for a patient, M.M., 
compared. In the control group, there is a 
relatively constant relationship between the 
two parameters, each reaching a plateau 
by the three-minute sample. In patient 
M.M., there is a distinct delay in the rise 
of the oxygen content of the blood, which 
is accompanied by a more rapid rise in the 
plasma p 0 2.
D iscu ssio n
General Considerations
The experiments reported above were 
designed to assess the ability of different blood specimens to react with and to trans­
port oxygen. With the tonometry appar-
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atus, techniques of ventilation and inter­face exposure were standardized, hence, 
variations among different specimens can be ascribed to the specimens themselves. Among the severely ill patients, there were 
several patterns of variability. Some ap­peared to have an abnormality of the 
HOCC. In general this capacity was re­
duced, but in one patient it was exception­
ally high. In some, there appeared to be an 
anomaly in the relationship between the 
pOa and oxygen content at different time 
intervals in the tonometry studies.
In an attempt to analyze the reported 
observations, we considered the physical- 
chemical phenomena involved in the up­
take of oxygen by the erythrocyte under 
two headings: first, the factors affecting 
the reversible chemical reaction between 
hemoglobin and oxygen; and second, the 
physical-chemical phenomena affecting the 
rate and extent of diffusion of oxygen into 
and through the erythrocytes.
Factors affecting the reversible chemical 
reaction between hemoglobin and oxygen — 
With respect to the reversible chemical re­
action between oxygen and hemoglobin, 
Allen, Wyman and Smith1 and Schruefer 
et air studied fetal hemoglobin first as free 
hemoglobin and second as contained with­
in the fetal erythrocytes. Both studies 
demonstrated that the higher hemoglobin- 
oxygen affinity of the fetal hemoglobin was 
due to the electrolyte media in which the 
hemoglobin was suspended, rather than to 
specific differences in the hemoglobin it­
self. These experiments demonstrated that 
hemoglobin has a variable affinity for oxy­
gen which is most sensitive to its electro­
lyte environment. The Bohr phenomena, in 
which the oxygen-hemoglobin affinity de­
pends upon the hydrogen-ion concentra­
tion of the media in which the hemoglobin 
is suspended, further illustrates the sensi­
tivity of the reaction between hemoglobin and oxygen.3' 4
The biophysical characteristics of the 
chemical reactions between hemoglobin and oxygen were further delineated by Rossi-Fanelli, Antonini and Caputo,5 who 
studied the Hb.-02 reaction in different solute suspensions and concentrations. They showed that this reaction depends not only 
upon the ionic strength of the media, but
further, that it is sensitive to the type of electrolytes in the media—different values 
were obtained for reactions in a potas­
sium from those in a sodium solution. Som- 
merkamp et al.tt confirmed the effect of base excess and cation concentrations on 
the oxyhemoglobin dissociation curve. 
These demonstrations of the dependence 
of the flb.-tb reaction upon the ionic con­
centrations and character of the media can 
be appreciated more clearly if one con­
siders certain aspects of the hemoglobin 
molecule. The protein moiety of the hemo­
globin molecule has a high number of re­
active carbamino loci with a high electron 
resonance and, as such, is sensitive to the 
ionic media in which it is suspended. The 
stability of the protein moiety affects the 
imidazol groups with which the oxygen 
reacts; any variation in the electron reson­
ance affects the strength of the imidazole- 
oxygen bond and, hence, the equilibration 
point of the reversible chemical reaction. 
As the electrolyte and hydrogen-ion media 
in which the hemoglobin is suspended may 
vary, the reactivity of the hemoglobin and 
oxygen may also be affected. Surgenor4 and 
Roughton3 have discussed these properties 
of the hemoglobin molecule in detail.The physical-chemical phenomena affect­
ing the rate and extent of diffusion of oxy­
gen into and through the erythrocytes — 
The physical-chemical phenomena affect­
ing the rate and extent of oxygen diffusion 
control the supply of reactants and clear­
ance of products of the oxyhemoglobin re­
action and, hence, directly affect the ex­
tent to which the reaction may take place 
within the erythrocyte. The diffusion of 
gases across the membranes of the erythro­
cyte wall and through the hemoglobin mass 
has been described by Forster.7 Factors 
that may impair the diffusion rates include 
the erythrocyte coatings, first described by 
Bloch and Powell,8 and the aggregation of 
erythrocytes into clumps, aggregates, or 
rouleaux.9 In each instance, the surface 
area of the erythrocyte membranes avail­able for diffusion is reduced with a pro­
portional reduction in the diffusion rate. 
When red cells aggregate, they reduce the 
surface area:mass ratio of the hemoglobin mass and impair the diffusion of oxygen 
through the cell. With rouleau fonnation
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the relationship between surface area and 
mass is such that when only five cells ad­
here, oxygen diffusion is decreased by 50%, 
which is approximately the maximal re­
duction attainable. These changes affect 
both the uptake of oxygen by the erythro­
cytes in the lung and the release of oxygen 
in the tissues. Roughton and Forster10 
have presented evidence of the importance 
of red cell resistance in diffusion and re­
action rates.
Chemical reactions between hemoglobin 
and oxygen are conducted as a “flow” pro­
cess in which the time allowed for the re­
action to come to completion is controlled 
by the pulmonary circulation. Vogel,31 who 
studied the blood flow in the lung capil­
laries of the cat, attempted to calculate 
the interface exposure time. His data indi­
cate that the flow rate of 0.05 cm./sec. 
allows an exposure time of approximately 
0.1 seconds. Using Roughton’s values for 
the reaction rates of hemoglobin in solu­
tion and in dilute red cell suspensions,3 
the half-time for the reaction between 
hemoglobin and oxygen at 37° C. is 0.071 
seconds in a 1 in 40 to 1 in 100 dilution 
of whole blood. The time required for 
equilibration of the Ilb.-CT reaction in the 
alveolar-capillary interface is, therefore, 
nearly the same as the interface exposure 
time reported by Vogel. These data empha­
size that both alveolar-capillary interface 
exposure time and I lb.-C)2 reaction rates 
may become critical factors limiting the 
oxygen transport mechanism.
Since these studies were completed, 
interest in hemoglobin oxygen-carrying 
capacity as a factor in hypoxia has been 
developing rapidly, and many different ap­
proaches are now being exploited.12
Consideration of the Clinical Data
Many potential defects in the oxygen­
carrying loading mechanism may be re­
sponsible for the defects observed in the 
clinical studies; however, one point deserves 
particular emphasis: defects in the oxygen 
transport mechanism do occur at the 
erythrocyte level in the severely ill patient. 
We have briefly reviewed the physical- 
chemical phenomena involved in the oxy­
gen transport mechanism to draw atten­
tion to the sensitivity of the oxyhemoglobin 
reaction to many influences and to the 
complexity of multiple-stage diffusion re­
actions. Intra-erythrocyte electrolyte levels 
and the mechanism by which these are 
maintained may have important influences 
on the oxygen transport mechanism. This 
mechanism is outlined by Passow.13 The 
ability of ouabain to interfere with this 
process is significant particularly since 
many of our ill patients are digitalized.
The labile nature of the factors con­
trolling the Hb.-02 reaction suggests that 
this component of the oxygen transport 
mechanism is a potential point of failure 
in the severely ill patient.
It should be clearly emphasized that the 
factors described above may allow both an 
increase and a decrease in the HOCC. 
Neither an increase nor decrease from 
normal should be considered advantageous, 
because as the oxygen reactivity of hemo­
globin is increased, the release of oxygen 
at the peripheral tissues is impaired; and, 
as the reactivity is decreased, oxygen re­
lease is facilitated. The H b.-02 reaction 
is a reversible chem ical reaction  and is 
governed by the many factors governing 
such physiochemical reactions. A zone of 
reactivity is defined as normal for normal 
physiologic conditions, but physiochemi- 
cally reactivity may vary in both direc­
tions.
In instances of severe refractory hypoxia, 
exchange transfusion with fresh erythro­
cytes might be given to restore the oxygen­
carrying capacity of the blood. Earlier 
demonstration of an impairment of the 
HOCC by the techniques outlined would 
provide the indications for such an under­
taking.
Summary
With more frequent determinations of 
blood-gas values, arterial hypoxia has been 
recognized more frequently as a physio­
logic derangement in severely ill patients. 
In certain of these patients there is no 
direct support for the diagnosis of pulmo­
nary ventilatory perfusion defects and they 
remain hypoxic despite the administration 
of oxygen in high concentrations.
The present study assessed the capacity
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of the blood of severely ill patients to re­
act with and to transport oxygen. We ob­
served defects in the hemoglobin oxygen­
carrying capacity ( HOCC) and in the 
normal relationship between the p 0 2 of 
the plasma and the oxygen content of the 
blood.
A brief review outlines some of the 
current concepts concerning the factors 
affecting the reversible chemical reaction 
between hemoglobin and oxygen, and the 
physical-chemical phenomena affecting the 
rate and extent of diffusion of oxygen into 
and through the erythrocyte. W e suggest 
that the observed abnormalities of the oxy­
gen transport mechanism might be ex­
plained after a more thorough considera­
tion of the basic physical-chemical re­
actions involved.
The extent and severity of the reported 
defects in erythrocyte function appear 
capable of contributing significantly to the 
refractory hypoxia so commonly seen in 
the severely ill patient.
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R e su m e
Un recours plus frequent a la mesure des gaz 
du sang a eu pour resultat de permettre de de- 
couvrir plus frequemment le trouble physiologi- 
que qu’est l’hypoxie arterielle chez des malades 
dont l’etat est critique. Chez certains de ces 
malades, il n’existe aucun facteur susceptible de 
confirmer le diagnostic d’anomalies de la ventila­
tion pulmonaire et meme radministration 
d’oxygene a forte concentration ne met pas fin 
a l’hypoxie.
La presente etude avait pour objet devaluer la 
capacite du sang des sujets tres malades de 
reagir avec l’oxygene et de la transporter. Nous 
avons note des anomalies dans la propriete de 
l’hemoglobine de transporter l’oxygene et dans la 
relation qui doit exister entre la p(.)= du plasma 
et la teneur sanguine en oxygkne.
Dans une breve revue, nous avons rappele 
quelques-unes des theories recentes sur les facteurs 
qui entrent en jeu dans la reaction chimique re­
versible entre l’hemoglobine et l’oxygene et dans 
le phenomene physico-chimique qui affecte la 
vitesse et l’6tendue de la diffusion de l’oxygene 
au niveau du globule rouge. Nous estimons que 
les anomalies constatees dans le mecanisme du 
transport de l’oxygene pourraient etre expliquees 
par un examen plus approfondi des reactions 
physico-chimiques profondes qui sont en cause.
Les anomalies qui ont ete notees dans la fonc- 
tion erythrocytaire, selon leur etendue et leur 
severity, peuvent jouer un role important dans 
l’hypoxie rebelle qui s’observe si souvent chez le 
malade gravement atteint.
November 1971 BATHTUB BURN 399
r
r > ‘
r 
r »-
rn
THE BATHTUB B U R N - A  PEDIATRIC DISASTER0
H. G. THOMSON, M.D., M.S., F.R .C .S.[C ],f and BEN SHORE, B.Sc., M.D., 
C.M., F.R .C .S.[C ],t Toronto, Ont.
According to Artz and Reiss1 “the home 
rather than the workshop is the place 
where bums are most likely to occur”, and 
this opinion has been corroborated in large 
“burn studies” in the United Kingdom and 
North America.2’6 However, the continuing 
emphasis on ignition and conflagration 
burns relegates the bathtub burn to ob­
scurity among the common scalds. Few 
reports specifically mention the bathtub 
bum.711 In 1968 Crikelair et al.,1'2 reporting 
on a series of burns from all causes, noted 
that of the four children who sustained 
bathtub burns, one died. They emphasized 
that the bathtub bum is a disastrous injury 
and all medical practitioners should be 
alert to its significance.
In the thermostatically-controlled electric 
or gas-heated tank, the water temperature 
is 130° to 160° F., hence, it is not surpris­
ing that immersion for a short time at these 
temperatures will cause death. Physicians 
consider most scalds, including bathtub 
bums, primarily first- and second-degree 
burns which will spontaneously re-epi- 
thelialize. This is true if the patient lives 
until re-epithelialization can occur. There­
fore, death due to a bathtub burn is par­
ticularly tragic because it is preventable, 
its seriousness initially may be overlooked, 
and the patient may not live for the 15 days 
necessary for the burned area to re-epi- 
thelialize. The purpose of this paper is to 
direct attention to the consequences of this 
type of thermal injury, which has aroused 
little concern to date.
Material and M ethods
In the 20-year period, 1945 to 1965, 3195 
children with new bums from all causes
° From the Department of Surgery, The Hospital 
for Sick Children, Toronto, Ont.
fPlastic Surgeon, The Hospital for Sick Children, 
Toronto.
^Resident in Plastic Surgery, The Hospital for 
Sick Children.
Reprint address: Dr. H. G. Thomson, Department 
of Surgery, The Hospital for Sick Children, 555 
University Avenue, Toronto 101, Ont.
were admitted to the Hospital for Sick 
Children, Toronto, for primary therapy. 
Scalds accounted for 50% of these ad­
missions.13'15 Of this group, 93 children 
sustained bathtub bums as a result of 
sitting or falling into the tub with or with­
out their clothes on. If initial treatment 
was given in another hospital and the pa­
tient was subsequently transferred to this 
hospital, he was not included in this series.
In these 93 children, there was almost 
equal distribution between male (48) and 
female (45).  The age range was 7 months 
to 8 years. There were no children under 
6 months of age. To calculate morbidity 
and mortality, patients were separated into 
Group A—under 24 months of age, and 
Group B—over 24 months of age.
The average length of stay in hospital 
for patients of both groups was 17 days, 
suggesting that most of the bums were 
first and second degree and had spontane­
ously re-epithelialized. No patients in this 
series required skin grafting. This fact 
suggests that those infants and children 
who died did so without extensive third- 
degree burns.
Five patients in Group A and six in 
Group B died—a mortality rate of 12%. 
This compares with 3%  to 4%  reported in 
other bum series involving all types of 
burns.15 Of those children who died, the 
average surface area burned was 45.6% in 
Group A and 48.0% in Group B. The 
average time of death after trauma was 
seven to nine days in both groups. The 
average time in Munro, Farmer and 
Csima’s series,15 which excluded bathtub 
and inhalation burns, was 28.9 days.
The combined LA 50 (lethal area) for 
Groups A and B was 43%. Although our 
rate is less than the 49.88% reported by 
Munro, Farmer and Csima13 and suggests 
a higher mortality rate with the involve­
ment of a smaller area, the difference is not 
statistically significant and may have been 
owing to chance.
Necropsy, which was completed on eight 
of the 11 children who died, showed the
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following changes: in four patients there 
was apparent adrenal gland exhaustion 
with antemortem hemorrhages; in five, 
gastrointestinal ulceration (esophagus, 
stomach, small and large bowel); in five, 
septicemia ( hemolytic Streptococcus, 
Staphylococcus, Klebsiella and Pseudo­
monas ).
These findings suggest that major com­
plications occur much earlier and more 
frequently in the child with a bathtub burn 
than in patients with other types of burns.
For each patient who died, we attempted 
to determine whether antibiotic therapy or 
fluid replacement or both had been de­
ficient. Five of these 11 patients were given 
penicillin on admission and it was con­
tinued in appropriate dosage for age. No 
broad-spectrum antibiotics were used. 
There was no apparent relationship be­
tween antibiotic therapy and mortality.
The volume of parenteral fluid replace­
ment for the first 48 hours was determined 
on a retrospective basis using the Evan’s 
formula as modified for children. These 
volumes were then compared to those 
volumes of replacement fluid actually 
given. No relationship between parenteral 
fluid underload or overload and mortality 
was established. None of the patients re­
ceived cortisone derivatives.
D iscussion
This study strongly suggests that chil­
dren with a bathtub burn are more likely 
to die and to die much earlier than chil­
dren with other types of burns. The at­
tending physician’s underestimation of the 
initial area and depth of the burn surface, 
and later inadequate parenteral therapy, 
does not appear to have been a major factor 
in the increased number of earlier deaths. 
During the period covered by this study, 
broad-spectrum antibiotics were relatively 
unavailable or condemned for prophylaxis. 
The high percentage of antemortem 
adrenal changes and the frequency of 
gastrointestinal ulceration suggest a more 
severe acute stress reaction. The suspected 
incidence of adrenal exhaustion is much 
higher in this series than reported in the 
general burn literature.16'18 However, it is 
difficult to correlate accurately the evidence
of microscopic adrenal exhaustion and 
clinical adrenal insufficiency. It would be 
better to anticipate this problem in this 
particular type of burn by blood cortisol 
levels and other laboratory investigations. 
The pathologist reviewed paraffin sections 
of the adrenal glands of the four patients 
presumed to have had adrenal exhaustion 
and reported that “The medulla and para- 
medullary areas of the zona reticulata show 
intense congestion with focal microscopic 
hemorrhage and both adrenal glands are 
lipid-depleted. These adrenals are ap­
proaching functional exhaustion but the 
morphologic changes are not sufficient to 
warrant a positive diagnosis of hypoadreno- 
corticalism. In one patient, one adrenal 
gland was totally destroyed and the other 
was approaching functional exhaustion. 
These particular changes are slightly more 
severe than similar changes in the other 
three patients.”
Although these 11 children shared no 
single common factor that could be at­
tributed to their demise, this study suggests 
that the child with a bathtub burn in an 
involved surface area greater than 20% 
should probably have early prophylactic 
broad-spectrum antibiotics and cortisone 
derivatives as supportive treatment. This 
can be justified because of the more ex­
tensive area of absorptive dermis that is 
immediately exposed to all external influ­
ences; the third-degree burn has its own 
semi-protective envelope for at least two 
weeks before these secondary problems 
develop.
Conclusions
This study demonstrated that the bath­
tub burn is potentially lethal; 11 out of 
93 children with such bums died. These 
patients need aggressive and early therapy 
to prevent death and to permit re-epithel- 
ialization of the burned areas to occur in 
15 to 20 days.
Summary
Ninety-three infants and children had 
bathtub burns and 11 of them died. At 
post mortem they had gastrointestinal 
hemorrhages, evidence of adrenal exhaus-
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tion, and septicemia. We believe that these children should receive aggressive anti­
biotic and cortisone therapy.
The authors wish to thank Dr. M. W ood, bio­
statistician, and Dr. M. J. Lynch, pathologist, for 
their assistance in the preparation of this paper.
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Resume
La signification clinique de la brulure par eau 
bouillante ( dans la baignoire) > n’a pas pris tout 
son relief par le fait qu’on l’a classee dans la 
categorie des echaudures banales. Rares sont les 
rapports qui mentionnenent ce type de brulure. 
L ’objet du present article est d’attirer l’attention 
sur la nature inquietante de ce type de lesion.
Les auteurs passent en revue les histoires clini- 
ques de 93 enfants qui ont ete hospitalises au 
Hospital for Sick Children de Toronto, de 1945 
a 1965. Cette etude retrospective a revele que la 
mortalite a atteint 12% , le deces etant survenu 
dans un delai de sept a neuf jours. La LA 50 com- 
binee (region letale) a ete de 43% . Chez quatre 
des huit enfants qui sont decedes, on a constate 
a 1’autopsie un epuisement des surrenales. On 
n’a pas decouvert de relation entre la mortalite et 
le remplacement liquidien par perfusion. Les 
auteurs conseillent, dans ce type de brulure, de 
recourir rapidement a des perfusions de remplace- 
nient energiques et de prevoir le risque d’epuise- 
ment des surrenales.
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BENIGN LYMPHOID POLYPOSIS OF ILEUM: THREE CASES AND A 
REVIEW OF THE LITERATURE0
V. K. PATEL, M.B., B.S. and C. F. AWEN, M.D., C.R.C.P.[C], F.A.C.P.,t
Saskatoon, Sask.
In 1966 Fieber and Schaefer1 reviewed 
eight cases of lymphoid hyperplasia of 
terminal ileum described in the literature 
and reported four additional cases of then- 
own. The first case of lymphoid hyper­
plasia of the terminal ileum was recognized 
roentgenologically and presented by 
Marina-Fiol and Rof-Carballo in 1941 
under the name “enteritis follicularis” .
The formation of discrete polypoid 
lesions from the hyperplastic lymphoid 
tissue of the terminal ileum is a rare patho­
logic process. Thomford and Greenberger2 
in 1968 described a case of lymphoid 
polypi of ileum associated with Gardner’s 
syndrome. In the same year Anthony3 re­
ported a 10-year-old boy who, after re­
current abdominal pain of eight months’ 
duration, underwent laparotomy. The re­
sected terminal ileum showed hyper­
plastic lymphoid polypi. In 1969 Keller4 
described an asymptomatic patient with 
benign nodular lymphoid hyperplasia of 
small intestine involving duodenum, jejun­
um and ileum.
Although several different terms have 
been applied to these benign lymphoid 
polyps, the term “benign lymphoid poly­
posis” more clearly reflects the histopath- 
ology of the lesion. Cornes5 in 1961 called 
the malignant counterpart of this lesion 
“multiple lymphomatous polyposis” .
Symptomatic cases previously reported 
were chiefly among young people who 
ranged in age from 3*4 to 22 years; 
asymptomatic cases appear to involve a 
middle or older age group.
In this paper we wish to report three 
asymptomatic cases of benign lymphoid 
polyposis of the terminal ileum found inci- 
dently at autopsy.
* From the Department of Pathology, University 
Hospital, University of Saskatchewan, Saskatoon, 
Sask.
tDepartment of Pathology, Beilin Memorial Hos­
pital, Green Bay, Wisconsin, U.S.A.
C ase Reports
Case 1—A 64-year-old man was involved 
in a car accident and sustained a rupture of 
the gallbladder and a soft-tissue injury. He 
died of bile peritonitis subsequently.
Case 2.—A 60-year-old woman sustained 
multiple traumatic injuries in a car accident 
and died from septicemia and pulmonary 
embolism six weeks later.
Case 3.—A 58-year-old diabetic farmer, who 
suffered from Shy-Drager’s syndrome, died 
from massive pulmonary embolism.
In all three cases, the gross pathology 
was more or less similar but histologically 
there was some difference.
Gross Pathology
Case 1 had multiple small polypi in the 
terminal ileum measuring from 0.1 cm. to 
0.3 cm. in diameter. The polypi tended to 
be sessile (Fig. 1). In Case 2 the polypi 
were more slender and had delicate stalks. 
The tips of the polypi were somewhat
Fig. 1.—Close-up of the lymphoid polypi from 
Case 1. The polypi tend to be sessile.
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Fig. 4.—A tissue section of the polypi from 
Case 2. The polypi are supported by delicate thin 
fibrovascular stalks and the lymphoid nodules are 
seen only in the tips.
adjacent normal mucosa were diffusely re­
placed by abundant lymphoid tissue ob­
scuring the mucous glands, while in Cases 
2 and 3 the mucosa adjacent to the polypi 
was fairly free from lymphoid tissue. 
Another interesting difference was the 
presence of mitotic figures found frequently 
in Case 1 (Fig. 5) and infrequently in 
Cases 2 and 3. The lesions in all three 
cases showed eosinophils. Reticulum cells 
showing large pink nucleoli were more fre­
quent in Case 1 than in Cases 2 and 3.
Para-aortic and mesenteric lymph nodes 
from Cases 1 and 2 were examined under 
the microscope to determine if the process 
of lymphoid hyperplasia was generalized. 
However, these specimens did not reveal 
any neoplastic or hyperplastic process.
D iscussion
These rare polypoid lesions of the small 
intestine consist predominantly of lymphoid
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supported by thick stalks and covered with 
many microvilli. The terminal ends of the 
polypi were clubbed. The stroma of the 
polypi was invariably replaced by abun­
dant lymphoid tissue, which often extended 
to the mucosal layer of the polypus, obscur­
ing the basic tissue architecture and form­
ing secondary lymphoid nodules (Fig. 3). 
The polypi ef Cases 2 and 3 revealed a 
lesser amount of lymphoid tissue in the 
stalk as well as in the tips of polypi ( Fig. 
4 ). In Case 1, the stalk of the polypus and
Fig. 2.—Lymphoid polypi of Case 2. The polypi 
are more slender and delicate. The tips of polypi 
are somewhat clubbed.
clubbed (Fig. 2). Case 3 had polypi simi­
lar to Case 2.
M icroscopic Pathology
Even though gross pathology showed 
somewhat similar polypi in all three cases, 
histopathology revealed interesting differ­
ences.
In Case 1, the multiple globular poly­
poid structures were made up of hyper­
plastic lymphoid tissue. These polypi were
Fig. 3.—A tissue section of the polypi showing 
plump stalks and clubbed tips with many secon­
dary lymphoid nodules. The mucosa between the 
polypi is densely populated by lymphocytic ele­
ments (H & E).
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Fig. 5.—Microscopic features of the polypi dis­
playing unusual numbers of reticulum cells. Five 
mitotic figures could be seen in this chosen field 
(H & E, original magnification X 480).
tissue with or without hyperplastic change. 
The benign form of this lesion, “lymphoid 
polyposis”, is pedunculated and has a 
delicate fibrovascular stalk. According to 
Cornes,8 the malignant counterpart of this 
lesion forms in the mucosa and submucosa 
as a mucosal thickening, as sessile and 
pedunculated polyps, or as raised nodular 
patches. Except for one case reported by 
Keller4 and our three cases, both benign 
and malignant forms appear to produce 
symptoms. Three of the five patients re­
ported by Cornes had radiologic evidence 
of intestinal polyposis and the other two 
were diagnosed at autopsy or laparotomy. 
These patients suffered from diarrhea, 
weight loss, tiredness and anorexia. In one 
case reported by Nagle,6 small intestinal 
lymphomatous polyposis was associated 
with intussusception. Swartley and Stay- 
man' reported a 7-year-old boy with 
cramping lower abdominal pain who under­
went appendectomy and ileotomy; micro­
scopic examination of tissues showed 
lymphoid hyperplasia.
Cornes8 in 1965 studied the number, 
size and distribution of Peyer’s patches in 
human small intestine and observed that 
these patches were easily seen even in 
elderly people. Some patches measured
more than 4 cm. in length. Thus, lymphoid 
tissue of small intestine seems to remain 
functionally active despite the ageing pro­
cess. Benign symptomatic lymphoid poly­
posis usually involves young individuals, 
and their lymphoid follicles are usually 
large with prominent germinal centres.
In an 18-year-old youth reported by 
Fieber and Schaefer,1 polypoid lesions in 
some segments of the terminal ileum dis­
played atypical lymphoid hypeiplasia, and 
in others showed tissue change thought to 
be a forerunner of lymphosarcoma.1 The 
lesion in our first case also demonstrated 
atypical features—a fair number of mitotic 
figures and replacement of mucosa between 
the polypi by dense lymphoid tissue con­
taining abundant reticulum cells with 
mitotic figures. Our first case and the case 
reported by Fieber and Schaefer appear to 
be premalignant. In fact, these authors 
suggest that lymphoid hyperplasia may be 
a precursor of “lymphoblastoma”. In our 
cases, the lymph nodes collected from 
mesenteric and para-aortic regions did not 
have any atypical features.
The etiology of lymphoid polyposis is not 
clearly understood. According to Helwig 
and Hansen,9 the structure of the lymphoid 
polyp suggests that the change is one of 
hyperplasia. However, they did not elabor­
ate on the pathogenesis any further. It is 
possible that under infectious, immunologic 
or other unknown stimuli, the lymphoid 
tissue of the small intestine may undergo 
hyperplastic polypoid changes. If pro­
longed, such stimuli may convert benign 
lymphoid polypi to their malignant counter­
part—a lymphomatous polyposis—and this 
lesion may pathologically appear as lymph­
osarcoma, reticulum sarcoma or Hodgkin’s 
disease. On gross examination, it may be 
difficult to distinguish the malignant form 
from the benign; however, the malignant 
variety tends to be larger and appears as 
sessile or raised nodular patches. The 
regional lymph-node involvement or gen­
eral nodal enlargement favours the po­
tential or apparently malignant variety. 
The benign fonn is usually small and in­
variably pedunculated. When the benign 
form produces symptoms and requires ex­
cision, local resection appears curative.
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Su m m a r y
Three cases of lymphoid polyposis of the 
terminal ileum are presented and the 
literature is reviewed. Fifteen such lesions 
were reported in the literature and all 
except one produced symptoms. Our three 
patients were middle-aged to elderly and 
had no symptoms. Lymphoid polyposis 
seems to be more common in men than 
in women.
The lesions in one patient (Case 1) 
showed histologic evidence of atypical 
features. These atypical features suggest 
possible early malignant transformation 
progressing to multiple lymphomatous 
polyposis.
The authors are grateful to Mr. John Junor for 
the photographic preparation.
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R esum e
Les auteurs decrivent trois cas de polypose 
lympho'ide benigne de Fileum, du reste asympto- 
matiques, qu’ils ont observes chez trois malades 
d’age moyen ou avance. Le processus pathologi- 
que fondamental de ces polypes est une hyper- 
plasie lympho'ide. Dans la phase benigne, ces 
lesions sont petites et pedonculees: au point de 
vue histologique, elles sont atypiques. Dans les 
formes premalignes et malignes, les lesions sont 
generalement plus etendues, sont sessiles ou se 
presentent sous forme de plaques nodulaires sure- 
levees. La presence d’une atteinte ganglionnaire, 
regionale ou generalisee, augmente le i-isque d’une 
forme maligne, notamment lymphosareome, sar- 
come a cellules reticulees ou maladie de Hodgkin. 
La forme benigne, quand elle est symptomatique, 
impose l’operation: la resection locale est curative.
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DETERMINATION OF INDIVIDUAL HUMAN TUMOUR SENSITIVITY 
TO ANTITUMOUR AGENTS BY TISSUE-SLICE INCUBATION*
H. W. WILLOUGHBY, Ph.D., G. B. MAUGHAN, M.D., P. C. TREMBLAY, M.D.
and N. WOOD, B.Sc., Montreal, Que.
Selecting the most effective of several 
types of antitumour agents for the treat­
ment of an individual cancer often is diffi­
cult on the basis of clinical experience 
alone. A reliable and fast method for de­
termining individual tumour sensitivity to 
individual drugs would be of great value 
in cancer therapy. Screening has been at­
tempted using tissue or organ culture tech­
niques,1-4 incubation of tumour tissue fol­
lowed by estimation of enzyme levels5 and 
incubation of tumour tissue with radio­
active substrates.6' 7
This last method was used by Bickis and 
Henderson,6, 7 who incubated tumour slices 
for two horns in a medium containing 
adenine and leucine (each labelled with 
14C). To each experimental flask they added an antitumour agent whose effec­
tiveness was determined from the depres­
sion of incorporation of these radioactive 
compounds into ribonucleic acid (RNA), 
deoxyribonucleic acid (DNA), and protein fractions of the tissue, and the depression 
of oxygen uptake during the incubation.
For our studies with human tumours, 
we modified the procedure of Bickis and 
Henderson6’ 7 omitting the oxygen uptake 
determinations and using 14C-labelled 
adenine and tritium-labelled L-leucine, i.e. 
double labelling.
The studies outlined below were under­
taken to assess the reproducibility of label 
incorporation in replicate tumour-slice in­
cubations in an attempt to ascertain 
whether this method of screening human 
tumours against assorted antitumour agents 
could provide reliable guidelines for pa­
tient chemotherapy.
°From the Department of Obstetrics and Gynae­cology, Royal Victoria Hospital, Montreal 112, One.
tMedical Biochemist, Queen Elizabeth Hospital, 2100 Marlowe Avenue, Montreal 260, Que.
This project was supported by The John R. Fraser Memorial Trust, McGill University.
M ethods
Seven tumour specimens were obtained 
for this study; the individual diagnoses are 
given in Table I.
Five to 20 g. of tumour tissue, obtained 
at the time of operation, were carried im­
mediately in ice-cold saline to the labora­
tory, sliced with a Stadie-Riggs microtome, 
and treated as described by Bickis and 
Henderson except for the following altera­
tion in the incubation and analytical pro­
cedures:
(1) Krebs-Ringer bicarbonate (KRB) 
plus glucose medium only was used, and 
to each Erlenmeyer flask containing 3.0 ml. 
of this medium we added 0.1 /xc. of ade- 
nine-8-14C and of L-leucine-4-5-T.
(2) Four control flasks were incorporated 
in each tumour study, when the quantity 
of tumour obtained was great enough, and 
also two additional control flasks contain­
ing dimethylsulfoxide (DMSO).
(3) Each determination with one drug 
or drug combination was performed with 
duplicate flasks and eight drugs or drug 
combinations were tested with each tumour 
if we had enough tumour tissue.
(4) The incubations were carried out 
in Erlenmeyer flasks in a Dubnov shaker 
in air for two hours at 37° C. rather than 
in a Warburg respirometer.
(5) 0.5 N sodium hydroxide was used 
to hydrolyze the RNA, then the DNA and 
protein were precipitated by hydrochloric 
and trichloracetic acids.8
(6) Aliquots of the RNA and DNA frac­
tions were removed for colourimetric 
analyses.9-10 After drying, these fractions 
were dissolved in hyamine or N sodium hydroxide for 14C estimation in a Packard 
Tricarb scintillation counter, Model 3002. 
The protein residues were dissolved in N sodium hydroxide from which aliquots 
were removed for colourimetric analysis11 and for tritium estimation in the same 
counter. Various scintillation mixtures were
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TABLE I.—I ncorporation  of u C I nto th e  RNA and DNA Fractions and  T ritiu m  into  P rotein  Fractions of T umour T issu e  S lices D uring
I ncubation in th e  C ontrol F lasks*
Cases 1 2 3 4 5 6 7
Adeno- Adeno- Adeno- Carcinoma Carcinoma
Diagnosis carcinoma carcinoma carcinoma of Carcinoma Carcinoma of
of ovary of ovary unknown colon of ovary oj ovary colon
A B A B A B A B A B A B A B
Controls 22,550 72,300 20,600 16,630 13,700 11,470 28,300 98,200 10,440 42,600 11,240 43,000 35,450 92,800
21,700 69,500 22,420 14,600 16,800 16,620 27,500 92,000 8,940 30,500 26,800 274,000 20,930 85,800
RNA 42,700 88,700 28,400 13,620 15,600 13,370 23,350 87,200 19,900 61,900 11,340 47,900 — —
fractions 33,000 79,000 27,400 19,900 20,200 16,610 57,400 73,900 22,000 63,800 — — '— —
DMSO 3,770 10,700 12,300 9,160 15,650 7,350 — — 1,610 5,430 4,795 24,100 — —
Controls 2,580 8,000 13,760 8,790 10,450 12,470 — — 1,323 5,030 — — — . —
1,130 14,420 1,140 4,600 240 1,420 1,005 7,800 506 1,744 672 5,290 1,362 4,760
14C into 475 3,800 1,610 5,750 445 2,870 2,040 10,300 532 1,715 515 3,600 592 2,265
DNA 1,170 9,680 1,4 0 4,600 340 2,4i5 1,673 10,000 1,339 3,100 463 3,405 — —
fractions 1,205 9,770 2,250 7,580 560 3,145 3,910 11,880 970 2,043 — — — —
DMSO 210 1,840 455 1,835 195 1,275 — — 219 260 227 1,360 —
Controls 150 1,427 610 2,325 190 1,385 — — 238 248 — — — —
Controls 120,500 28,300 14,525 3,500 — _ 4,550 942 1,830 627 3,125 1,406 4,710 2,140
Tritium into 130,000 25,200 24,100 3,460 — — 4,530 1,040 2,140 919 1,055 776 2,130 783
protein 295,000 40,450 22,600 2,445 — — 3,140 501 2,965 1,272 1,033 295 — —
fractions 320,000 51,600 — — — — 10,300 1,345 2,500 878 — — — —
DMSO 9,215 1,662 11,050 2,155 ___ — — — 206 93 530 234 — —
Controls 2,425 546 12,915 2,057 — — — — 894 562 — — — —
*A =  D/min./lOO g. wet weight of tissue: B = D/min./mg. of DNA, RNA or protein (specific activity).
used but corrections for quenching were 
always carried out.
The drugs used in this study were: 1- 
bis ( 2-chlorethyl) amino-l-oxo-2-aza-5-oxa- 
phosphoridin ( Procytox); 2,3,5-triethylene- 
imino-l,4-benzoquinone (Trenimon); meth­
otrexate; thiotepa; 5-fluorouracil; N-di- 
chloroacetyl-DL serine (Na salt) (Blevi- 
don ); 17-ahydroxy-6a-methylpregn-4-ene-3, 
20-dione acetate (Provera); NM-16° and 
NM-38A,f in the doses per flask used by
Results
The counting data for the control flasks 
are given in Table I as disintegrations per 
minute (D /m in .) in the RNA, DNA and 
protein fractions in 100 mg. wet weight 
of tissue (A  values in the tables), and as 
specific activity, i.e. D/min./mg. of DNA, 
RNA or protein in each incubation flask 
(B values in the tables). The agreement of 
the results obtained with replicate tissue
T A B L E  II.— A v e r a g e  D e v ia t i o n s , a s  P e r c e n t a g e s  o f  t h e  M e a n s , o f  t h e  C o n t r o l  V a l u e s  in  T a b l e  I 
Cases 1 2 3 4 5 6 7
A B A B A B A B A B A B  A B
R N A ......................  29 . 0  8 . 4  13 . 0  13.3 11.8  14.4 3 4 . 0  6 . 6  3 7 . 0  36 . 6  4 2 . 0  8 3 . 0  2 4 . 9  3 . 9
D N A ...................... 26.1 29 . 7  19.9 18.3 2 6 . 8  2 1 . 8  5 6 . 0  11 . 0  3 8 . 0  22 . 0  15.4 19.3 3 9 . 4  3 5 . 5
Protein..................  42.1 26.1 19.1 14.7 — —  4 1 . 3  2 4 . 6  15 . 8  18.8 53 . 2  35.1  3 7 . 7  4 6 . 4
Bickis and Henderson,7 except for the last 
two drugs for which the doses were de­
termined in rats with Walker 256 carcinoma 
in our laboratory. The last three drugs are 
insoluble in water, so appropriate doses 
were dissolved in 0.2 ml. of DMSO, except 
for Case 1 in which 0.4 ml. of DMSO was 
used, which was incorporated in the 
medium.
,,N M -16-N -bis(2 chlorethyl)-2 benzamidopro- 
pionamide; Charles E. Frosst & Company, Mont­
real, Que.
tNM-38A—the salt of Nor-nitrogen mustard and 
naptholic acid; Charles E. Frosst & Company, 
Montreal, Que.
incubations was poor. The average devia­
tions of the control results, expressed as 
percentages of the means (Table II ) , gave 
a range from 11.8% to 56% for the A 
values, and from 6.6% to 83% for the B 
values.
In the results from the duplicate DMSO 
flasks, in spite of the very poor agreement 
in two of the 12 pairs of results in Table 
I, we can conclude that the incorporation 
of labelled substrates was markedly re­
duced.
When the results from the incubations 
for single or combined drugs were ex­
amined, in 29%, 14% and 36% of the
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duplicate A results, and in 22%, 12% and 
27% of the duplicate B results (as A and 
B above), one result was more than twice 
its duplicate. Thus, some improvement in 
agreement was noticed when the counting 
data were expressed as specific activities. 
A statistician consultant commented that 
these data showed such poor agreement 
that a more elaborate evaluation of them 
would only be a waste of time; they have 
not been included in this paper.
D iscussion
The omission of the determinations of 
oxygen uptake and carbon dioxide produc­
tion allowed us to increase the numbers of 
incubation flasks. Bickis and Henderson0’ 7 
probably were limited by the number of 
determinations that can be done in a War­
burg incubator and thus did two, or oc­
casionally three, replicate control flasks 
while we were able to do four replicate 
control flasks. Also, we were able to do 
duplicate determinations with each drug 
if enough tissue was obtained from the pa­
tient, while those authors were limited to 
a single flask for each drug. Thus, we 
were able to examine this procedure more 
minutely for reproducibility.
From the data in Table I it is obvious 
that the agreement of the values from 
replicate flasks was so poor that reliable 
control incubation values could not be ob­
tained. Standard deviations, as percentage 
value of the averages of replicate deter­
minations are greater than 25% in 14 of 
the 20 values reported in Table II. The 
spread is reduced when the B values are 
examined similarly; only nine of the 20 
average deviations fell above 25%. The 
results for the pairs of drug flasks men­
tioned above were equally discouraging 
and we are forced to conclude that, in our 
hands, this method gave results whose 
reproducibility was so poor that it is use­
less as a guideline for cancer patient 
chemotherapy.
It is possible that the poor agreement 
could be due to variation in cell type in 
the tissue added to each flask. Human 
tumours often contain more than one type 
of cell and the proportion of each type 
present in a tissue slice could vary from
slice to slice even though the tissue was 
grossly similar in each slice. Also, necrosis 
may vary in tumour tissue and, if present 
in small scattered pockets of cells, would 
not be detected by visual examination. As 
the tissue slices were completely destroyed 
in the procedure, we could not examine 
the slices microscopically to determine 
homogeneity of the tissue. Tchao et al 
in their organ culture studies with human 
tumour tissue, reported marked variations 
in different cell populations in adjacent 
slices from the same tumour.
The only positive finding in this study 
was that DMSO, either 0.2 ml. or 0.4 ml. 
in 3.0 ml. of medium, lowered the incor­
poration of 14C and tritium into nucleic 
acids and protein respectively. The recent 
finding that DMSO, 2% in the medium, 
strongly inhibited the growth of HeLa cells 
and, 12% in the broth, inhibited the 
growth of E. coli, supports our findings.12
Some success in determining the sensi­
tivity of human tumours to individual anti­
tumour agents has been achieved by 
culture methods including tissue culture,2 4 
organ culture5’ 13 and rooster plasma clot 
cultures.14,15 The determination of drug 
sensitivity was based on morphologic dam­
age of tissue determined microscopically 
and this approach promises more success 
than the incubation procedure we followed.
C onclusions
The reliability of the incorporation of 
labelled adenine and L-leucine into nucleic 
acids and protein has been investigated.
Replicate results obtained with this tech­
nique showed such poor agreement that 
no recommendations for patient therapy 
could be made.
Dimethylsulfoxide lowered the incorpora­
tion of these metabolites into tissue com­
ponents.
We wish to thank Dr. I. Horowitz of the De­
partment of Epidemiology and Public Health, 
McGill University for his statistical appraisal of 
the data we obtained in this study.
The experimental drugs were provided by 
Charles E. Frosst & Company, Montreal, Que.
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R e s u m e
Les auteurs se sont servis d’adenine et de 
leucine marquees qu’ils ont incorporees aux acides 
nucleiques et aux proteines pendant l’incubation 
de la tranche tissulaire, pour evaluer Faction des 
antitumoraux sur les tumeurs humaines individu- 
elles. La repetition de Fincubation avec des 
tranches de la meme tumeur a donne des con­
cordances entre metabolites marques tellement 
mediocres qu’on ne pouvait se servir de ces 
donnees comme guide pour le choix de la chimio- 
therapie a appliquer au malade. L ’addition de 
dimethylsulfoxyde (DMSO) au milieu d’incuba- 
tion a reduit l’incorporation de ces metabolites 
marques dans les tranches tissulaires.
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EXTRADURAL METASTASIS FROM A PRESUM ED CAROTID-BODY 
TUMOUR PRODUCING PARAPLEGIA: A CASE REPORT
D. N. GONGAL, B.Sc., M.B., M.S., F.I.C.S.,* GORDON J. MACK, M.D., 
F.R.C.S.[C], F.A.C.S.f and B. B. VAIDYA,| Kathmandu, Nepal
T h e  surgical management of carotid-body 
tumours carries a significant serious mor­
bidity and mortality. One important con­
sideration in the decision to operate is 
whether the tumour is to be considered 
benign (admittedly with local potential of 
fatal complications) or malignant. Only a 
few confirmed cases of distant metastasis 
have been documented and these have 
been collected in the excellent reviews of 
Morfit, Swan and Taylor,1 Hendrick,2 and 
Westbury.3
C a se  R ep o r t
S.S.P., a 34-year-old man from East Nepal, 
was admitted on June 30, 1969, in critical 
condition with paraplegia of one year’s dura­
tion, severe urinary tract infection and de­
cubitus ulcers. There was no history of trauma. 
He was managed, within the limits of our 
facilities, on a hospital-made “Stryker” frame, 
and with bladder training; eventually the 
ulcers were covered with rotation flaps and 
skin grafting.
Fig. 1.—The tumour in the left anterior superior 
cervical triangle was three inches in diameter and 
had been present for five years.
'Senior Staff Surgeon, Bir Hospital, Kathmandu, 
Nepal.
JSenior Surgeon, Shanta Bhawan Mission Hos­
pital, Kathmandu.
^Pathologist, Military Hospital, Kathmandu.
An almost incidental finding, considering 
the patient’s desperate condition, was a firm 
non-tender oval tumour in the left anterior 
superior cervical triangle; three inches in 
diameter, it transmitted pulsation and had 
been present for five years (Fig. 1). His 
cerebrospinal fluid was clear, scanty and at low 
pressure indicating a proximal block. It 
showed only a trace of protein with five cells. 
The VDRL test was negative. Radiographs of 
the chest and thoracic spine were negative, 
but a myelogram, when dye was eventually 
obtained,- revealed a complete block at the 
level of T7.
Following at least partial control of his life- 
threatening complications and elevation of his 
hematocrit from 28% to 39%, a laminectomy 
was performed under general anesthesia, un­
covering T5, T6 and T7. A soft pale well- 
demarcated dorsal extradural soft-tissue tumour 
was exposed which peeled easily from the 
dura. On opening the dura, no further ob­
struction was encountered to an exploring 
catheter.
On gross examination, the pathologist de­
scribed “a smooth greyish firm tumour meas­
uring 2 x 1.5 x 1 cm. There is evidence of 
bony erosion by tumour.” Histologically it was 
reported “Tumour shows nests of large poly­
hedral cells with rounded nuclei arranged in 
alveolar pattern and separated from each other 
by connective tissue and vascular stroma. This 
is consistent with secondary from primary 
carotid-body tumour.” (Figs. 2 and 3 ). A later 
supplementary report of the biopsy of the 
decalcified lamina did not confirm the gross 
appearance. The pathologist added “no evi­
dence of secondary carotid-body tumour. 
Necrotic foci are probably pressure necrosis.”
Following Swan’s policy, we had the slide 
reviewed by an independent pathologist. He 
reported “The morphology of the lesion is 
typically that of a chemodectoma or para­
ganglioma, and as such could be a carotid-body 
tumour. While not histologically malignant it 
has obvious bone within the tumour and 
hence fits a vertebral metastasis. In interpret­
ing a case of this kind it is imperative to know 
that there is not one or more chemodectomas 
in the neck, thorax, or abdominal retroperi- 
toneum.”
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Fig. 2.—Low-power view of the tumour. Note 
the arrangement of anaplastic cells in solid ball­
like masses penetrated by a capillary network. 
Larger fibrous septa are also seen (H & E, original 
magnification X 60).
Fig. 3.—Higher power view of the tumour. The 
tumour cells are small with darkly stained round 
or ovoid nuclei and relatively abundant pale- 
staining cytoplasm. In the lower right of the 
micrograph, the stroma is homogeneous, hyalin- 
ized and resembles amyloid (H & E, original 
magnification X 350).
D iscussion
In Morfit, Swan and Taylor’s compre­
hensive review,1 they found one previous 
case of metastasis to the thoracic vertebrae 
(T5 and T6), and added one of their own 
proved at autopsy. Westbury:i described a 
man with a 20-year history of tumour who 
had a local metastasis removed and con­
firmed, then six months later became para­
plegic with a lumbar-spine deposit diag­
nosed at autopsy as “metastasizing carotid- 
body tumour”.
Our case has several obvious deficiencies. 
The cervical tumour was never identified 
pathologically. Once afebrile, with his 
ulcers healed, although his neurologic state 
was unimproved, the patient returned with 
his family by stretcher to a remote area of 
the country completely lacking in medical 
care, where he has probably now suc­
cumbed to paraplegic complications—with­
out an autopsy.
The presumptive evidence for metasta­
sizing carotid-body tumour producing 
paraplegia is sufficiently strong, however, 
to warrant recording this case report.0
Summary
A 34-year-old man was admitted to hos­
pital with paraplegia, urinary tract infec-
“ Editor’s note. Pathologists who reviewed this 
paper concluded that the sections represented 
metastatic carcinoma of the thyroid. A consultant 
described the section in the following terms: “The 
tumour is highly cellular and characterized by 
nests and masses of anaplastic small round or 
ovoid cells with staining cytoplasm (Fig. 2 ). The 
tumour cell nuclei are hyperchromatic. There is 
little cellular pleomorphism. The stroma between 
the cell masses is rich in capillaries. Fibrous tra­
beculae traverse the lesion. In some areas the 
stroma is brightly eosinophilic, hyalinized and 
suggestive of amyloid (Fig. 3 ).”  He drew the 
following conclusions about the source of the 
tumour: “From the structure of this tumour and 
its location, there is no doubt that this lesion is 
a metastatic carcinoma. The histogenesis of the 
tumour is not certain. Origin from a carotid-body 
tumour is possible but spread from a medullary 
carcinoma of the thyroid would be more likely, 
in my opinion. To confirm this view, it would be 
necessary to find a primary tumour in the thyroid 
or to demonstrate amyloid fibrils in the tumour 
and the specific granules within the cytoplasm of 
the tumour cells. In a recent case o f this type 
at the Toronto General Hospital, the diagnosis of 
medullary carcinoma was established with cer­
tainty only after amyloid fibrils and cytoplasmic 
specific granules were demonstrated by electron 
microscopy.”
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tion and decubitus ulcers. During treat­
ment, we found a firm non-tender three- 
inch tumour in the left superior cervical 
triangle; it had been present for five years.
At laminectomy, a soft well-demarcated 
dorsal extradural tumour was removed 
without complication. On gross examina­
tion, the appearance of the tumour was 
consistent with a secondary from a primary 
carotid-body tumour, but this was not 
confirmed by biopsy of the decalcified 
lamina. However, a report by an independ­
ent pathologist led us to believe that this 
patient’s paraplegia was probably caused 
by a metastasizing carotid-body tumour.
The authors wish to thank Dr. M. J. Phillips, 
Department of Pathology, Toronto General Hos­
pital, for his help in preparing this paper for 
publication.
References
1. Morfit HM, Swan H, Taylor ER: Carotid 
body tumours; report of twelve cases in­
cluding one case with proved visceral dis­
semination. Arch Surg (Chicago) 67: 194, 
1953
2. Hendrick JW : Carotid body tumours. Sur­
gery 31: 385, 1952
3. Westbury G: Management of carotid body
tumours; with report of seven cases. Brit 
J  Surg 47: 605, 1959
R e su m e
Un homine de 34 ans ete hospitalise pour 
paraplegie, infection des voies urinaires et ulceres 
de decubitus. Pendant le traitement, nous avons 
decouvert dans le triangle cervical superieur 
gauche une masse ferine de trois pouces de 
longueur qui y etait presente depuis cinq ans.
Au moment de la laminectomie, nous avons 
excise sans complication une tumeur dorsale 
extradurale, molle, bien delimitee. A l’examen 
macroscopique, la tumeur donnait a penser qu’elle 
etait secondaire a une tumeur primaire du glomus 
caroticum, mais cette hypothese n’a pas ete con­
firmee par la biopsie de la lame decalcifiee. 
Cependant, un rapport foumi par un pathologiste 
independant a porte les auteurs a croire que la 
paraplegie dont souffrait le malade avait ete 
probablement causee par une tumeur metastati- 
que du glomus caroticum.
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IMPROVED ATTACHMENT FOR STEINMANN-PIN TRACTION
R. L. AILSBY, B.Sc., M.D.,** Saskatoon, Sask.
Sk ele ta l  traction applied through a Stein- 
mann pin is a successful method of manag­
ing certain fractures.1'3 The usual method 
of attaching this has been by a stirrup 
arrangement. We believe that this is not 
entirely ideal because (1) the pin may ro­
tate in the bone as a result of friction be­
tween the stirrup and the pin clamp; (2) 
the single rope attached to the stirrup inter­
feres with the foot; and (3) the stirrup 
may place unequal stress on the ends of 
the pin if the traction rope is not at right 
angles to the pin.
0
Fig. 1.—Anteroposterior view of the assembled single attachment.
Fig. 2.—The component parts of a single attachment.
We have developed an attachment which 
incorporates a minimal-friction bearing 
with a stabilizing traction arm (Figs. 1 
and 2). Over the last two years, by using 
two of these light highly mobile attach­
ments placed at the ends of the protruding 
threaded Steinmann pin, and by applying 
traction directly to these attachments, we
Fig. 3.—Close-up view of the leg of a patient with two attachments and cords.
“Department of Orthopedic Surgery, University Hospital, University of Saskatchewan, Saskatoon, Sask.
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have achieved effective skeletal traction 
(Fig. 3). In addition, this improved design 
has the following advantages: (1 ) even 
and equal traction can be applied to both 
ends of the pin and an even pull main­
tained in the desired plane no matter in 
what position the patient places his limb; 
(2) minimal binding between the pin and 
traction arm allows movement of the area 
under traction with no rotatory or angula- 
tory stress on the pin. This in turn reduces 
movement of the pin in the bone to near 
zero and reduces the pain and risk of in­
fection at the pin site; (3) two-point attach­
ment allows the traction ropes to remain 
clear of the limb distal to the traction site; 
and (4) the almost frictionless movement 
obtained by this method greatly facilitates 
active physiotherapy.
This attachment incorporates a steel ball­
bearing0 and modified low-friction nylonf 
(replaceable) bearing in a stainless steel 
hub. The attachment, which is firmly held 
to the Steinmann pin with a machine set­
screw, can be disassembled easily for 
cleaning and changing of the bearings if 
necessary. The bore of the attachment 
allows it to fit firmly to any size Steinmann 
pin. There is an exchangeable arm on the 
mobile section of the apparatus for trac­
tion-rope fixation.
The apparatus permits greater mobility 
and fewer complications (pin bending and 
pin movement) in three ways: (1 ) reduced 
friction, (2 ) application of balanced pin 
torque, and (3 ) clearance of the foot from 
rope interference.
As pointed out above, the key to this 
improved traction is its mobility and torque - 
absorbing qualities due to the low-friction
“Standard grease-sealed ball-bearing (machine 
quality) S.K.F. type.
tStandard type 7 Snap in Nyliners; Thompson 
Industries— Dupont Nylon.
bearing. In certain instances (Russell trac­
tion),2 a stirrup attachment is still needed 
and these bearings are incorporated into 
the ends of the classical stirrup.
Su m m ar y
We have found this method of traction 
especially useful in fractures requiring 
tibial (fractured femur) and calcaneal 
(tibial fracture) traction. The apparatus 
permits an earlier and a more active level 
of physiotherapy with the resultant earlier 
pain-free knee movement and quadriceps 
maintenance. We therefore recommend 
traction with this mobile attachment in the 
management of selected fractures.
I wish to thank Mr. Hans Dommasch of the 
Medical Photography Department, University of 
Saskatchewan, for his help and advice.
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R esume
Toute traction effectuee sur un clou de Stein­
mann risque de provoquer plusieurs complications. 
Le present article decrit un appareil qui permet 
de n’appliquer la traction qu’aux niveaux desires 
et qui reduit le pliement du clou, ses rnouve- 
ments et l’infection au niveau de l’insertion du 
clou dans les tissus.
Le nouvel appareil comporte un petit roule- 
ment, tres leger, virtuellement exempt de friction 
et qui absorbe le couple de torsion. II est contenu 
dans un moyeu qui se fixe facilement aux extre- 
mites saillantes d’un clou de Steinmann. Cette 
methode de traction nous a permis de reduire 
sensiblement les complications au niveau du clou. 
Elle presente un grand interet dans le traitement 
des fractures des membres inferieurs qui exigent 
une traction sur le tibia ou le calcaneum. Grace a 
cet appareil, il est possible de commencer rapide- 
ment des traitements physiotherapiques actifs et 
de les poursuivre activement, prevenant de la sorte 
l’atrophie musculaire et la raideur articulaire.
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TH E C A N A D IA N  JO U R N A L OF SURGERY
All communications concerning this journal 
should be marked “The Canadian Journal of 
Surgery” and addressed to the Editor, 530 
Scarlett Road, Suite 1002, Weston 626, Ont.
The Journal is published bi-monthly. Sub­
scription is $15 per year ($7.50 per year for 
trainees in surgery), and starts with the Janu­
ary issue of each year. Single copies are $2.50 
each, payable in advance. (It would be greatly 
appreciated if subscribers would add bank ex­
change to their cheques.)
INSTRUCTIONS TO CONTRIBUTORS 
Manuscripts
Manuscripts in duplicate of original articles, 
case reports, and other contributions should 
be forwarded with a covering letter re­
questing consideration for publication in The 
Canadian Journal of Surgery. Acceptance 
is subject to the understanding that they 
are submitted solely to this Journal, and 
will not be reprinted without the consent 
of the author and the publishers. Accept­
ance or rejection of contributions will be 
determined by the Editorial Board. As 
space is available, a limited number of 
case reports will be published. Articles 
should be typed on one side only of un­
ruled paper, double-spaced, and with wide 
margins. The author should always retain a 
carbon copy of material submitted. Every 
article should contain a summary of the 
contents. The Concise Oxford Dictionary 
will be followed for spelling. Dorland’s 
Illustrated Medical Dictionary will be fol­
lowed for scientific terminology. The Edi­
torial Board reserves the right to make the 
usual editorial changes in manuscripts, in­
cluding such changes as are necessary to en­
sure correctness of grammar and spelling, 
clarification of obscurities or conformity 
with the style of The Canadian Journal of 
Surgery. In no case will major changes be 
made without prior consultation with the 
author. Authors will receive galley proofs 
of articles before publication, and are asked 
to confine alterations of such proofs to a 
minimum.
Reprints
Reprints may be ordered on a form which 
will be supplied with galley proofs. It is 
important to order these before publication 
of the article, otherwise an extra charge 
for additional type-setting will be made.
References
References should be referred to by numer­
als in the text. They should include in 
order: the author’s name and initials in capi­
tals, title of the article, abbreviated journal 
name, volume number, page number and 
year. The abbreviations of journal names 
should be those used in Index Medicus. 
References to books should include in order: 
author’s name and initials, title of book, 
number of edition (e.g. second ed.), city 
of publication, title of publishing house, 
year of publication, page number if a 
specific reference. For examples, see this 
journal January 1971 issue onwards.
Illustrations
A reasonable number of black-and-white 
illustrations will be reproduced free with 
the articles. Colour work can be published 
only at the author’s expense. Photographs 
should be glossy prints, unmounted and 
untrimmed, preferably not larger than 8" 
x 6". Prints of radiographs are required 
and not the originals. The magnification of 
photomicrographs must always be given. 
Photographs must not be written on or 
typed on. An identifying legend may be 
attached to the back. Patients must not be 
recognizable in illustrations, unless the 
written consent of the subject for j  ublica- 
tion has been obtained. Graphs anu dia­
grams should be drawn in India ink on 
suitable white paper. Lettering should be 
sufficiently large that after reduction to 
fit the size of the Journal page it can still 
be read. Legends to all illustrations should 
be typed separately from the text and sub­
mitted on a separate sheet of paper. Illustra­
tions should not be rolled or folded.
Language
It should be clearly understood that con­
tributors are at full liberty to submit 
articles in either English or French, as they 
please. Acceptance will be quite independ­
ent of the language of submission. If the 
contributor wishes, he may submit an in­
formative summary of not more than 300 
words in the language other than that in 
which he has submitted the article. For 
example, an article in English must carry 
an English summary and may, if the author 
wishes, carry a more detailed summaiy in 
French.
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LE JOURNAL CANADIEN DE CHIRURGIE
Toute communication concernant le Journal 
devra porter la mention “Le journal canadien de 
chirurgie” et etre adressee a l’Editeur, 530 
Scarlett Road, Suite 1002, Weston 626, Ont,
Le journal est publie a tous les deux mois. Le 
prix de l’abonnement est de $15. par an ($7.50 
par an pour les medecins qui sont residents en 
chirurgie) et commence avec le numero de 
janvier de chaque annee. Un exemplaire isole 
coute $2.50 et est payable d’avance. (Nous 
serions reconnaissants aux souscripteurs de vou- 
loir bien ajouter a leur cheque le montant des 
frais bancaires eventuels).
INSTRUCTIONS A NOS
COLLABORATEURS
Manuscrits
Les manuscrits d’articles originaux, de rap­
ports cliniques etc. seront envoyes en deux 
exemplaires, accompagnes d’une lettre deman­
dant qu’on veuille bien considerer leur publica­
tion dans L e journal canadien de chirurgie. Ils 
ne seront acceptes qu’a la condition qu’ils 
n’aient ete soumis qu’a notre Journal et qu’ils 
ne soient pas reimprimes sans le consentement 
expres de l’editeur et l’auteur. L’acceptation 
ou le refus des articles soumis releve du Con- 
seil de la publication. Si la place est disponible, 
un nombre limite d’histoires cliniques pourront 
etre publies. Les articles seront dactylographies 
sur un seul cote d’un papier non ligne, a double 
espace et avec une large marge. L ’auteur devra 
toujours conserver une copie au papier carbone 
du texte soumis. Tout article devra etre ac- 
compagne d’un resume. L’orthographe sera 
celle adoptee par le dictionnaire Larousse. 
Quant a la terminologie scientiflque, elle sera 
basee sur le Dictionnaire des termes techniques 
de medecine ou tout autre ouvrage de refe­
rence serieux. Le Conseil de la publication se 
reserve le droit d’apporter au texte les change- 
ments qu’il jugerait a propos pour assurer la 
correction grammaticale et Torthographe, pour 
eliminer d’eventuelles obscurites ou pour ren- 
dre la presentation conforme au style du Jour­
nal canadien de chirurgie. Aucun changement 
important ne sera apporte au texte sans que 
Tauteur ait ete prealablement consulte. Les 
auteurs recevront avant la publication des 
epreuves d’imprimerie de leur texte, auxquelles 
ils sont pries d’apporter le minimum de correc­
tions.
Tires-a-part
On pourra commander des tires-a-part sur 
une formule qui est envoyee avec les epreuves. 
II est important de les commander avant la 
publication de l’article, sous peine de devoir 
payer un supplement pour une nouvelle com­
position.
Bibliographic
Les references bibliographiques seront indi- 
quees par des numeros dans le corps du texte. 
Elies comprendront dans 1’ordre: le nom de 
1’auteur et ses initiates, en majuscules, le titre 
abrege du Journal, le numero du volume, le 
numero de la page et l’annee. Les abreviations 
admises pour les noms de revues sont celles qui 
figurent dans I’lndex Medicus. Les renvois aux 
livres comprendront dans l’ordre: le nom de 
Tauteur, ses initiales, le titre de l’ouvrage, le 
numero de l’edition (p. ex. deuxieme ed.), la 
ville et le nom de la maison d’edition, et 
l’annee de la publication; enfin, le numero de 
la page s’il s’agit d’un renvoi precis. Pour 
examples, voyez Tissue de janvier 1971 et ceux 
a venir.
Illustrations
Le journal accepte de publier gratuitement 
un nombre raisonnable d’illustrations en noir 
et blanc. Les reproductions de cliches en eou- 
leurs seront publiees aux frais de Tauteur. Les 
photographies seront imprimees sur papier bril- 
lant, ne seront ni montees ni calibrees et d’un 
format maximum de 6" x 8". En ce qui con- 
cerne les radiographies, nous demandons des 
copies et non pas Toriginal. On devra toujours 
fournir un agrandissement de microphoto­
graphies. Il ne faut jamais ecrire ou dactylo- 
graphier un texte quelconque sur les photo­
graphies. Une legende les identifiant pourra 
etre jointe au dos. Dans les illustrations mont- 
rant des malades, ceux-ci ne pourront etre 
reconnus, a rnoins qu’ils n’en aient donne le 
consentement ecrit prealablement a la publica­
tion. Les graphiques et diagrammes seront des- 
sines a l’encre de Chine sur un bon papier a 
dessin blanc. Le lettrage devra etre ecrit en 
caracteres assez grands pour que, apre reduc­
tion proportionnelle au format du Journal, ils 
soient encore lisibles. Les legendes devant 
accompagner les illustrations seront dactylo­
graphies sur une feuille independante du 
texte. Les illustrations ne seront ni roulees ni 
pliees.
Langue vehiculaire
II doit etre clairement etabli que les colla- 
borateurs ont pleine liberte de soumettre leurs 
articles en frangais on en anglais, a leur choix. 
L’acceptation de l’article sera entierement inde- 
pendante de la langue choisie par Tauteur. Si 
le collaborateur le desire, il peut decrire le 
contenu de Tarticle en un sommaire ne depas- 
sant pas 300 mots et dans une langue differente 
de la langue choisie pour Tarticle lui-meme. 
Par exemple, un article ecrit en frangais doit 
comporter un resume en frangais et peut, si 
Tauteur le desire, etre accompagne d’un som­
maire plus detaille en anglais.
I I 
i 
K 
e 
e 
n 
:l 
e 
II' 
l l 
ii' 
I-
ii-
an 
n-
es 
11'S 
o-
0· 
0-
J'f\ 
11-
re 
le 
l· 
~-
,\ 
~ 
s 
l 
Nc>i:e111/1cr 197 J BOOK HEVIE\ 419 
BOOK REVIEWS 
ANESTHESl FOR TUE AGED. Paul H . Lor-
han . JS:J pp . C harles C Thomas Publisher, 
S11ri11glleld Ill ,; ,\I Crnw-Hill Canada, Toronto, 
197 J. . ' I 0 .00. 
This is not lh fi rst hook th auth r ha~ 
writt 11 in the fie ld of geriatri · anesthesia . 
Once mor he brings lo us his cl eep know! dg 
of the Id rly pati nt, with sp cine emphasb 
on the basi · pathophysiologic chm1g that 
Ot' ur with th age.in pro ·ess. He has mas-
tered th difficult task of writing a brief, 
easil )' read book, wJ1ich is well documented 
nnd contains th e most urrcnL informat ion 0 11 
this particular aspect of anesthesia . 
If compared to th monob•raph " ri a tric 
nesthesia" publi.~hed in Hl55, the form and 
:1rrange111 nl of this book js almost id ntical. 
This prescrv s th , origin ii purpose of the 
book which is dire· ted to those who are 1101 
lnmilinr with th in 1nagc111 ' llt of th e ttgcd 
pali •nt. 
1'or those who are in volved regular! in 
g riatric anesthesia, this book rem ains a good 
general sou r ·e of information and is verv r -
freshing. rt is recon un en<led for ge11 °rnl ' hos-
pit al libraries t1t th fair price of $10.00. 
B NNELL'S SUHCERY OJ~ THE HA ' D. 5th l'd. 
Hcviscd by J oseph H. Bu>' ·s. 727 pt>. lllust. 
J. B. Li1>1>in<.-ott Company, Phil11dclphi11; J. n. 
ippincott Com1>tmy or Canada Ltd., Toronto, 
1970. '35.75. 
Once a~ni n in Dr. Jos ph Boy .~• r vised fifth 
ec.lilion of '' Bu11nell's Surg ry or Iii J land". 
we find •xt nded x e lle11c ,, The II w lexl 
hns a mor compa ' l nature with ven hell r 
orgn11 izatio11 than th last edition . Many addi-
tio, a l clinicn l and ha lf-ton photographs 
further 111odify the subj c t 11 alt 1·. l\losl of the 
previous colour photos J1 ave heen d le ted. 
This n w ed ition, as a lways, ,. rn ains a 111 11s t 
in <•very surgeon's library nnd hop full y, n 
fr qu •nt r fer nee i11 his hand! 
CAMPBELL' OPEHATIVE OHTHOPAEDTC . 
2 vols. 5th eel. Edit ed by A. H. Crenshaw. 
20<14 Ill>, nnd indexes. lllust . Thl' C. \I. Mosb , 
Company, SI. Loui ·, 1971 . $83.50, 
Th . fifth clition of "Campbell's Op rntive 
Orthopaedics" also marks th go lden anniver-
s~1y of th foundin~ of th , Campbell linic. 
!his ed ition maintains the high . standards of 
ll~ pr dee ssors • th "Encyc loped ia J~dt-
la11ic-:1'' of orthopedic surg ry: In th e ight 
)'ears that s parnle this c· litio11 from the last, 
!llany new surgical ted111 iq ues hav b n 
introdul'cd and most of lh . are incl11decl-
:1 uniq ue achievemen t when 011 considers the 
111 vitahle d lay be twc n the time th m :111u-
sc1·ipt is "put lo bed" a11d the moment th · 
Vol~n cs ar fina l! published. 
1 he formal nnd clrnp t r l1endings of th is 
dition • re identi al to the previ us on . The 
r ader familiar with " ampbell's" will 1101 on! 
f e l al home hut also will lie pleas d b the 
addition of iniprov d ill11slrations uncl . om " 
new opern tiv t chnology-notabl in the 
fields o l partial amputations of th e hand, im-
mediate posloperotiv fitting of prosth ses, 
anterior approa hes lo th spinal column for 
various disor ers, spinal d)'staphism and, last 
hut not I as t, instnun ntation for scoliosis. In 
regard to .~colir,sis, 110 m 11tion is made of 
Dw)'er's techniq ue fot· th • correction ()f spinal 
curvature doubtless be,·aus • tbe technique was 
p11hlished too recently to be included. 
nut despite these improv ments t·here m·e 
some glaring omissions. Sp c ificall)', H is frus-
trating to find that tota l rcplac menL arthro-
plas t)' of the hip is liismi.~s d as an xp ri-
men ta l proc dme. when ii ha n hicvecl such 
world-wid succ ss over sev ra l year ·. This 
i. particul. rly so when the hri f (.'Ollllll nt 
about it (one-half page) fo llows no less than 
42 pages on mould arthroph1sty, a procedur 
that many consid r of rath r 1· slric ted va lu . 
As the s ction on mould arlhroplnsty was 
writte1 by a gue l editor, wh)' was an 
au thoril.y on total liip r 11lacement not invil cl 
lo be a g11es t dito r too? Similarly, in th e sec-
tion 0 11 kn ee 11rthroplasty it is astonishing to 
find that the on ly t chnique describ t1 is 
fasdal arthroplas ly. Smel)' most l't!lllr s ha ve 
replaced this with the much m re us ful Ma • 
l.11 tosh tibial-plateau prosthesis? furth rmor , 
ther is no men tion whatsoe ' r of Swanson's 
Silnslic joint replacements. 
I11 th sections on nerv i11jLn"ies, no m n-
tion is made of fascicular suture; 011 • ques-
tions th , value of th section on joint den rvn-
tion, u procedu re most c ntre. have found lo 
be of little permanent value. 
Finally, th book s11ffcrs from the inclusion 
of too much d etailed description of historic-
a lly important but 110w oulmodec.1 procedures. 
For exmnpl , does anyone nowadays use 
lbe 's or llibh' t chniques f r spina l fusio11 
as they were clescrih d in 19 l l ? Perhaps th 
d itots sho11ld have pr faced ea h sccti n with 
11 histori('n) paragraph i11 whi h aha11done<l but 
n vertheless d assic prOC'etl ures are summarized 
(, ith ref r ' nee.~ lo th litern tur ) rn thc r than 
giving d tai l <l de.~c:riptions of the opera tivp 
t c hniqu · . 1n makinv; these critici sms, one 
r cognizes with respect the enormous task the 
editor.~ undertake in sift ing \ hat is II w u11d 
, alunble :111d discarding what is history. 
Despit Hs astronornienl price {$83 .. 50 ) tlw 
11 wl)' tra ined orthopedic surg on or resid 111 
ca nnot nfford lo do without this 11 ew edition 
of "C(1111pb ll's". However, those who ow11 th 
our th dHio11 might compare it ca r r t11l )1 with 
th 11ew firth •<lilio11 hc for · d<- ·id ing to r -
place it. 
(C<> 11l/1111cd 1111 J\ d . 1wge 2.J.) 
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The third edition of this well-known book 
maintains the extremely high standard set by 
previous editions. This edition incorporates | 
much new material and many sections have 
been entirely rewritten. This has been done 
without deleting much of the original content 
of the book. A review of the expanding field | 
of experimental oncogenesis of the nervous 
system has been included. The contributions 
of electron microscopy have been incorporated. | 
The text also includes a chapter on tissue J 
culture of tumours of the nervous system by 
Professor C. E. Lumsden. The entire text is 
completely up to date. The book maintains its | 
place as the leading exposition on the path­
ology of nervous system tumours.
TEXTBOOK OF DISORDERS AND INJURIES 
OF THE MUSCULOSKELETAL SYSTEM. An [ 
Introduction to Orthopaedics, Rheumatology, 
Metabolic Bone Disease, Rehabilitation and 
Fractures. Robert Bruce Salter. 551 pp. Illust. 
The Williams & Wilkins Company, Baltimore; 
Burns & MacEachern Limited, Toronto, 1970. 
$21.75.
This book is clearly written and well illus­
trated. It is, as the author states, a textbook 
written for undergraduate students. The organ­
ization is excellent and gives a good introduc­
tion to the subjects in the text. This is an ( 
excellent book for the undergraduate medical 
student who desires a short description of | 
virtually all orthopedic disorders and most 
common injuries. It will be difficult, however, 
for the undergraduate to read and absorb all 
the material during his rotation on the ortho­
pedic service as a clinical clerk. It is written 
in a manner that would be easily understood 
in the early years of a medical course and the 
book would be satisfactory to retain for later 
use in a general practice office.
For postgraduate students this reviewer 
would recommend the book highly as an intro­
duction to a course of studies in the musculo­
skeletal system because it is a well-organized 
relatively complete introduction to the entire 
field. Of particular value is the classification 
of large subjects. Because the descriptions of 
the disease entities for the most part are brief, 
it is inadequate as a resident’s reference book 
for details of a disorder or in the management 
of injuries in detail. The author, however, has 
stated this to be the case and has not intended 
it to be a reference book.
This textbook is recommended to medical 
undergraduate students and. in addition, to 
any student in the field of musculoskeletal 
medicine and surgery. Those engaged in the 
teaching of orthopedics would be well ad­
vised to purchase the book and read it for it 
should help them to be better teachers. 
Finally, the book is good value for the price 
of $21.75.
w h e n  laxa t ives  a re  u n w is e
SURFAK
Surfak is a safe, effective fecal 
softener which prevents the for­
mation of hard, dry stools thus 
reducing pain and discomfort, 
undue straining and irritation. 
Surfak is not a laxative. . .  it 
acts solely to permit normal bowel 
function by preventing the for­
mation of hard, dry stools. 
Composition: Each capsule con­
tains 50 mg. or 240 mg. of dioctyl 
calcium sulfosuccinate. Indica­
tions; Prevention and treatment 
of constipation, especially in he­
morrhoids, anal fissures, geriatrics, 
pediatrics, immobilized patients, 
pregnancy, following anorectal 
surgery, ulcerative colitis, divert­
iculitis, and to avert straining after 
abdominal surgery, in cardiac 
patients and hypertensive patients. 
Contraindications: None known. 
Precautions; None known. Ad­
verse effects: Mild, transitory
cramping pains may rarely occur. 
Dosage: Usual adult dose is 240 
mg. daily; .children and adults with 
minimal needs, 50 to 1 50 mg. daily. 
Supply: Red, soft gelatin 240 mg. 
capsules in bottles of 100; orange, 
soft gelatin 50 mg. capsules in 
bottles of 100.
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Books are acknowledged as received, but 
in some cases reviews will also be made 
in later issues.
Atlas of Ear Surgery. 2nd ed. William H.
Saunders and Michael M. Paparella. 390 pp. 
Illust. The C. V. Mosby Company, St. Louis, 
1971. $33.60.
Chest Injuries. Physiologic Principles and Emer­
gency Management. Emil A. Naclerio. 383 pp. 
Illust. Grune & Stratton, Inc., New York, 19/1. 
$28.50.
Congenital Absence of the Ear. Eric W. Peet. 
39 pp. Illust. E. & S. Livingstone Ltd., Edin­
burgh; Longman Canada Limited, Toronto, 1971. 
$7.25.
Fettstoffwechselstorungen. Ihre Erkennung und 
Behandlung. Edited by Gotthard Schettler. 184 
pp. Illust. Intercontinental Medical Book Corp., 
New York; Georg Thieme Verlag, Stuttgart, 1971. 
DM 24,00. $7.00 (approx.). Paperbound.
Gastrointestinal Motility. International Sym- 
posion on Motility of the GI-Tract, Erlangen, 
July 15th and 16th, 1969. Edited by Ludwig 
Demling and Rudolf Ottenjann. Georg Thieme 
Verlag, Stuttgart; Academic Press Inc., New York, 
1971. $7.50.
Kurze HNO-Operationslehre fur Arzte und 
Studierende. Band 1: Operative Eingriffe an Nase, 
Nasen- und Mundrachen, Hypopharynx, Kehlkopf 
und ausserem Hals. Gerhard Theissing. 308 pp. 
Illust. Intercontinental Medical Book Corp., New 
York; Georg Thieme Verlag, Stuttgart, 1971. DM 
49,00. $14.30 (approx.). Paperbound.
Lungenmykosen. Vortrage der Fruhjahrstagung 
der Rheinisch-Westfalisehen Vereinigung fiir 
Tuberkulose- und Lungenheilkunde am 14. Marz 
1970 in Diisseldorf. Edited by Hans Bartsch. 64 
pp. Illust. Intercontinental Medical Book Corp., 
New York; George Thieme Verlag, Stuttgart, 
1971. DM 22,00. $6.40 (approx.). Paperbound.
Nephron Failure. Conservation. Substitution. 
Replacement. John B. Dossetor and M. Henry 
Gault. 303 pp. Illust. Charles C Thomas, Pub­
lisher, Springfield, 111.; McGraw-Hill Company of 
Canada, Toronto, 1971. $23.75.
Orthopadische Therapie. George Chapchal and 
Detlev Waigand. 533 pp. Illust. Intercontinental 
Medical Book Corp., New York; Georg Thieme 
Verlag, Stuttgart, 1971. DM 98,00. $28.65 (ap­
prox.).
Peptic Ulcer. Edited by Carl J. Pfeiffer. 356 
pp. Illust. Munksgaard, Copenhagen, 1971. Dan. 
Kr. 50.00. $7.20 (approx.). Paperbound.
Plastic Surgery in Infancy and Childhood.
Edited by John Clark Mustarde. 581 pp. Illust.
E. & S. Livingstone, Ltd., Edinburgh; Longman 
Canada Limited, Toronto, 1971. $25.25.
Review of Medical Physiology. 5th ed. William
F. Ganong. 573 pp. Illust. Lange Medical Pub­
lications, Los Altos, California, 1971. $8.50. 
Paperbound.
Rontgendiagnostik des Schiidels. W. Loepp and 
R. Lorenz. 2nd ed. Edited by R. Lorenz. 397 pp. 
Illust. Intercontinental Medical Book Corp., New 
York; Georg Thieme Verlag, Stuttgart, 1971. DM 
158,00. $45.50 (approx.).
The Structure and Support of Contemporary 
Residency Programs in Surgery. Transactions of 
the 13th Annual Meeting of the Allen O. Whipple 
Surgical Society. Edited by Harold G. Barker. 
290 pp. Charles C Thomas, Publisher, Springfield, 
111.; McGraw-Hill Company of Canada, Toronto, 
1971. $15.00.
The Surgical Control of Behavior. A Sym­
posium. Edited by Arthur Winter. 90 pp. Illust. 
Charles C Thomas, Publisher, Springfield, 111.; 
McGraw-Hill Company of Canada, Toronto, 1971. 
$9.50.
Transplantation Today. Proceedings of the Third 
International Congress of the Transplantation 
Society, September 7-11, 1970, The Hague, The 
Netherlands. Edited by Hans Balner, D. W. van 
Bekkurn and Felix T. Rapaport. 978 pp. Illust. 
Grune & Stratton, Inc., New York; Longman 
Canada Limited, Toronto, 1971. $28.75.
SIMULTANEOUS PROSTATECTOMY AND IN­
GUINAL HERNIORRAPHY. Sidney R. Wein­
berg, Albert Kovetz and Stephen M. Lazarus. 
51 pp. Illust. Charles C Thomas, Publisher, 
Springfield, 111.; McGraw-Hill Company of 
Canada, Toronto, 1971. $8.00.
This short monograph is written by a urologist 
for urologists. It will make little impact on the 
general surgeon because it is most unlikely 
that he will be persuaded to refer his patients 
to a urological colleague for the combined 
procedure of prostatectomy and inguinal 
herniorrhaphy, nor will combine with him in 
a procedure in which he performs the hernior­
rhaphy. The surgeon will be largely influenced 
in these opinions by the recurrence rate of 
12% quoted by the authors in the combined 
procedure. Equally he is unlikely to agree 
with the figures quoted by the authors for the 
recurrence rates of both indirect and direct 
inguinal herniorrhaphy alone. In both groups 
much lower figures are now regarded as ac­
ceptable. Nor is he likely to agree that separat­
ing the operations carries with it increased 
operative risks sufficient to warrant adoption 
of the simultaneous combined procedure. On 
the contrary, after a study of the results, the 
general surgeon is more likely to persuade his 
urological colleague that he is better advised 
to confine his activities to the prostatectomy 
alone.
These impressions are confirmed by the gen­
eral balance of the book. It is strongly 
orientated to the problems of prostatectomy 
while the section dealing with inguinal herni­
orrhaphy is indifferent.
